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SUMMARY
This research project was designed to investigate
the nature of the speech disorders consequent upon lesions
of the basal ganglia. For many years it was assumed that
the speech disorders associated with basal ganglia damage
were no more than a manifestation of underlying rigidity.
However, experience has shown that surgery which successfully
ameliorates the rigidity in no way lessens the speech
disturbance of patients with Parkinson's disease. Indeed,
in some studies, there are reports of speech disturbances
being induced by the operation.
From the literature, it seems that there is a strong
case for the assumption that the speech disturbances are
due not to rigidity, but to akinesia. This project was
designed to test this hypothesis.
The background literature upon which the hypothesis
is based is reviewed in the first four chapters of this
thesis. Chapter 5 describes the experimental design
(in which dopamine - an amine implicated in akinesia was
used as an experimental variable); the experimental
group (a series of patients with either paralysis agitans
or post-encephalitic Parkinsonism. The group included
some patients who had previously undergone stereotactic
surgery);and the tests and tasks set the subjects.
The results of the investigation are presented in
Chapter 6 to 9. These results are evaluated in Chapter
10. In brief, it may be said that the results vindicate
the hypothesis of the investigation. This chapter also
includes a consideration of the clinical and theoretical
implications of the findings.
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INTRODUCTION
It is only in the past decade that the nuclei of grey
matter situated deep within the cerebral hemispheresthe
'basal ganglia', have become amenable to serious
investigation. Before the advent of stereotactic surgery,
and before the important, recent, developments in
biochemistry of the brain, the function of these ganglia
could be postulated only on the basis of clinical
observation.
Lesions of the basal ganglia dramatically disturb
motor function and in the past it was to this aspect that
attention was directed. However, lesions of the basal
ganglia also disturb speech. Patients with Parkinson's
disease or with Wilson's disease, or with diseases which
fall within the category of 'hyperkinetic' motor
disturbances (such as athetosis) frequently exhibit
disordered speech.
It is tempting to dismiss these speech disturbances
as being no more than a special case of the more general
motor disturbance. But the relationship between speech
and motor disturbance is not really so simple or clear
cut. The one disturbance may be exhibited in the absence
of the other. When they do occur together, medication
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"has often improved gross motor functions but has not
usually been effective in improving speech" (Cariter, 1961).
Stereotactic surgery, too, has a differential effect. It
alleviates, often spectacularly, tremor and rigidity, but
all too frequently it has the unfortunate side-effect of
exacerbating existing speech disorders, and, in some
cases with previously unimpaired speech, of inducing not
only the speech but also language disturbances (see, for
example, Cooper, 1961; Allan et a!,, 1966; and Hermann
et al., 1966).
The nature of the relationship between speech and the
basal ganglia is not readily apparent. Hughlings Jackson
(1866) touched briefly on the subject and provided a simple
rule-of-thumb: "I think it will be found that the nearer
the disease is to the corpus striatum, the more likely is
the defect of articulation to be the striking thing, and
the farther off, the more likely it is to be one of the
mistakes of words". The French neurologist Pierre Marie
considered the subject to be far more complex than other
neurologists of the time would concede. For Marie language
and speech could not so readily be considered discrete;
their area of overlap was well demonstrated in that
disorder referred to by a variety of names - 'Broca's
aphasia', 'motor aphasia', 'cortical dysarthria', or, in
Marie's own terminology, 'anarthria'. Working from the
premise that the basal ganglia are part of the effector
mechanism whereby 'language' is manifest as 'speech',
Marie insisted that damage to subcortical structures had
2
a more serious effect on communication skills than the
mere production of "simple dysarthria". (See Chapter 4
for a full discussion of these theories).
Unfortunately, differences of opinion as to the
nature of the role played by subcortical mechanisms in
communication are not solely a philosophical problem. As
the recent experience of serious impairment to communi¬
cation resulting from stereotactically-induced pallidal
and thalamic lesions has proved, both from a clinical and
from a theoretical standpoint, the question of speech
disorders and lesions of the basal ganglia can no longer
be ignored.
The experimental work reported in this thesis is
based on a group of patients with either Parkinson's
disease or post-encephalitic Parkinsonism. This group of
patients were selected for a number of reasons. The
Parkinsonian syndrome is today considered "the most
characteristic or most representative" of diseases
involving lesions of the basal ganglia (DeJong, 1 967); it
is also one of the more common subcortical diseases. A
new approach to the treatment of Parkinsonism, based on
recent advances in biochemistry, promises the possibility
of being able for the first time to ameliorate not only
gross motor, but also speech disturbances.
3
CHAPTER 1
PARKINSON'S DISEASE AND THE PARKINSONIAN SYNDROME
HISTORY OF THE SYNDROME
Involuntary tremulous motion, with lessened
muscular power, in parts not in action and
even when supported; with a propensity to
bend the trunk forward, and to pass from
walking to a running pace: the senses and
intellect being uninjured.
James Parkinson, 1817.
In 1817, James Parkinson, a London physician,
published a slim monograph describing, for the first
time, a disease that had "not yet obtained a place in the
classification of nose 1ogists". In 1 955 , a bicentenary
volume of papers dealing with Parkinson's disease was
published. In it, Francis Walshe reflected on the value
and merit of Parkinson's work:
It was his discernment of the slow unfolding of a
constant pattern of symptoms that enabled Parkinson to
pick out the malady now commonly named after him from
the clinically undifferentiated mass of illness in which
tremor was a presenting symptom; and though succeeding
generations of nosographers have added further items of
the visible as well as of the palpable to the syndrome
thus so succinctly described, Parkinson's account remains
remarkable for what it contained and for its clarity and
conciseness.
Parkinson referred to his disease by two names,
'shaking palsy' and paralysis agitans'. The latter
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seems to have gained almost instant popularity (see, for
example, Cooke, 1823). Today the term 'paralysis agitans'
and the eponym, 'Parkinson's disease', introduced by
Charcot, are used interchangeably.
The monograph, An Essay on the Shaking Patsy3 began
with the now-famous clinical definition quoted above. As
Parkinson so clearly stated, the disease is essentially
one involving motor dysfunction. It is characterized by
a 'triad' of motor symptoms: rigidity, tremor, and loss
of associated and automatic movements (Souques, 1921).
It is a progressive disease, and affects adults in the
second half of life. The cause of the disease is still
unknown. Its incidence is large, with a prevalence of
approximately 1 in every 1,000 of the population. Apart
from vascular disease, Parkinson's disease and the
Parkinsonian syndrome may be considered the commonest
disabling disease of the nervous system.
Apart from this idiopathic form described by
Parkinson, there are several 'secondary' forms of the
disease. The first of these forms to be described in
medical literature emerged during the last years of the
First World War, in a series of epidemics.
Von Economo, in May 1917, published a report on an
epidemic in Vienna of what he termed 'encephalitis
lethargica'. The epidemic, however, was also much in
evidence throughout France (Cruchet et al., 1917), and
Britain. By the 1 920's, it was found in other parts of
Europe (the Netherlands, Germany, Warsaw, Italy, Sweden,
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the Ukraine and Switzerland) and in other parts of the
world (Algiers and South Africa, North America, India,
the Phillippines, and Guatemala) (Hall, 1924). Although
the disease itself was not new, these epidemics differed
sufficiently from previous outbreaks of encephalitis to
prompt Arthur Hall, and other neurologists, to conclude
that this particular epidemic was "something sui
generis". Not only.did the extent and severity of this
particular outbreak of encephalitis set it apart from
previous epidemics, but the 'residua' evident either
immediately, or some time, after the acute phase of the
disease had passed, had new and unprecedented aspects.
As Hall explained :
Epidemic encephalitis has established itself as a
separate disease chiefly by the number and the
peculiarity of its later manifestations. "By their
fruits ye shall know them" is indeed applicable to this
dis ease.
Of the late manifestations or residua, perhaps the
most frequent and certainly the most unexpected, is that
strange clinical picture the resemblance of which to
paralysis agitans of advanced years is in some respects
so close. To this ' post-encephalitic' group of symptoms
the term 'Parkinsonian syndrome' or 'Parkinsonism' has
been given by the French School.
In one of the earlier surveys, it was estimated that
25% of 'fully developed' cases of epidemic encephalitis
had as a consequence some form of Parkinsonism. However,
by 1922, Goldflam said of the epidemic at Warsaw in 1920,
"We may almost speak of an epidemic of paralysis
agitans". Hall (1924) concurred: his figures suggested
that, if not all, then an extremely large proportion of
the 'fully developed' cases who survived exhibited
Parkinsonian residua. As is to be expected, since
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encephalitis is not restricted to any particular
age-group, post-encepha1itic Parkinsonism, unlike
paralysis agitans, is found across an extremely large
age-range of patients.
In 1929, Critchley argued the case for yet another
'secondary' form of Parkinsonism - arteriosclerotic
Parkinsonism. In his article he admitted that a
definition of this syndrome was not possible, but he
listed the points of clinical distinction between
arteriosclerotic Parkinsonism and Parkinson's disease.
He paid particular attention to the pathological changes
that distinguish the two, and which are revealed on post
mortem. It is only on the basis of post mortem
examination that an unequivocal diagnosis of
arteriosclerotic Parkinsonism can be made. A provisional
diagnosis on history and symptomatology, however, may
sometimes be made. Symptoms of arteriosclerotic
Parkinsonism usually appear after the age of sixty;
tremor is mild or absent and often.the patient shows
psychological signs of organic brain disease not commonly
associated with idiopathic or post-encephalitic
Pa rkins onism.
'Secondary', or 'symptomatic' Parkinsonism has also
been attributed, but far more rarely, to toxic substances
(such as manganese, carbon monoxide), to biochemically
active substances (such as reserpine, chlorpromazine),
and to trauma (usually repeated minor forms, such as
boxing). It may also, occasionally, be associated with
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degenerative neurological disorders of unknown aetiology
(such as Creutzfeldt-Jakob disease) and with others (such
as syphilis). The association between Creutzfe1dt-Jakob
disease and Parkinson's disease is particularly-
interesting in the light of a recent report that
Creutzfe1dt-Jakob disease is transmittable to a lower
species, such as the chimpanzee (Mathews et al., 1969).
This indicates that Creutzfeldt-Jakob disease is one of
the 'slow virus' diseases, and since it is (occasionally)
associated with Parkinson's disease, there is some
ground for the question: Is Parkinson's disease itself
not one of the 'slow virus' diseases?
It is debatable whether or not paralysis agitans
and the various "secondary" forms of Parkinsonism are
indeed one syndrome. Houston Merritt (1954) believed
"the symptom-complex identified by Parkinson stems from
a variety of causes", and Critchley (1929) extended this
proposition, claiming that the features which make up the
Parkinsonian syndrome may have many different pathological
causes but that the site of the pathology is always the
same. Juxtaposing GowerlVs) view (1910) on this topic
highlights one of the aspects to be explained by
advocates of such a nul 1-hypothesis: "It is curious that
the poisons which cause tremor do not cause paralysis
agitans".
Walshe (1955), on the other hand, was adamant in his
opposition to the 'one-syndrome' approach. He firmly
believed "that Parkinson's shaking palsy is not precisely
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the same sequence of events, or at any given time the
same picture, as that presented by what we call post¬
encephalitic Parkinsonism. Still more clearly does it
differ from the so-called arteriosclerotic Parkinsonism".
Furthermore, he maintained: "To ignore these differences
in the interests of what is a false simplicity is not to
make useful generalizations, but to blur the fine points
of clinical discrimination and to regress to a lower
level of observational precision".
The experimental work reported herein is based on an
acceptance of the premise that the various forms of
Parkinsonism are sufficiently different to warrant
treatment as entities in their own right. There is
growing evidence to support this. For example, post
mortem histological analysis shows qualitative
differences between paralysis agitans and post¬
encephalitic Parkinsonism (see Chapter 3); paralysis
agitans and the various 'secondary' forms of Parkinsonism
respond differently to medication. Even among the
smaller subset of 'secondary' Parkinsonian patients there
is no universal form of treatment - syphilitic
Parkinsonism responds (albeit occasionally) to
penicillin, and drug-induced Parkinsonism to withdrawal
of the offending substance.
Unfortunately, firm diagnosis of which type of
Parkinsonism a particular patient is suffering from is
not always easy. It is the patient with no significant
diagnostic facts in his medical history, presenting at
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an early age with Parkinsonian symptoms, who is difficult
to categorize. Walshe (1955), perhaps a trifle long-
windedly, explained the problem:
...for there can be no doubt that at this time the
diagnostician faced by an example of Parkinsonism makes
his choice between these two aetiologies: the post-
infective and the degenerative, not on the signs alone,
certainly not on the history which may be innocent of
aetiological pointers, but on the patient's age at onset
of the illness. If the patient be young, the tendency
is to label the syndrome as post-encephalitic almost as
a matter of course, despite the absence of any indication
of an attack of epidemic encephalitis in the past. This
view is based on the assumption - not justified - that
juvenile or early adult paralysis agitans does not occur,
or at least is so rare as not to demand consideration.
My impression is that amongst the cases of the pure
paralysis agitans syndrome, as I shall call it, that I
have seen of late years, there is a larger proportion of
patients in whom the onset dates from the thirties and
the forties of life than was formerly the case.
Used as we are to thinking of paralysis agitans as
a degenerative or involutional disease, we tend without
due grounds to regard these younger cases as post¬
encephalitic in origin: not considering that over the
years the picture of disease and its age incidence may
show changes that do not call for the invoking of new
and special aetiologies.
It may be that in our time paralysis agitans is
showing a tendency to earlier appearance, and if this be
a speculation as yet unproved, it is surely not more so
than the bland general assumption that all cases of the
paralysis agitans syndrome developing in early life or
early adult life are encephalitic in origin.
In the categorization of patients in this
investigation, the bias has been to diagnose as post¬
encephalitic only those patients with the characteristic
history and compatible clinical picture. When this was
in doubt, patients were considered to be of the paralysis
agitans type. The speech of paralysis agitans patients
is generally considered, on clinical evidence, to be less
disturbed than the speech of post-encepha1itic patients.
Weighting the design of the investigation against this
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popular belief was considered to be no disadvantage.
Identifying the arteriosclerotic patient is , however, a
somewhat different and difficult task, for arterio¬
sclerotic changes are part of the normal ageing process.
The clinical distinction between an idiopathic and an
arteriosclerotic aetiology is frequently doubtful and
made upon the basis of probabilities rather than any
distinctive clinical features. Although for the purposes
of this investigation patients with any of the following
features were considered as arteriosclerotic (and
excluded), it is to be accepted that, given the present
state of the art, screening methods do produce a small
number of fa 1se-positives and false-negatives:
hypertension, retinal vascular changes, dementia,
'strokes', pseudobulbar palsy and bilateral pyramidal
signs.
CLINICAL FEATURES
Although Parkinsonism has an insidious onset, and
the disease is slowly progressive, a patient with even
mild Parkinsonism of short duration does present a
characteristic picture. His posture is one of slight
flexion of the neck and a round-shouldered stance; his
face is immobile and his skin may be rather less wrinkled
than would be expected for someone of his age and it may
be slightly seborrhoeic. His eyes may show slight
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widening, his blinking rate may be reduced, and there
usually is a distinct lack, or slowness, of the normal
play of facial expression during conversation.
A reduction of associated movements is particularly
characteristic in the early stages. The patient appears
wooden; gestures using the hands are minimal and, when
sitting in a chair, the patient is quite still, with
none of the normal small changes of posture over time.
The patient's walking may be slower, and his paces may
tend to be shuffled.
As the disease progresses, the intensity of the
symptoms and signs of Parkinsonism increases. The
symptom of primary interest here, that of disturbed
speech, is discussed fully in Chapter 4. The present
discussion is thus confined to the other major symptoms.
TREMOR
The Parkinsonian tremor typically begins in one
upper limb and later involves the lower limb on the same
side. The contralateral limbs may be similarly affected
after some time. The hand is the most affected, having
a 'pill-rolling' movement. Small muscles, according to
Wilson (1954), are particularly prone to show tremor,
thus the muscle groups of the lips, tongue and larynx
are frequently affected.
The rate of Parkinsonian tremor is between 4 and 8
oscillations a second. Brain (1954) believed the tremor
of paralysis agitans to be slower than that of post-
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encephalitic Parkinsonism. Tremor is typically present
in paralysis agitans. It is less common in post¬
encephalitic Parkinsonism, and rare in all other
varieties of 'secondary' Parkinsonism.
The tremor is evident when the affected limb is at
rest but it disappears during sleep. Some patients
notice moderate relief of mild tremor after drinking
alcohol but this is never as dramatic as the relief
alcohol produces in essential tremor. Conversely,
Parkinsonian tremor is adversely affected by increases
in intravenous adrenaline. Patients frequently report
an increased intensity of tremor associated with strong
emotional states. Noradrenaline, however, has no such
effect.
RIGIDITY
Rigidity is the second of the three cardinal features
of the disease. Rigidity, that is the resistance felt by
an examiner when a limb of the patrent is passively
moved, may classically be one of two types. The
resistance may either be constant throughout the range
of movement in whatever direction the examiner chooses
('lead pipe' rigidity) or it may have regular
fluctuations of resistance ('cogwheel' rigidity).
Rigidity is generally first evident in the more
proximal joints. It may be detectable in only one
movement of one joint and is usually more easily
demonstrable at the shoulder or elbow than in the
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fingers. Disturbance of the respiratory muscles can
often be demonstrated by a reduction in peak expiratory
flow rate.
AKINESIA
The third cardinal symptom of the disease, akinesia,
is difficult to define. Unlike tremor, its presence is
not self-evident, and unlike rigidity, it is not felt on
examination of the patient. Instead its presence is
inferred on observing that certain normal movements are
delayed, slow and 'weak', and others are reduced in
number or even absent. At its least powerful level,
'akinesia' may be considered an intervening variable to
account for reduction or loss of movements. However,
recent advances in biochemistry indicate that akinesia is
more than an extremely useful hypothetical construct;
akinesia is dependent upon and modifiable by certain
biochemical agents (see Chapter 3). De Ajuriaguerra
(1971) has suggested (but rejected,' for obvious reasons)
as a pragmatic, and simple, definition that "akinesia is
what L-dopa modifies".
Over the years, a variety of terms and descriptive
phrases have been used to refer to what is now called
'akinesia'. Parkinson described what he saw as a form
of paralysis, "palsy", of gradual onset, that was never
complete even in the advanced stages of the disease; it
was always evident as an extreme slowness of movement.
Souques (1921) who appears to be the first to have
14
referred to the 'triad' of Parkinsonian symptoms, wrote
about "a loss of associated and automatic movement".
Wilson (1925) originally used "akinesia" to describe
"poverty or economy of movement".
The clinical picture presented by patients with
marked akinesia, while being instantly recognizable,
may vary from individual to individual. In the early
stages, particularly where tremor is not the presenting
symptom and rigidity is not felt, the akinetic picture
is diagnostica1ly important. The mask-like facies, with
wide eyes, reduced blinking rate, slightly seborrhoeic,
smooth skin is often seen. The patients appear to change
facial expressions infrequently, and as Walshe (1955)
pointed out, extremely slowly: "The immobile face ...
can be made to show some natural play of expression: for
example, if the patient be adequately amused he can
smile again, though the movement of the smile is long
drawn out, and hangs upon the face, as it were, almost
like a posture".
Gait is frequently disturbed by akinesia. Parkinson
considered this to be pathognomonic, and the second1
cardinal feature of his disease. Patients may have
difficulty in starting to walk. Once started, they may
exhibit "a propensity ... to pass from walking to a
running pace" (Parkinson, 1817). Parkinson noticed a
similar disturbance to speech, i.e. uncontrolled
tremor was the first; rigidity was not recognized by
Parkinson
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hastening, and used the term "festi nati ori" to describe
both the speech and the gait disorder.
Movements of the upper limbs, either gestures in
conversation, or arm-swinging in walking, tend to be
minimal. Handwriting, and other tasks requiring a
similar high degree of dexterity and fine manipulation
are impaired. Patients frequently complain of 'weakness',
not a true muscular weakness such as an inability to lift
objects, but rather a weakness as after sustained
activity or effort; a myasthenic weakness. Furthermore
patients complain of 'slowing up1, and are very much
aware of how much longer than previously it takes them
to dress, wash or feed.
RESPIRATORY DISTURBANCES
Although Parkinson observed a patient who "fetched
the breath rather hard", only four studies to date have
considered the question of respiratory disturbance in
Parkinsonism; the first of these were carried out in
Germany by Schilling in 1925.
Schilling found that the rest breathing patterns
of his patients (all had Parkinson's disease of recent
onset) were markedly irregular, with long apneic periods
between respiratory cycles. Cramer, in 1941, reported
similar observations but on a group of six post¬
encephalitic Parkinsonian patients of long duration.
She found, in addition, that their breathing was shallow,
with little difference between the depth of quiet and
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forced respiration. All her patients had rapid breathing
rates, tremor of the respiratory muscles and seriously
reduced vital capacities.
A more recent study, Nugent et al. (1958), however,
failed to corroborate all of Cramer's findings. The
respiratory characteristics of nine Parkinsonian patients
who complained of dyspnoea on mild exertion were studied.
Five cases were found to have greatly reduced maximum
breathing capacities, but with only a mild reduction in
vital capacity. Nugent and associates firmly believed
that no "primary disease process other than the
neurological disorder itself" could account for this
respiratory insufficiency. However, although rigidity
and 'weakness' of the thoracic musculature were suggested
as possible causes, no definitive conclusions were
reached concerning the physiological dysfunctions
leading to the respiratory disturbances in these patients.
Two years later, in 1960, de la Torre and his
co-workers reported the results of pulmonary function
tests on twelve patients with various forms of
Parkinsonism. Their results confirm Nugent's findings,
and add an additional feature: the rest breathing
patterns of the patients revealed obvious abnormalities
of rate and depth. No correlation was found between
clinical judgements of severity of rigidity of the trunk
and the obtained respiratory measurements. The authors,
therefore, suggest "incoordination of the respiratory
musculature" might be responsible for both the
1 7
irregular rest breathing and the reduced maximum
breathing capacities.
MENTAL CHANGES
Parkinson was quite clear that in his disease "the
senses and intellect [are] unimpaired". Dillar and Riklan
(1956) empirically confirmed this, testing a large group
of Parkinsonian patients on the Wechsler-Bellevue Scale.
Nonetheless, they reported that a high percentage of
their patients had psychological disturbances. Five par
cent were diagnosed as schizophrenic; twenty-four per
cent were described as "severely disturbed"; twelve per
cent were shown to have organic brain syndromes, and
only fifty-nine per cent were considered to be 'normal'
with respect to psychological function. However, until
we have a clearer understanding of how psychological
functions are affected by a long, progressive illness,
and by the experience of increasing dependency on
others, it is perhaps rash and nai've to conclude that
mental changes are essential features of Parkinsonism.
As Noyes (1953) pointed out, in Parkinsonism, as in all
chronic diseases, increased dependence may of itself
create serious emotional problems. The suggestion by
Laszewski (1956) that paranoid traits tend to occur in
patients with severe tremor should, therefore, be
regarded with scepticism. MacDonald Critchley (1955) in
his introductory chapter to the bicentenary volume of
papers on Parkinson and his work made a valid observation;
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"Every physician knows that some of these Parkinsonian
patients contrive to continue in business, industry, or
in one of the trained professions, for a decade or more".
There are, in addition to the signs and symptoms
already mentioned, other less striking yet highly
characteristic symptoms of Parkinsonism. Blepharospasm,
or involuntary tonic closure of the eyes, occurs
particularly in post-encephalitic Parkinsonism. In
idiopathic Parkinsonism there frequently is impairment
of convergence. Excessive salivation is the most common
autonomic abnormality in all forms of the disease.
Seborrhoea, while common to all forms, is particularly
evident amongst the post-encephalitic group. Postural
hypotension is also seen, particularly in the akinetic
patients. In the post-encephalitic patients oculogyric
crises are evident.
HISTORY OF TREATMENT
In spite of Parkinson's caution "until we are better
informed respecting the nature of this disease the
employment of internal medicines is scarcely
warrantable", throughout the nineteenth century patients
were subjected to a great variety of purgatives, salts of
heavy metals, arsenic and alkaloids. Parkinson himself
recommended blood-letting from the upper part of the neck
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followed by "vesicatories to be applied to the same part".
Ordenstein (1867), a student of Charcot, observed that
belladonna alkaloids were beneficial, and for many years
it was held that the Bulgarian extract of belladonna was
superior to all others. Gowers (1910), although
recommending hyoscyamus as an efficacious treatment,
viewed the question of treatment with some despair:
"but of all the degenerative diseases of the nervous
system this is the least amenable to therapeutic agents
and least capable of arrest". Belladonna and hyoscine,
nevertheless, remained routine medication until 1945,
when the synthetic compounds used today became
available.
Of the synthetic anticholinergics, benzhexol ,
benztropine, procyclidine, ethopropazine, caramiphen
and methixene are commonly used. "None of these",
according to Mawdsley (1970), "is obviously better than
the others and each physician tends to have his own list
of favourites". Moreover,
The principles of dosage are common to all these
preparations. The drug is introduced in small amounts
and gradually increased to the limit of tolerance.
Dryness of the mouth and blurring of vision usually set
the upper limit of dosage. The object is to achieve
improvement without disabling side effects. If this be
not possible with one drug, another attempt, using a
different preparation, should be made. (Mawdsley, 1970)
Unfortunately, anticholinergic drugs have limited
efficacy. The very large number of different
preparations commercially available at present perhaps
reflects the fact that the therapeutic response to these
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drugs is often disappointing. It is the patient with
mild symptoms (particularly mild rigidity) who shows
greatest improvement with anticholinergic therapy.
However, as the disease progresses, the effectiveness
of all the anticholinergic preparations becomes less and
the toxic effects more troublesome.
Mawdsley (1970) pointed out that another group of
drugs, the antihistamines, have been used, and although
they, too, have limited effect and tend to induce side-
effects, thoughtful choice of treatment tnay turn these
to use: "Diphenhydramine is helpful, but produces
drowsiness, but sometimes this is helpful if the patient
is already suffering from restlessness and excitement
induced by an anticholinergic drug. Orphenadrine has the
advantage of a euphoriant effect".
In the search for either an adjunct to enhance the
somewhat limited benefits of, or as a more efficacious
alternative to, medical treatment, many viewed surgery
with what now in hindsight appears to have been
unjustified hope. The fortuitous discovery by Cooper
(1954) is well known: he ligated the anterior choroidal
artery and hence damaged the medial globus pallidus, the
ansa 1enticularis, red nucleus and substantia nigra, and
this produced dramatic improvement of tremor and
rigidity.
Two years later, Cooper published (1956a; 1956b)
detailed reports of clinical success through the use of
surgical procedures aimed at destruction of the intact
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grey matter of the globus pallidus and found that of the
two procedures he had used, chemopa11idectomy was more
successful than anterior choroidal occlusion. Cooper's
work received world-wide attention, and soon different
neurosurgeons had perfected a variety of techniques
(from the use of heat to high-frequency sound waves) for
inducing subcortical lesions, with varying degrees of
success. In 1969, at the Third Symposium on Parkinson's
Disease3 Gillingham, in his "Introduction to Scientific
Sessions", claimed:
By 1963 increased precision of stereotactic surgery had
made bilateral lesions safer. This was an important
step forward for bilateral parkinsonism has always been
the hard core of the problem. Another five years of
follow-up since the last Symposium have allowed surgeons
to look more closely at the long-term effect of well-
placed bilateral surgical lesions on the progress of
parkinsonism. We are of course vulnerable in respect
of measurement of the speed of deterioration before and
after operation. This is a difficult problem but there
is no longer any serious doubt, if we study patterns of
daily activity before operation and during follow-up of
10 years or more, that in an increasing number of
patients the progress of the disease appears to have
been greatly slowed down or even halted. 1
There are, however, those who'do not subscribe to
Gillingham's belief. The literature clearly does not
bear it out (see Chapter 4 for a review of literature
on this point, with particular reference to side-effects
on speech); neither do the large number of post¬
operative patients who still return to Parkinsonian
clinics and who are now on medical treatment (22 such
patients are included in the present study). Indeed, the
xwriter's own ita 1ics
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pessimism with which Schlesinger viewed the topic of
stereotactic surgery as early as 1954, appears to reflect
a more accurate evaluation of the efficacy of the
technique:
Surgery directed at the disturbed physiologic
mechanisms of Parkinson's syndrome has produced much
more in the way of laboratory insights than in clinical
relief. No single operative approach to date has become
a standard therapeutic tool. However, certain facts
have been derived from the sum of various procedures.
Chief among these is that rigidity responds poorly, even
in proportion to the generally imperfect effect upon
tremor.... The second conclusion to be drawn from
surgical experience is that the efficiency of effect upon
tremor, with notable exception, seems to be directly




FUNCTIONAL ANATOMY OF THE BASAL GANGLIA
Embedded in the white substance of each cerebral
hemisphere are several bodies of grey matter. These were
identified and described long ago. In 1543, Vesalius
produced excellent woodcuts of various sections through
the hemispheres to illustrate the shape and spatial
relationship of these masses. They develop from the
ectoderm layer of the primitive neural tube which bends
over itself. Histologically, they are composed of
motor-type (multipolar) cells. The functions subserved
by these masses are not yet fully understood. Since they
lie deep within the hemispheres, these structures are
difficult to investigate by experimental methods. Until
recently it had been almost impossible to place a lesion
in one grey mass without inflicting damage on others, on
adjacent fibre tracts, and, often, on superficial cortical
structures as well (Brodal, 1959). The introduction of
stereotactica1ly produced lesions, mere precise in
localisation and more restricted in size than those of
previous methods, and the use of silver impregnation for
the tracing of connecting fibres, have made these grey
bodies and their interconnections amenable to study.
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Pathological changes in these bodies of grey matter
have been observed in Parkinsonism. This chapter is
intended to serve as a background to Chapter 3 which
consists of a discussion of some current concepts of
pathology in Parkinsonism. This chapter describes the
parts concerned, their interconnections, and their
biochemis try.
TERMINOLOGY
A confusing system of terms has developed for these
areas of the brain. As Brodal (1969) explained:
In the course of time the term "basal ganglia" has
carried different connotations. The old anatomists used
it as a common denominator for all the large nuclei in
the interior of the brain, including the thalamus. When
the development of the brain became better known, the
thalamus was excluded, while for instance, the
amygadloid nucleus was included. There is still no
generally accepted definition of what one should include
in the concept "basal ganglia" although all authors
consider the caudate nucleus and the lentiform nucleus
with its two divisions, the putamen, and the globus
pallid us, as representing the main mass. The claustrum
is usually included, while the amygdaloid nucleus, on
account of its largely different connecti or.s , and functions,
is often excluded. It is common to consider the
subthalamic nucleus and the substantia nigra in
conjunction with the basal ganglia... The term striate
body or corpus striatum is often used as almost
synonymous with the basal ganglia and covers the
claustrum, caudate, putamen, and globus pallidus. The
name refers to the appearance in mye1in-sheath-stained
sections, where a number of myelinated fibre bundles
traverse the cellular masses and give them a striated
appearance.
To avoid confusion, in this and subsequent chapters,
the terms 'basal ganglia' and 'basal nuclei' will be used
interchangeably to comprise the striatum (caudate nucleus
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+ putamen), pallidum, subthalamic nucleus, red nucleus,
and substantia nigra. The term 'subcortical structures',
is used as a usefully loose term which permits inclusion
of the thalamus within its scope of reference.
THE SUBCORTICAL STRUCTURES
THE CORPUS STRIATUM
The corpus striatum consists of three nuclei - the
caudate, the putamen and the globus pallidus. The last
two, the putamen and globus pallidus, are frequently
referred to as the 'lentiform nucleus' though they are
phylogenetically and histologically dissimilar. These
structures are illustrated in FIGURE 1.
The caudate nucleus is an elongated c-shaped mass,
so positioned that the lateral ventricle may be seen to
curl around it. Its cephalic end (the head) is distended
and bulges into the anterior horn of the lateral ventricle.
Its body passes backwards, lateral to the thalamus and
separated from it by the internal capsule, and tapers
gradually around to form its tail. The tail of the
caudate curves around into the roof of the inferior horn
of the lateral ventricle, and extends rostrally as far as
the amygdaloid^nucleus. Within the curve described by
the caudate lies the 'lentiform', comprising two other
nuclei of the corpus striatum - the putamen and the
globus pallidus (or pallidum).
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DIAGRAMS TO ILLUSTRATE THE NEURO-ANATOMY OF THE BASAL GANGLIA
centra! sulcus anterior limb
a. The corpus striatum
viewed from its lateral aspect
to show the relationship
with the internal capsule and
its position in the brain.
b. Posterior view of the
basal ganglia.
c. A coronal section through
the cerebral hemisphere to




















The putamerij the larger and more laterally situated
of the two nuclei, is separated from the pallidum by the
external medullary lamina, from the claustrum by the
external capsule, and only partially from the caudate
nucleus by the internal capsule. Anterior to the
anterior limb of the internal capsule the putamen and
caudate are joined together by bands of grey matter. As
Ranson and Clark pointed out (1959), it is now customary
to group the caudate nucleus together with the putamen
as the 'striatum' (as opposed to the 'corpus striatum').
Histologically the two nuclei are similar, and,
furthermore, they have the same phylogenetic development
(together they constitute the 'neostriatum').
The pallidum, on the other hand, is a smaller, more
medially situated nucleus, which differs from the
striatum both histologically and phy1ogenetically . It is
the oldest of the grey bodies (hence 'palaeostriatum' ),
and consists of multipolar cells and many myelinated
fibres. It is the preponderance of these myelinated
fibres that gives the pallidum its pale appearance. The
pallidum is subdivided by the internal medullary lamina
into an anterior-1ateral and a posterior-medial portion.
The pallidum is separated from the caudate nucleus, lying
superior to it, and from the thalamus, medial to it, by
the internal capsule. Caudally, however, the pallidum is
continuous with the rostral area of the substantia nigra.
THE SUBTHALAMIC NUCLEUS
The subthalamic nucleus, often referred to as the
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'body of Luys' after the man who first identified it, is
situated in the basal part of the diencephalon. It is
roughly oval in shape, and both caudally and ventrally it
is continuous with the substantia nigra. It is
relatively large in man, is composed of medium sized
multipolar cells, and this is histologically similar to
both the pallidum and substantia nigra.
THE SUBSTANTIA NIGRA
The substantia nigra is particularly well developed
in man. It can be seen with the naked eye as a thick,
darkly coloured strip. Situated in the cerebal peduncle
of each side of the mid-line, it extends from the sub¬
thalamic region down in the mid-brain. The substantia
nigra is composed of two sections, the dorsal 'zona
compacta' and the ventral 'zona reticularis'. Its dark
appearance is due to the abundance of melanin dispersed
in the cytoplasm of its cells, particularly in the zona
compacta. Histologically the substantia nigra resembles
the two nuclei with which it is in close anatomical
connection, the pallidum and the subthalamic nucleus.
THE RED NUCLEUS
The red nucleus is situated within the upper part
of the substance of the mid-brain, at the level of the
superior colliculi. It comprises two distinct grey




The thalamus is a large nuclear mass comprising the
dorsal portion of the diencephalon. It lies immediately
lateral to the third ventricle, and is bound laterally
by the internal capsule. The epithalamus lies above it,
the subthalamus below and behind, and the hypothalamus
below and in front of it. Internally, the thalamus is
divided into anterior, medial, lateral, ventral and
central nuclear groups. Each of these is further
subdivided according to their different connections.
CONNECTIONS OF THE SUBCORTEX
CORTICAL-SUBCORTICAL CONNECTIONS
Cortico-striatal Connections
It appears that all parts of the cerebral cortex
project fibres to the striatum (Glees, 1944; Mettler,
1945; Carman, Cowan and Powell, 1963; Webster, 1961,
1965). Furthermore, these projections are topologically
organized. Carman, Cowan, Powell and Webster (1965)
demonstrated that anterior cortical lesions result in
degeneration in anterior parts of the striatum, and
posterior cortical lesions cause degeneration in its
posterior parts. They also showed that most of this
cortico-striatal projection is ipsilateral. The only
area to have bilateral connections is the primary
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sensorimotor cortex. The contralateral connection is
established by fibres crossing in the corpus callosum.
Innervation reaches the caudal part of the head of the
caudate through the fasciculus subcallosus, and the
putamen through the external capsule .
Cortico-subthalamic Connect ions
Mettler (1945) established that (in the monkey)
efferent fibres connect Brodmann's area 6 with the
subthalamic nuclei. Subsequently, (again, in the monkey)
a connection was found between the prefrontal lobe and
the subthalamic nuclei (De Vito and Smith, 1954). Meyer
(1949) has presented evidence to suggest that these
fibres also exist in man. The fibres appear to end in the
cellular region rostral and dorsal to the subthalamic
nucleus, in the zona incerta.
Cortico-nigral Connections
In 1956 Rinvik found a tenuous cortico-nigral
connection in the cat. He felt that this apparent
contradiction of early findings of a more substantial
connection might be due to differences of experimental
technique. He suggested that when using the Marchi
method (as opposed to the Nauta and Gees methods) it is
easy to misidentify a set of fibres as ending in the
substantia nigra when in fact they merely pass through,
to end in the red nucleus and reticular formation.
The projection from the cortex is, according to
Rinvik, predominantly ipsilateral, descending through
the internal capsule and cerebral peduncle. It arises
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from the primary and secondary sensorimotor cortices,
supplementary motor area, and the gyrus pro reus (in the
cat this is in front of the primary sensorimotor area).
Rinvik's description, however, is substantially
different from that given by Jung and Hassler (1960).
They described a "major pathway of efferent fibres"
from the frontal cortex (areas 9 - 12) to the anterior
part of the substantia nigra, and a centralateral
projection from the cortical area 6 and from precentral,
parietal and temporal areas to the large cells of the
posterior part of the substantia nigra.
INTER-SU3C0RTICAL CONNECTIONS
The Striatum
The striatum receives fibres from the centrum
medianum of the thalamus. From the dorsal part of the
nucleus, larger cells project to the caudate, and, from
the ventral part, smaller cells project to the putamen
(Nauta and Whitlock, 1954; Powell -and Cowan, 1956). It
is suggested that the striatum receives another set of
fibres - the nigro-putamen pathway (Mettler, 1964;
Carpenter and McMasters, 1964).
The striatum itself projects fibres to at least three,
and probably four, different areas within the subcortex.
It sends most of its efferent fibres (via the strio-
patHdal connection) to its neighbouring pallidum.
These caudate ^pallidum and putamen+pal1idum connections
have been shown to exist in the cat (Johnson and Clemente,
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1959; Voneida, I960), and in the monkey (Szabo, 1962;
Nauta and Mehler, 1966). The most interesting finding,
however, was made by Cowan and Powell (1956). They
showed that the striatopa11ida 1 projection is
topologically organized: each part of the striatum sends
fibres to a circumscribed part of the pallidum. According
to Cowan and Powell, however, it is not possible to
differentiate between the two segments of the pallidum
on the basis of these striatopallidal projections. This
is in direct contradiction to the findings of Jung and
Hassler. According to them, the pallidum receives
afferent fibres (striopa11ida 1, and others) in only the
external segment; the internal segment receives afferent
fibres only from the external segment.
The strionigral connections are the second set of
efferents emerging from the striatum. The caudate nucleus
sends efferents - along the ventral surface of the
internal capsule - to the anterior part of the
substantia nigra. In addition, a small number of fibres
lead to the posterior part. The putamen sends its
efferents through the pallidum and peduncle to the large
cell groups of the posterior substantia nigra (Jung and
Hassler, 1960; Szabo, 1962).
The third set of efferents from the striatum lead
to 'restricted parts' of the inferior olive (Walberg,
1 956) .
Finally, there is a strong possibility that the




The major afferent projection to the pallidum, as
already described, comes from the striatum, (v.'hich in
turn receives afferents from all cortical areas), This
is a topologically organized connection. Thus, different
parts of the pallidum are influenced, via the striatum,
by specific regions of the cortex.
The efferent fibres leaving the pallidum are
numerous. Brodal (1969) has described them:
The efferent fibres from the pallidum form rather
massive bundles which were observed by the classical
neuro-anatomists and labelled by them.- Unfortunately,
there is much confusion in the literature concerning
nomenclature... Most authors describe a fairly compact
bundle, the ansa lentioularis, emerging from the ventral
aspect of the inner segment of the pallidum and turning
in a mediocaudal direction... A branch of the bundle,
taking a more dorsal course, is often referred to as the
fasciculus lenticular is3 Hz-bundle or dorsal division
of the ansa... This appears to arise more dorsally than
the ansa proper. A middle division of the ansa is
sometimes referred to as the subthalamic fasciculus3
passing to the nucleus of the same name.
The pallidum thus sends efferents to the thalamus,
to the substantia nigra, the subthalamic nucleus, the red
nucleus, the mesencephalic reticular formation, the
inferior olive, and the hypothalamus.
Nauta and Mehler (1966) confirmed the original
statement by Ranson, Ranson and Ranson (1941) that fibres
of the ansa originate only from the internal segment of
the pallidum. However, they found that fibres to the
subthalamic nucleus are an execption. These arise from
the external segment, and furthermore , they are
organized topologically . It is not yet known whether
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other efferent projections from the pallidum are
similarly organized.
The Suhtha1amic Nucleus
The subthalamic nucleus receives afferents
(topologically organized) from the cortex, from the
pallidum, and probably from the striatum. Some efferent
fibres pass through the fasciculus of Fore! to the
pallidum and the putamen, and others lead to the
thalamus. In addition, the subthalamus communicates
through the subthalamotegmental tract with the tegentum
of the mid-brain, and through the supramami11 ary
decussation of Forel, with the contralateral subthalamic
nucleus. Furthermore, it has been hypothesized that the
subthalamus has connections with the red nucleus and with
the substantia nigra (DeJong, 1967).
The Substantia Nigra
The corticonigral and strionigral afferent
connections have already been mentioned. In addition,
the substantia nigra receives afferents from the
tegmental nuclei, and possibly also from the red and
subthalamic nuclei (DeJong, 1967).
In its turn, the substantia nigra establishes
numerous sets of connections. It sends efferent fibres
to the superior colliculus, to reticular (mesencephalic)
formation, and to the red nucleus (Llamas and Reinoso-
Sudrez, 1959); it sends efferents to the thalamus, i.e.
to the ventrolateral , ventromedial and ventro-anterior
thalamic nuclei (Cole et al., 1964 ; Afifi and Kaelber,
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1 965 ; Carpenter and Strominger, 1 967; Llamas and
Reinoso-Suarez, 1969); it sends efferents to the
internal and external segments of the pallidum and to
the putamen (Ferraro, 1925, 1928; Llamas and Reinoso-
Suarez, 1969; but not shown in studies using silver
impregnation methods by Carpenter and McMasters, 1964;
Cole et al., 1964; Afifi and Kaelber, 1965; Carpenter
and Strominger, 1967); to the head of the caudate
nucleus (Llamas and Reinoso-Suarez, 1969 which is in
agreement with the physiological results of Frigyesi
and Purpura, 1967); and finally, to areas 4 and 6 of
the cerebral cortex (Llamas and Reinoso-Suarez, 1969;
confirming the description by von Monakow, 1822, 1895;
Molina, 1965; Llamas and Reinoso-Suarez, 1969; but
denied by Ferraro, 1925).
The Red Nucleus
The red nucleus which receives afferents from the
cortex (Poirier, 1971), from the substantia nigra (see
above) and from the pallidum, gives'off a complex system
of efferents (see FIGURE 2). The parvicellular area
gives rise to fibres which end in the ipsilateral
inferior olive (Poirier and Bouvier, 1966). From here, a
neural loop is elaborated to the contra 1atera1 cerebellar
cortex, then to the cerebellar nuclei, and, from there,
back again to (the now contralateral) red nucleus
(Poirier, 1971). (There are other parallel loops at this
level establishing contralateral connections - see
Poirier, 1971). Importantly, cortical connections are
i
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established with these nuclei - from the precentra] gyrus




The thalamus receives all the sensory pathways of
the central nervous system: somatosensory fibres in the
ventroposterior nucleus; auditory fibres (the lateral
lemniscus) in the medial geniculate body; optic fibres
in the lateral geniculate body; and finally, fibres from
the cerebellum, red nucleus and pallidum in the ventro¬
lateral nucleus. Together these four nuclei form the
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ventral complex of nuclei in the thalamus. They have two
important characteristics. Unlike the other five chief
thalamic nuclei groups, the ventral group receive their
total afferent input from nuclei lying outside the
thalamus, and they project all their efferents, somato-
topically organized, to the primary motor and sensory
areas of the cortex.
The intralaminar group of the thalamic nuclei (which
includes the centrum medianum) has rather complicated
connections. Afferents are from two sources - from
within the thalamus, from the other nuclei; and from
outside the thalamus, from the ascending reticular system.
Efferents are specific and diffuse. There are somato-
topically organized connections with the caudate and
putamen, and (probably via the thalamic reticular nucleus)
diffuse connections with the whole cortex.
The four other groups of thalamic nuclei receive
fibres from within the thalamus, and project in a
topologically organized manner to the cortex. The large
dorsomedial groups project to the frontal lobe; the
anterior group to the cingulate gyrus; the lateral
group together with the pulvinar project to the
association areas of the cortex in the parietal and
occipital lobes.
Thus, there are both specific and non-specific
thalamocortical connections. Bowsher (1962) emphasized
the importance of these connections to concepts of the
cerebral cortex:
Thus the whole telencephalon, except some of the
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neocortex of the temporal lobe, can be regarded as an
umbrella cover, whose hub is the thalamus and the spokes
of which are the specific point-to-point thalamo-
telencephalic projections... It can be seen from this
that the true definition of a functional cortical area
depends not upon the fortuitous folding of its surface
into sulci and gyri, not upon its cytoarchitecture
(though this is related), but upon its specific
projection from a particular thalamic nucleus. For
example, the primary and somatosensory cortex (roughly
defined as the postcentral gyrus) is, in precise terms,
only and entirely that area of cortex which receives its
specific projections from the ventroposterior nucleus of
the thalamus. Primary motor and sensory areas, as well
as the hypothalamic-rhinencephalic areas of the neocortex,
are easily understood as those cortical areas which
receive their specific projections from thalamic nuclei
whose afferents are extra-thai amic. The parieto-occipital
association areas, on the other hand, receive their
specific projections from thalamic nuclei whose afferents
are i ntrathal ami c (1 a tera 1 - p u 1 vi ria r group). Specific
thaiamo-cortical fibres may be seen to terminate in the
fourth layer of the cortex, where they are known as the
outer stripe of Baillarger.
SUBC0RTIC0-M0T0NEURONE CONNECTIONS
There are two descending connections arising from
the basal ganglia which together represent the final
pathway for motor impulses originating in the cortex, and
relayed through subcortical structures, to the motor
neurones of the spinal cord.
Major descending fibres arise in the magnocel1ular
division of the red nucles (see FIGURE 3). They cross to
the contralateral side (Poirier and Bouvier, 1966), and
most of the fibres descend in the spinal cord. Two other
groups of descending fibres, apparently of tegmental
origin, join the rubro-spinal fibres. According to
Poirier and Bouvier (1966) one group crosses the mid-line
(more rostrally in the ventral tegmental decussation than
39
do the rubro-spinal fibres) and send at least some fibres
to the spinal cord; ands according to Poirier et al .
(1969a), another group of tegmental fibres join the
rubro-spinal tract at the level of the superior olive.
It has not yet been established whence these fibres lead
(Poirier et al., 1969b).
As has previously been described, the red nucleus
and its surrounding tegmentum receive fibres from
(contralateral ) cerebellar nuclei, the (ipsi1ateral)





(ipsi1atera1 ) substantia nigra. This rich afferent input
has lead Poirier (1971) to suggest that "the rubro¬
spinal fibres and the accompanying descending tegmental
fascicles probably represent the most important extra-
peduncular pathways reaching the spinal cord from the
upper brain stem. They constitute the crossed rubro¬
spinal tract." Massion (1967) has shown the tract to be
somatotopically organized and to be involved in the
excitation of a-motor neurones and static to y-motor
neurones of flexor muscles.
The second major descending tract (see FIGURE 13 on
page 74) arises from the striatum and the pallidum. It
leads to the (ipsi1atera1 ) gigantocel1ular nucleus of the
medulla. From this medullary reticular nucleus, fibres
descend as the medial reticulospinal tract and end at the
alpha motor neurones of the spinal cord (Denny-Brown,
1969). The gigantocellular nucleus corresponds to the
'inhibitory area1 described by Magoun and col 1aborators
(Magoun and Rhines, 1946; Lindsay, Scnreiner and Magoun,
1949). Fibres also arise from pontine reticular nuclei
("facilitation area" of Rhines and Magoun, 1946; or,
more cumbersomely, "nucleus reticularis pontineoralis"
and "nucleus reticularis pontis caudalis", Brodal, 1969),
and descend to the spinal cord as part of the reticulo¬
spinal tract. According to Brodal (1969), the medullary
contribution consists of both crossed and uncrossed fibres;
the pontine contribution is uncrossed. There appears to




A complex system has been described whereby impulses
from the motor cortex (in particular) may impinge on the
motor neurones of the spinal cord and cranial nerve
nuclei. The system is conventionally referred to by the
unsatisfactory term (see Meyers,1953) 1extra-pyramidal1
to distinguish it from the direct corticospinal
('pyramidal') tract which passes from the motor cortex,
down through the internal capsule (in a somatotopi cal ly
organized manner), to the level of the medullary pyramids
where (the majority of) its fibres decussate across the
mid-line, and then descend in the lateral column of the
spinal cord to synapse onto the motor neurones there,
(see FIGURE 4)
The 'extra-pyrami da 1' system, in contrast, is a
highly complicated, multisynaptic, interconnected motor
system. It receives cortical afferents (via the cortico-
striatal, cortico-subthalamic, cortjco-rubral, cortico-
nigral and cortico-claustral connections). It returns
efferents to the cortex (via the diffuse centrum
medianum - cortical connection, the specific thalamo¬
cortical connection established by the ventral thalamic
nuclear group and the nigro-cortical connection to
cortical areas 4 and 6). It communicates with the motor
neurones of the spinal cord and cranial nerve nuclei
through two major tracts - the rubro-spinal and the
reticulospinal. Between the input and the output
42
is a system of interconnection loops; a network of
connections providing for sophisticated bilateral
sensorimotor feedback and modification of input,
(see FIGURE 5)
THE 'PYRAMIDAL' TRACT1







Central to our understanding of the function of the
subcortical nuclei, is an understanding of the synapse
and the chemical basis upon which the synapse depends.
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'Synapse', a term derived from the Greek for 'to clasp',
was introduced by Sherrington (1897). It refers to the
point where the axon terminal of one nerve cell comes into
functional contact with another nerve cell. Over the past
70-odd years, we have learnt much of the synapse; in the
beginning, however, progress was.slow, paced by the
limitation of technique and equipment.
By the turn of the century the light microscope was
already exploited to its limits of resolution and the
major stains, usually involving silver salts, had been
developed to reveal the nerve fibres and their synaptic
contacts. However, the limited resolution revealed
little specialized structure at the synapse other than
a bulbous expansion or, sometimes, a curious ring shaped
or tennis racket like structure at the axon terminal.
While such synaptic structures could be demonstrated
in lower centres of the nervous system, particularly in
the spinal cord which is directly concerned with muscle
control, reflexes and so on, the silver stains essential
for light microscopy failed entirely to reveal any such
synaptic bulbs or rings in the higher brain centres such
as the cerebral cortex. Many workers therefore regarded
the cortex as a highly specialized part of the nervous
system where the nerve cells reacted with one another in
some complex manner that did not involve the sort of
synaptic contacts found in the lower centres. Another
enigma was the presence of numerous small spines
projecting from the surface of dendrites in the cerebral
cortex.
The interpretation of these structures and whether
there was protoplasmic continuity across the synapse or
whether it was a region of discontinuity, having a minute
gap beyond the resolution of the light microscope, caused
much concern with the classical investigators, Hans Held,
Santiago Ramon-y-Caja 1 and Camillo Golgi amongst others.
Synaptic detail was clearly beyond their grasp...
(Grey, 1967).
Although it proved difficult to learn of the
structure of the synapse, the physiology of the synapse
was better understood. In 1939, J.Z. Young inserted
electrodes into the pre- and post-synaptic component of
the giant synapses in the squid, and was thus able to
register and stimulate impulses. Much of our knowledge
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of synaptic functioning dates from this work. It is
clear that the transmission of nerve impulses across the
synapse is a chemical process. The nerve impulses
arriving at the axon terminal cause a chemical to be
released. This transmitter substance rapidly diffuses
across the intersynaptic cleft, excites the post-synaptic
terminal, and is then destroyed.
Early work concentrated on acetylcholine which is
manufactured by the acetylation of the fat choline with
acetyl-CoA, by the enzyme choline acetylase, and
destroyed post-synaptica1 ly by the enzyme cholinesterase .
(see FIGURE 6). Acetylcholine is a transmitter substance
between nerves and muscles; it is important, and
vulnerable. "Anything which interferes with the
r~
diffusion of the transmitter across... jthe synaptic
cleftj will prevent the message being passed on, and
many drugs which interfere with acetylcholine or with its
subsequent destruction by cho1inesterase thus block
synaptic transmission and result in a sort of chemical
paralysis." (Rose, 1970).
Sir John Eccles (1964), and his colleagues, developed
a technique for inserting extremely small electrodes into
single neurones. On the basis of investigation using this
technique, they were able to draw at least two important
conclusions: firstly, that the brain and spinal cord do
have a chemical basis of transmission; and, secondly,
that there are two types of synaptic activity -
excitatory and inhibitory.
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In the early I950's, knowledge of the synapse was
more advanced in physio-chemical terms than in terms of
structure. However, the introduction of the electron
microscope dramatically changed the situation. "Then
for the first time", according to Grey (1967), "we were
able to obtain high resolution pictures of thin sections
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of the brain, showing its minute structure with great
clarity and revealing an enormous complexity that in
many respects is still far from understood."
The axonal bulb of the synapse (1-2y across) is
surrounded by a thin surface membrane. Oval bodies,
the mitochondria, and swarms of small spherical capsules,
the vesicles, lie inside the bulb. (see FIGURE 7). The






pre- artel post-synapti c bulb are separated by a 200A cleft,
which, as Eccles (1964) pointed out, is an extracellular
zone narrow enough to permit rapid diffusion of a
transmitter substance across the cleft for 'split second'
responses. Seen under a microscope, the vesicles appear
to be moving towards the synaptic cleft, and aggregate
near the pre-synaptic membrane. They are believed to
contain the transmitter substance. The mitochondria,
which occur not only in the pre-synaptic bulb but also
in the post-synaptic dendrite or cell body, provide 'fuel'
by liberating energy-rich adenosine triphosphate (ATP).
The physiological action of the catecholamines
within the central nervous system is not well understood.
The current theory, which holds that monoamines are
stored within the synapse in two forms, is concisely and
simply explained in terms of the adrenergic system by
Tilleard-Cole and Marks (n.d.):
The monoamines are thought to exist in the tissues
in a stored and in a free form. The free amines show
biological activity and are capable of being metabolized
by 0-rnethyl transferase , The stored" ami nes occur in two
storage sites within the neurone in special storage
granules, are biologically inactive and are protected
from metabolism by the granule covering. Part of the
storage amines, located close to the nerve endings, is
released into the synaptic space on nerve stimulation.
There it stimulates the adrenergic receptor and is then
inactivated. Some 95 per cent of this inactivation
occurs by restorage in the granules and only a small
fraction is metabolized by 0-methyltransferase...
The second monoamine storage pool is situated in the
vicinity of structures containing monoamine oxidase
(i.e. mitochondria). A balance exists between the two
intracellular storage areas, but any catechol amine
released from the second storage area is metabolized
by monoamine oxidase before it exerts a physiological
effect.
In the central nervous system, however, practically
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the entire monoamine content is localized in enlargements,
the varicosities, of the monoamine nerve terminals (Fuxe
et a!., 1969). These varicosities are believed to
represent the pre-synaptic structures where the amines
are synthesized, stored, released and broken dcwri (Fuxe,
It
1965a). Moreover, Hokfelt (1968) has provided direct
morphological evidence that the varicosities make synaptic
junctions with cell bodies and with dendrites. Anden et
al. (1966) found that the monoamine cell bodies contain
only low concentrations of amines (10-100 pg/g); the
axons arising from these cell bodies also have very low
concentrations until they are transformed into the
terminal parts which have high amine concentrations
(1 ,000-10,000 pg/g ) .
TRANSMITTER SUBSTANCES RELEVANT TO
SUBCORTICAL NUCLEI
Several transmitter substances play a significant
role in the central nervous system. These are the
amines - serotonin (5-hydroxytryptamine), noradrenaline,
dopamine, and acetylcholine. Each of these amines
functions in a separate system (Fuxe et al., 1969).
Neurones and their synaptic contacts are, therefore,
generally defined according to the chemical nature of
their neurotransmitter; for example, 'dopaminergic
neurones' are those which have dopamine as their
transmitter.
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Although the dopaminergic system has come to occupy
an increasingly important place in relation to
Parkinson's disease, ail the amine systems are intimately
interrelated. The early work which discovered
noradrenaline and serotonin in the brain, and the effect
of reserpine on these amines illustrates this well. In
the mid-fifties, Marthe Vogt (1954) reported that
noradrena1ine (NA) was distributed within the mammalian
brain and that certain drugs were capable of altering the
levels of noradrenaline concentration. Simultaneously,
serotonin (5-HT), another biogenic amine was detected
(Amin et al., 1954: Twarog and Page, 1953), and the
serotonin-blocking action of lysergic acid diethylamide
(LSD) on peripheral tissues (Woolley and Shaw, 1954).
This led to speculations on the role cf this amine in
mental functions, and another important discovery was
made - the neuroleptic agent, reserpine, releases
serotonin from its tissue stores. Moreover, reserpine
was found to have more widespread effects; in addition
reserpine depletes tissue stores of adrenaline (Holzbauer
and Vogt, 1956). This depletion of amine stores leads
ultimately to transmission failure of peripheral
adrenergic nerves. Carlsson et al . (1 958) demonstrated
in experimental animals that this reserpine-induced
syndrome is "dramatically" reversed by the administration
of L-dopa.
Although levels of amine concentration are
undoubtedly important, it may well be the ratio between
different amine-levels or the turnover of dopamine that
51
is fundamentally important in maintaining normal
functioning of the motor system.
SEROTONIN
Tryptophan is hydroxylated and then decarboxyIated
to produce serotonin (5-hydroxytryptamine, or 5-HT).
Serotonin is catabolised by an oxidative deamination,
yielding as the main end-product 5-hydroxyindole 3-acetic
acid (5HIAA); the enzyme involved in the reaction is
monoamine oxidase. (see FIGURE 8)







5-hydroxymdole-3 acetic acid (5-HIAA)
FIGURE 8
Serotonin is found in several subcortical nuclei.
Fuxe (1965) identified serotonin-containing nerve
terminals in both the pall id urn and the substantia nigra;
and Ti11eard-Cole and Marks (n.d.) state that "high
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concentrations (of serotonin!' are found in theL _J
hypothalamus and caudate nucleus with lower
concentrations in other grey matter. Negligible amounts
of serotonin-are found in areas which consist predominantly
of myelinated fibres." However, according to Fuxe et al.
(1969), it is the limbic mid-brain area that contains
the largest amount of serotonin cell bodies in the
brain.
The effect serotonin has upon these structures and
upon behaviour has been investigated to a limited extent.
Its action has been described as being predominantly
fl
depressant in the caudate (Herz and Zieglgansberger,
1968) and in the ventrolateral nucleus of the thalamus
(Phillis and Tebecis, 1967). The administration of
serotonin plus a monoamine oxidase inhibitor, tc animals,
increases brain serotonin levels of concentration. "Such
elevation of serotonin produces behavioural changes
similar to those resulting from the a dministrati on of
lysergic acid diethylamide (LSD)." (Ti11eard-Co1e and
Marks, n.d.). Anden et al. (1969) have shown serotonin
to be involved in thermoregulation; in the hypothalamus,
for example, serotonin actively decreases in hypothermia
and increases in hyperthermia.
NORADRENALINE
The biosynthesis and metabolism of noradrenaline,
according to Grey (1967), have been well worked out.
Phenylalanine, an essential amino acid, is converted to
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tyrosine; tyrosine is hydroxy 1ated to yield dopa;
L-dopa, in turn, is decarboxy1ated to dopamine; dopamine
is hydroxylated to give noradrenaline. Methylation of
noradrenaline produces adrenaline. This last stage is
believed to take place outside the central nervous system
(see FIGURE 9)




















































Carlsson, Falck and Hillarp (1962), using a
histochemica1 fluorescence method, were the first to find
indications of noradrenaline localized in the central
nervous structures. The largest concentration of
noradrenaline is to be found in nerve terminals of the
hypothalamus. According to Fuxe et al. (1969) these
adrenergic nerve terminals exhibit the thickest
varicosities in the brain (1-1.5y). Noradrenaline is
also found with considerable variations of concentration
throughout the terminals in the reticular formation; the
highest concentration is in the area surrounding the
superior cerebellar peduncles (Fuxe, 1966 ). It is also
found in the mid-brain tegmentum, the bulb, the thalamus
(particularly the medial thalamus, but also, in lesser
quantities, in the ventrolateral) (Adam, 1969), and in
the zona reticulata of the substantia nigra (Fuxe et
al., 1969). Afferent, adrenergic terminals to the cortex
have been described by Fuxe et al. (1968). These
afferents do net exhibit any distinct cytoarchitectonic
patterns. Instead they are diffusely distributed
throughout cortical areas; the cingulate region, in
particular, receives a "high density" of afferents.
ACETYLCHOLINE
It has long been established that acetylcholine is
a neurotransmitter substance at the neuromuscular
junction, in all automatic ganglia (i.e. adrenergic and
cholinergic) and in post-gang!ionic cholinergic terminals.
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This physiologi cally highly potent compound is also
found in the mammalian brain where it is considered to
fulfil the role of a central neurotrar.smi tter
(Hornykiewicz , 1971).
(See the preceding section - The Synapse ~ for a
description of the metabolic pathway of acetylcholine).
Acetylcholine is an extremely labile compound;
early studies of the distribution of acetylcholine relied
on the occurrence of the synthesizing enzyme choline
acetylase as an indicator of the presence of acetylcholine
(Feldberg and Vogt, 1948).
Acetylcholine is found in high concentration in the
caudate and putamen of laboratory animals (Macintosh,
1941), localized in nerve endings, specifically in
synaptic vesicles (Lloyd and Hornykiewicz, 1970). The
synthesizing enzyme, choline acetylase, and the
inactivating enzyme, acetylcholinesterase, are similarly
highly active in the striatum (Fahn and Cote, 1968). This
high level of concentration for all three substances
according to Hornykiewicz (1971) is equalled only by the
concentration in the nuclei of the cranial motor nerves
and motor nerve cells in the anterior horn of the spinal
cord. Furthermore, the rate of acetylcholine synthesis
in the caudate is high: Hebb et al. (1964) showed that
in in vitro experiments on the caudate nucleus of the rat
acetylcholine was synthesized at the rate of 8,000 to
10,000 yg.ACh per gm. tissue per hour, although the
figures for in vivo synthesis are lower.
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DOPAMINE
Like noradrenaline and adrenaline, dopamine is a
naturally occurring catecholamine. Chemically, dopamine
is 3-3, 4-dihydroxypheny1 ethyl ami ne or 3-hydroxytryami ne.
Pharmacologically, dopamine shares many of the peripheral
actions of noradrenaline and adrenaline; therefore it
seems in general justified to classify dopamine as a
sympathomimetic amine. Biochemically, dopamine formation
represents the step immediately preceding the biosynthesis
of noradrena1ine. Small amounts of dopamine are found in
all tissues where noradrenaline and adrenaline are
produced (Hornykiewicz, 1971). Moreover, in addition to
being the precursor of noradrenaline in the adrenergic
neurone and of adrenaline in the chromaffin tissue, Blashko
(1 S59) suggested, dopamine might have a physiological
function of its own, and Carlsson (1959) envisaged the
possibility of the central action of dopamine. Several
workers since then (see e.g. Poirier, 1971; and
Hornykiewicz, 1971) have demonstrated that dopamine
satisfies many of the criteria of a physiologically active
substance; it is now generally considered that dopamine
fulfils two roles - one as the precursor of adrenaline and
noradrenal i ne, and the other, as a neurotransmitter in its
own right.
Metabolism and Turnover of Dopamine
Dopamine is formed from L-dopa, its immediate
precursor, by the enzyme L-dopa decarboxylase. (L-dopa,
in turn, is formed from tyrosine, by the enzyme tyrosine
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hydroxy! ase) . (see FIGURE 10). The reaction of L-dopa ->•
-BIOSYNTHESIS AND METABOLISM OF DOPAMINE
FIGURE 10
dopamine appears to be very efficient and to proceed at a
considerable rate (Holtz, 1959). Although there is no
strict correlation between the regional distribution of
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the enzyme and the catecholamines in the brain
(Hornykiewicz , 1966), it is clear that the highest
enzyme activity is present in the caudate nucleus, the
hypothalamus, and the mesencephalon (Bertler and
Rosengren, 1959a; Bogdanskie et al., 1957; Holtz and
Westermann, 1 956 ). Levitt et al . (1 965 ) have suggested
that the limiting step in the biosynthesis of dopamine
and noradrenaline might be the formation of L-tyrosine
by the enzyme L-tyrosine hydroxylase. One would
therefore not expect appreciable amounts of L-dopa to
accumulate in brain tissue.
The relationship between dopamine and noradrenaline
is interesting, but not yet fully understood. The studies
by Glowinski et al. ( 1 965 ) and Masuoka et al . ( 1 963)
demonstrated that in the striatum the metabolism for
noradrenaline has quite different biochemical
characteristics from that of dopamine. Furthermore,
since in the caudate the activity of the enzyme dopamine-
B-hydroxylase (responsible for the conversion of dopamine
to noradrenaline) is high, one would not have expected
Steg's finding (1964) that in spite of a high level of
dopamine, noradrenaline is not formed at a commensurate
rate. Hornykiewicz (1966) suggested two possible
explanations for this finding: firstly, that the two
amines may be localized in two separate structures within
the striatum, and, secondly, that "either the dopamine and
the enzyme are localized in separate compartments of the
striatal cell or... there exists in vivo a lack of some
factors necessary for full activity."
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The main breakdown product of dopamine is homo-
vanillic acid (4-hydroxy-3-methoxyphenylaceti c acid,
often abbreviated as HVA). This is aided by at least
two enzymes: monoamine oxidase and catechol-Q-
methyltransferase (Axelrod, 1959). Dopamine is first
attacked by monoamine oxidase, and 3,4-dihydroxypheny1 -
acetic acid is produced. This compound, in turn, is
0-methylated, and homovanillic acid is formed. However,
Carlsson and Wa 1 deck (1964) have shown that small amounts
of dopamine may undergo 0-methylation before oxidative
deamination. The intermediary compound is 3-methoxy-
tyramine. Its concentration increases considerably under
the influence of monoamine oxidase inhibitors.
A11 available evidence indicates that brain dopamine
is turned over at a high rate. Holzer together with
Hornykiewicz (1959) injected harmine (a quick-acting MAO
inhibitor) into rats, and found that within 10 - 20
minutes, there was a significant rise in the concentration
of brain dopamine. Moreover, Undenfriend et al. (1953)
suggested that this turnover of brain dopamine is
comparable to that of brain 5-HT, but distinctly higher
than that of brain noradrena1ine. Vogt's observation
(1954) of the occurrence of relatively high concentrations
of HVA in the dopamine-rich parts of the brain and very
low concentrations of the acid metabolites of
noradrena1ine, suggested that dopamine is turned over at
a faster rate than brain noradrenaline. This hypothesis
is further substantiated by An den et al. (1964); Carlsson
and Lindqvist (1962); and Laverty and Sharman (1965).
60
Distribution of Dopamine in the Basal Ganglia
About 80 per cent of dopamine in the brain is
distributed within the basal ganglia. (see FIGURE 11)







In 1959 it was shown, simultaneously by Carlsson and by
Bertler and Rosengren that there is a regional
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distribution of dopamine in the animal brain, with the
highest concentrations of dopamine in the caudate
nucleus and the putamen. Subsequently, Hornykiewicz
(see Hornykiewicz, 1971) demonstrated that the compact
layer of the substantia and the globus pallidus
also have relatively high levels of dopamine.
Bernheimer (1964) showed that homovanillic acid (HVA)
has a characteristic'distribution pattern similar to
that of dopamine, with high levels in the caudate
nucleus and putamen. However, in the substantia nigra
there is a ratio of roughly 1:4 for dopamine and HVA,
and in the globus pallidus a ratio of 1:25.
Furthermore, Bertler and Rosengren (1959) found that
throughout the internal capsule between the substantia
nigra and striatum, there is an uneven, but
identifiable, pattern of HVA distribution: the lowest
concentrations were found in the caudal part, near the
substantia nigra, and the highest concentrations in
the anterior limb of the internal .capsule close to the
head of the caudate nucleus. Furthermore,
noradrenaline and dopamine appear to have mutually
independent areas of concentration: nuclei containing
high levels of noradrenaline (such as the hypothalamus)
are poor in dopamine, and nuclei rich in dopamine have
low levels of noradrenaline (Carlsson, 1959; Bertler
and Rosengren, 1959; Hornykiewicz, 1971). The
distribution of amines within neural structures is
summarized in TABLE 1.
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DISTRIBUTION OF AMINES IN MAMMALIAN BRAIN1-2
NEURAL AMINES




corpus striatum 3000 9900 700
thalamus 3000 240 500
hypothalamus 1900 250 1000 1700
central grey 400
tegmentum 1600 200 370 1000
bulb 1600 350 600
cerebellum 200
~!rUased on Adam (19691
2 mean estimates of concentration expressed
as ng/g. Only concentrations <100 given.
TABLE 1
NEUROCHEMISTRY AND THE SUBCORTEX
THE NIGRO-STRIATAL PATHWAY
There is strong evidence to suggest that there is
a dopaminergic nigro-striatal pathway. Fuxe (1965)
demonstrated that the neostriatum contains dopamine-
containing axon terminals, and Dahlstrom and Fuxe (1964)
showed that the neurones of the pars compacta of the
substantia nigra were powerfully fluorescent. Furthermore,
Anden et al. (1964) and Poirier and Sourkes (1965) found
that nigral lesions caused a drop in the dopamine content
of the ipsilateral striatum; Anden, Carlsson et al .
(1 964) and Anden, Dahlstrflm et al . (1 965 ) found ablation
of the caudate nucleus produced an increased fluorescence
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in the nigral neurones. Bedard et a], (1969) and Parent
and Poirier (1969) have suggested that these dopaminergic
fibres run in the medial forebrain bundle, and that there
is a topographical relationship between the substantia
nigra and the striatum.
Studies of the effects of iontophoretically applied
dopamine and the effect of nigral stimulation on the
caudate demonstrates clearly the function the dopaminerig
pathway subserves. Bloom et al. (1965), McLennan and
York (1966), and York (1967) found that 60 to 70 per cent
of cells whose activity was recorded were depressed by
dopamine; and Albe-Fessard et al. (1967) and Connor
(1968) found caudate nucleus cells (65 and 45 per cent
respectively) were depressed by stimulation of the
substantia nigra.
There is evidence to suggest that there are also
nigro-striatal neurones with an excitatory function.
Connor (1968), Feltz (1969), and Frigyesi and Purpura
(1967), and McLennan and York (1967) have observed this
effect in the caudate following electrical stimulation
of the substantia nigra. A latency response (in cats)
of 15 to 20 msecs. was usually found, indicating a
possibility that the transmission is monosynaptic.
Mettler, as early as 1945, suggested that there are axons
arising not from the melanin-containing cells of the pars
compacta, but from the pars reticulata, leading to the
caudate. It is unlikely, therefore, that this
excitatory connection between the substantia nigra and
the caudate is, in fact, dopaminergic.
THALAMO-CAUDATE PATHWAYS
The nucleus centrum medianum (CM) of the thalamus
(and certain other medial nuclei) is possibly
dopaminergic. Stimulation of the CM causes an increase
in the dopamine output from the caudate (McLennan, 1964),
and low-frequency repetitive stimulation of the CM
inhibits firing of those neurones of the caudate which
are depressed by dopamine (McLennan and York, 1967). The
depressant actions both of CM stimulation and of dopamine
application can be prevented by the iontophoretic
application of phenoxybenzamine to the neurone under
examination (York, 1967).
The ventral thalamo-caudate pathway in particular
has been investigated by McLennan (1964) and McLennan
and York (1966). Their studies provide strong evidence
that there is a cholinergic mechanism in the pathway.
Electrical stimulation of VA evokes an acetylcholine-
release-response in the caudate; electrical stimulation
of the caudate stimulates some neurones and inhibits
others: both excitatory and inhibitory responses can be
produced by iontophoretic application of acetylcholine to




Dahlstrom and Fuxe (1964) demonstrated that the
putamen possesses dopamine-containing neurones and, like
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the caudate, has an abundance of histo fluorescent
terminals. A year later, in 1965, McLennan showed that
electrical stimulation of the substantia nigra evokes a
detectable release of dopamine from the putamen. York
(1968, 1970) reported the effects of microiontophoretic
application of dopamine upon the putamen. In the
putamen, as in the caudate, a number of neurones were
depressed by dopamine, but a significant proportion
were excited. The neurones that were excited were those
neurones that are capable of being activated by nigral
stimulation. Both the chemically and electrically
induced excitations were blocked by the application of
dichloroisopropylnoradrenaline (nialamide). This
evidence suggests that dopamine may function as an
excitatory synaptic transmitter in the nigro-putamen
pathway. According to McLennan (1971), "there is no
inconsistency in the proposition that the same substance
may act in one situation as an excitatory, and in
another as an inhibitory, transmitter. Dopamine has been
shown to act thus at certain of the ganglionic neurones
of the mollusk A-plysia."
STRIO-NIGRAL PATHWAYS
The major outflow from the striatum is to the
pallidum, but there are also projections from the caudate
and from the putamen to the substantia nigra. There is
no pharmacological evidence, yet, on the striato-nigral
connection, and hypotheses regarding the synaptic
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mechanisms operating in the nigra are therefore based
on indirect evidence.
In 1967, two studies were reported suggesting that
the substantia nigra is neither morphologically nor
physiologically homogeneous. Bak (1967) described two
morphologically distinct synapse-types in the substantia
nigra: one type contained the granulated vesicles
characteristic of aminergic synapses, the other did not.
Frigyesi and Purpura (1967) observed that stimulation of
the caudate evoked in nigral neurones an excitatory post¬
synaptic response which was succeeded by an inhibitory
response. These two findings indicate that two chemically
distinct synaptic processes exist in the substantia nigra.
Histochemica1 evidence supports this hypothesis.
Localized in the zona reticulata of the substantia nigra
is a profusion of very fine serotonin-containing
terminals which establish contact with fibres of the
"comb bundle". Fuxe (1965) found that these terminals
and their connections exhibit cholinesterase stains, and
Olivier et al. (1970) described the disappearance of this
enzyme from the "comb bundle" fibres following striatal
1esions.
GLOBUS PALLIDUS
Evidence suggests that the pallidum is not
dopaminergic. The pallidum itself does not contain large
concentrations of dopamine (McLennan, 1963), nor does it
have dopamine-containing nerve terminals (Fuxe, 1965).
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There is, instead, evidence of serotonin-containing
terminals (Fuxe, 1965), and of AChE being contained
within the pallidal cells (McLennan, 1971). Malliani
arid Purpura ( 1 967) suggested that either within the
nucleus itself, or at the site of its projections, there
is a dual transmitter system: they found that caudate
stimulation evoked in pallidal cells an excitatory post¬
synaptic response followed by an inhibitory one.
PALLIDAL AND THALAMIC PROJECTIONS
Pallidal fibres project to several thalamic nuclei:
nuclei ventral is anterior (VA), ventral is lateralis (VL),
and nucleus centrum medianum (Nauta and Mehler, 1966).
In addition, afferents from the cerebellum passing
through the brachium conjunctivum (Desivaju and Purpura,
1969) lead to certain VL neurones.
The biochemistry of the other pathways is more
complex. Stimulation of the brachium conjunctivum
produces a monosynaptic response in-VL neurones which
are strikingly cholinoceptive (Davis, 1966; McCance et
al., 1968; McLennan et al., 1968). However, evidence
indicates that the cerebellar efferents themselves are
noncholinergic (McLennan, 1971). Although the
excitability of VL neurones is reduced by dopamine and
serotonin, noradrerial i ne has a complex effect. It
excites a significant proportion of the cells and
depresses others (Phi 11 is and Tebecis, 1967). It has been
suggested (McLennan, 1971) that MACh and noradrenaline
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act as synaptic transmitters in VL, respectively
mediating the excitatory and inhibitory input to the
cells from the mesencephalic reticular formation."
Furthermore, since acetylcholine has been detected in
pallidal neurones and some fibres of the ansa (McLennan,
1971) it may be supposed that the pallidal projections
are cholinergic. Unfortunately, evidence to date does
not support this view. Marshall and McLennan
(unpublished observation, cited in McLennan, 1971) found
"that atropine does not affect the electrical responses
of the ventrolateral entopeduncularis"; and Fuxe ( 1 965 )
did not find either serotonin- or catechol amine-
containing terminals in the ventrolateral nucleus.




striatum pal 1idum acetylcholine
pallidum VL, CM excitatory unknown (probably not ACh)
caudate nigra ? a-cetylchol ine; serotonin?
VA caudate excitatory acetylcholine
VA caudate inhibitory acetylcholine
CM caudate inhibitory? dopamine
nigra caudate excitatory unknown (but not DA)
nigra caudate inhibitory dopamine
nigra putamen excitatory dopamine
cerebellum VL excitatory unknown (probably not ACh)
1based on MoLennccn (1971)
TABLE 2
The distribution of monoamine connections between
subcortical structures is summarized in TABLE 2.
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CHAPTER 3
ASPECTS OF THE PATHOGENESIS OF PARKINSONISM
In this chapter evidence of the involvement of
dopamine in the abnormal functioning of some of the basal
ganglia is discussed. The hypothetical model of the
pathogenesis of Parkinsonism based on this evidence has
indicated a rational approach to treatment. Since the
present investigation explores certain effects of L-dopa
treatment in Parkinsonian patients, the question of
treatment will also be considered.-
NEUROPHYSIOLOGICAL AND NEUROPATHOL-OGICAL CONSIDERATIONS
Parkinsonism is characterized by a triad of motor
symptoms - rigidity, tremor and akinesia. The
neurophysiological mechanisms underlying these symptoms
have not yet been established, but current theory holds
that tremor and rigidity are 'positive' symptoms caused
by an over-activity or release of certain brain areas.
Since Parkinson's disease and post-encephalitic
Parkinsonism are chronic and degenerative, Purdon Martin
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(1959) pointed out that it is unlikely that there are
so-called 'discharging' lesions in Parkinsonism. Instead,
rigidity and tremor are considered to be 'release'
symptoms, due to lack of an inhibition normally
controlling excess of function, and resulting from
destruction of some definite sub-cortical area or areas.
Akinesia, on the other hand, is more properly considered
a 'negative' symptom, and is, according to Denny Brown
(1958), the "primary and fundamental" symptom of damage
to the basal ganglia. But what of the lesion itself?
The most consistent neuropathological finding in
Parkinsonism is the degeneration of the melanin-
containing nerve cells in the zona compacta of the
substantia nigra, (see FIGURE 12) Trdtiakoff (1919) is
often cited as providing the first important evidence of
these changes. Greenfield (1955) summarized his work:
Tretiakoff's important thesis (1919) was devoted
almost entirely to the substantia nigra. This was
examined in fifty-four cases of various kinds, including
nine typical long-standing cases of paralysis agitans
and three of encephalitis lethargica, which was at that
time a new disease. In the latter he found a
concentration of inflammatory lesions in the substantia
nigra, where most of the nerve cells had disappeared
and many of those which remained had undergone hyaline
or granular degeneration. This is one of the earliest
references to the destruction of the substantia nigra
in encephalitis lethargica, a lesion which was to have a
profound influence on later theories of the pathology of
idiopathic Parkinsonism. In his cases of the latter type
he found a varying degree of cell-loss in the substantia
nigra. Various changes were seen in the remaining
neurones, the most important being grumous degeneration
(degenerescence grumeleuse), neurofibri11ary alterations,
Lewy's spherical hyaline inclusions and bi-nucleation.
Lewy's inclusions were found in six of his nine cases of
typical paralysis agitans and in one atypical case.
After a full review of the literature he expressed the
opinion that the substantia nigra was constantly
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High power photomicrographs to illustrate
loss of pigmented cells in the substantia nigra
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affected, but that the lesions in it were always
associated with other senile lesions. In no case
could he find any lesions i ri the nucleus ruber.
Hassler (1 538, 1 95 3)» Foix and Nicolesco ( 1 925 ),
Greenfield and Bosanquet (1953), and Jung and Hassler
(1960) have confirmed Tretiakoff's findings, but Hassler
(1953) expressed the view that the observed degenerative
changes in other sub-cortical nuclei are probably
irrelevant to the Parkinsonian symptomatology. It is not
at all clear in which way degeneration of the substantia
nigra induces functional changes in other subcortical
nuclei to produce the characteristic Parkinsonian
symptomatology. There are, however, plausible hypotheses
of symptom-production.
RIGIDITY AND TREMOR
Denny Brown (1969) argued most persuasively the case
for considering rigidity and tremor as different aspects
of one pathogenesis. ("[Each is] ... a conflict of
released propriocepti ve reaction. The conflict is
released more slowly in rigidity, and more rapidly and
rhythmically in tremor.. Destructive lesions cf the
pre-motor cortex, basal ganglia, mid-brain or cerebellum
in primates have been used, to a large extent, as a basis
for models of rigidity. It is now generally accepted
that the final common pathway for dystonia is the
ct-motor neurone rather than the y-efferent, and that
there is a tendency towards flexor muscles being more
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involved, accounting, to some extent, for the flexed
posture of Parkinsonian rigidity (Denny Brown, 1960a,
1960b). The cells of this final common pathway are
situated centrally, in the gigantocellular nucleus of the
the medulla (Denny Brown, 1968). Destruction of this
descending pathway results in a facilitation of its output
to the a-motor neurones of muscles (particularly the
flexors). Thus, when it is sustained, the augmented
activity results in rigidity and the flexed dystonic
posture of Parkinsonism; when it is interrupted the
characteristic Parkinsonian tremor results, (see FIGURE 13)
DIAGRAM TO ILLUSTRATE THE PHYSIOLOGY OF DYSTONIA1
'extra pyramidal' areas




Hornykiewicz (1966), arguing from surgical evidence
showing that destruction of the pallidum or its
ventrolateral thalamic projections make rigidity and, to
a lesser extent, tremor, disappear, suggested a
pathogenesis for dystonia which complements rather than
challenges Denny Brown's theory. Horriyki ewi cz postulated
that "some inhibitory effect, normally suppressing an
excess of activity of the pallidum, is removed by
degeneration of the substantia nigra, and that this
results in rigidity. Probably this nigral inhibition
of pallidal activity is mediated by nigro-pallidal
fiber connection....-"
AKINESIA
To account for the relation between degeneration of
the substantia nigra and akinesia, Hassler (1953)
proposed that some of the facilitatory motor impulses
originating in the cortex are relayed via the substantia
nigra to the motor neurones, thus enhancing the
spontaneous movement. However, in addition to Hassler's
direct descending facilitatory influence, the substantia
nigra, through its intimate connection with the striatum,
is able to exert a second., and indirect, influence on
motor impulses.
Hornykiewicz has pointed out (1966) that there are
two equally plausible forms this indirect influence can
take, and each is equally supported by neurophysio1ogica1
and neuropathological evidence. On the one hand, it
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could be postulated (on the basis of Jung and Hassler,
1 960.) that the striatum has a depressant effect on
spontaneous activity, and that the substantia nigra in
inhibiting this depressant effect, enhances activity.
On the other hand, it could be postulated (on the basis
of Spiegel, 1964; Spiegel and Szekely, 1961) that the
striatum acts to enhance activity, and in this case that
the substantia nigra . reinfcrces this enhancement by
stimulating the striatum. In either case, destruction
of the substantia nigra would lead to decreased ability
of the individual to perform spontaneous voluntary
movements.
NEUROCHEMICAL CONSIDERATIONS
Following the discovery in 1958 of a regional
distribution of dopamine in the animal brain (see Chapter
2), it was suggested that dopamine might be involved in
the functioning of the basal ganglia, and in such
disorders as Parkinsonism. Carlsson and his co-workers
(1971) set forth their hypothesis and the evidence in its
favour as fol1ows:
The corpus striatum forms an important part of the
extra-pyramidal system, which is known to control motor
activity. Lesions in this system are accompanied by
different kinds of kinetic disorders. Thus the
parkinsonian syndrome is characterized by slowing and
enfeeblement of emotional and voluntary movement,
muscular rigidity, and tremor. Chorea, on the other hand,
presents features which are in some respects the opposite
of the symptoms of parkinsonism, with involuntary
movements and, frequently, emotional instability. It is
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interesting to note that reserpine, which depletes
dpoamine from the corpus striatum, may produce a syndrome
very similar to parkinsonism and appears to be efficient
in controlling the choreatic syndrome.
Thus the following facts argue for the assumption
that dopamine is involved in the control of motor
functions:
1. The presence of large amounts of dopamine in the
corpus striatum, which forms an important part of the
extrapyrami da 1 system.
2. The extrapyramidal actions of reserpine, which
depletes dopamine from the corpus striatum.
3. The ability of DORA to counteract the hypokinetic
action of reserpine. Whether this action of DOPA is
entirely due to formation of dopamine, or whether
formation of noradrenaline contributes to the effect,
remains an open question (Carlsson, 1971).
Extensive study of the behaviour of this biogenic
amine in the human brain, and particularly in the brain
of Parkinsonian patients, followed publication of this
hypothesis. Hornykiewicz has been in the forefront of
these clinical studies and his contribution to the
neurochemistry of Parkinsonism cannot be overestimated.
He, together with co-workers, has s'hown that iri
Parkinsonism the concentration of dopamine is decreased
to very low levels in the caudate nucleus, putamen
(Bernheimer et al., 1963; Ehringer and Hornykiewicz,
1960), and substantia nigra (Hornykiewicz, 1963).
(see TABLE 3) He has also shown that the concentration
of homovani11ic acid in these areas, as well as in the
globus pallidus and all portions of the internal capsule
between the substantia nigra and the striatum, was
significantly reduced (Bernheimer and Hornykiewicz,
1965; Hornykiewicz et al., 1968). The observations of
the concentrations of homovanillic acid are important,
for as Hornykiewicz (1971) pointed out, "they rule out
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the possibility that the low dopamine levels in
parkinsonism could be due to postmortem breakdown of this
rather labile amine, since homovanillic acid is a
perfectly stable compound under postmortem conditions."
Moreover, as Bernheimer et al. (1963) have shown, in
Parkinsonian patients treated with a monoamine oxidase
inhibitor, the striatal dopamine was approximately as
low as in untreated cases.
BIOCHEMICAL FEATURES OF PARKINSON'S DISEASE1
BRAIN AREA
DA yg/g. NA yg/g. 5-HT yg/g.
normal Park-Inson normal Park-inson norma I Parkinson
cortex 0.00 _ 0.03 0.04
caudate 3.50 0.32 0.07 0.03 0.33 0.12
putamen 3.57 0.23 0.11 0.03 0.32 0.14
pal 1idum 0.30 0.14 0.09 0.11 0.23 0.13
thalamus 0.01 0.01 0.09 0.05 0.26 0.13
hypothalamus 0.02 0.00 1.29 0.67 0.29 0.12
nigra 0.46 0.07 0.04 0.02 0.55 0.26
lbased on Homykiewicz (1964).
TABLE 3
Although there is generally a more marked dopamine
deficiency in the post-encephalitic form of Parkinsonism,
as compared to the idiopathic paralysis agitans form,
(Bernheimer et al., 1965; Ehringer and Hornykiewicz,
1960) this difference is not absolute. Indeed,
regardless of the clinical and pathological classification
of the examined cases, a correlation between the degree of
cell loss in the substantia nigra and the degree of
dopamine and homovanillic acid deficiency has been shown
(Bernheimer et al., 1965). A group of workers in France
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(Sharman et al . , 1967), using animals with experimental
nigral lesions, confirmed this correlation. An
unpublished study by Hornykiewicz and colleagues1 of
chronic manganese poisoning in a patient with Parkinson¬
like symptoms showed not only degeneration of nerve cells
particularly of the substantia nigra, but also very low
concentrations of dopamine in the striatum. From this
type of data Hornykiewicz (1971) drew the following
important conclusion:
This indicates that there is no direct connection between
the etiology of parkinsonism and the neurochemical
changes. On the contrary, it can be postulated that,
regardless of the etiology, parkinson-like symptomatology
can be expected in all instances following cell loss in
the substantia nigra ana the subsequent abnormally low
levels of dopamine and homovani11ic acid in the striatum.
Logically, findings such as these suggest
Parkinsonism should be considered a "striatal dopamine
deficiency syndrome" (Hornykiewicz's terminology - see
Hornykiewicz, 1970). But do the neurophysiological and
clinical observations, in fact, correlate with this
neurochemical implication?
As has been discussed in Chapter 2, not only has the
nigro-striatal tract been demonstrated, but it has also
been shown that neurones of the zona compacta of the
substantia nigra which contain dopamine have axons
ascending ipsi1aterally in the internal capsule to
terminate (after penetrating the globus pallidus) in the
caudate nucleus and in the putamen. Data such as that
1 cited in Hornykiewicz (1971).
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presented in TABLE 3 could thus be explained by a lesion
anywhere along this tract. The biochemical connection is
more than inferential, for depletion of dopamine in the
striatum has been shown to follow lesions which interrupt
the nigro-striatal tract between the cell body and the
nerve terminals (And£n et al., 1964; Dahlstrom and Fuxe,
1964; Poirier and Sourkes, 1965). Furthermore,
Hornykiewicz and colleagues (Ehringer and Hornykiewicz,
I960; Bernheimer et al., 1965) have demonstrated that
the deficiency of dopamine (and HVA) in the striatum of
Parkinsonian patients is well correlated with the degree
of cell-loss of the pars compacta of the substantia
nigra.
Clinically, "one of the best examples" (Hornykiewicz,
1971) illustrating the causal relationship between
striatal dopamine deficiency and Parkinsonian
symptomatology is demonstrated in a study (Barolin et al.,
1 964) of a patient with hemi-Parkinsonisrn. In this
patient, dopamine deficiency was much more pronounced in
the striatum contralateral to the side of the symptoms,
although striatal dopamine ipsilateral to the symptoms
was 'subnormal' (see TABLE 4). Moreover, similar changes
in dopamine concentrations are not found in other basal
ganglia disorders. Patients dying from Huntington's
chorea with advanced atrophy of the caudate nucleus were
shown (Bernheimer et al., 1965; Ehringer and
Hornykiewicz, 1960) to have normal dopamine
concentrations in the remaining striatal tissue.
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CONCENTRATION LEVELS OF DOPAMINE AND SEROTONIN IN THE STRIATUM
OF A RIGHT-SIDED HEMIPARKINSON IAN PATIENT.1

























1based on Hornykiewicz (1971).
TABLE 4
It is, therefore, reasonable to hypothesise that in
Parkinson's disease the typical neuropathological
changes with degeneration of the substantia nigra produce
degeneration of the nigro-striatal tract and its
termination in the striatum with resulting depletion of
striatal dopamine. This hypothesis provides the basis
for a model describing the striatum as a higher
regulatory centre: dopamine chemically transmits nigral
impulses inhibiting activity of the pallidum and nigral
impulses inhibiting (or enhanci ng) acti vi ty of the
caudate nuc1eus.
PHARMACOTHERAPEUTIC CONSIDERATIONS
In 1961, two independent groups of workers tested
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this hypothesis by replenishing the striatal dopamine.
Barbeau, Sourkes and Murphy in Montreal gave doses of
300mg. Laevodopa orally and found there was a significant
reduction in rigidity, with no effect on tremor.
Birkmeyer and Hornykiewicz in Vienna administered up to
150mg. Laevodopa intravenously to their patients and
found a "complete abolition or substantial decrease of
akinesia". Birkmeyer and Hornykiewicz were much
impressed by the efficacy of Laevodopa. They stated that
a qualitatively similar effect "could not be achieved to
any comparable degree by any other known drug."
Unfortunately, the unpleasant side-effects of
intravenous Laevodopa (particularly nausea, vomiting and
fluctuation in blood pressure) "made it practically
impossible to inject doses that were large enough to
increase the dopamine sufficiently in the striatum"
(Ehringer and Hornykiewicz, 1960). The publication in
1967 by Cotzias, Van Woert and Schiffer of results of a
study of patients given high oral doses of D,L-Dopa
suggested a possible solution. They showed that by
starting with low doses (approximately 0.3gm daily),
and gradually increasing the dose over several weeks to
about 6gm daily, it was possible not only to obtain
maximum beneficial responses, but also to overcome
several of the side-effects. The racemic D,Lcompound,
however, proved sufficiently toxic to limit its use:
large doses could not, with safety, be adminstered to
the mildest cases (Cotzias et al., 1967).
In another study, Cotzias and colleagues (1969)
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attempted to overcome this difficulty. Instead of the
racemic D,Lcompound, they used the amino acid precursor
dihydroxphenylalanine (dopa) - the amine previously used
(intravenously) by Birkmeyer and Hornykiewicz (1961), and
(in small oral doses) by Barbeau et al. (1962). It was
administered (as D,L-Dopa had been administered in the
previous study) orally, in gradually increasing doses.
Cotzias insisted that this gradually increasing dose
regime is of extreme importance: "... the optimum dose
was reached no sooner than after five to seven weeks. We
cannot over-emphasize the importance of slow increments
and of slow mobilization of these individuals. The
optimum dose was the daily dose which induced maximal
improvement with minimal side effects.... It varied
between 4 and 8g. per patient per day." The results of
the study were highly favourable. L-dopa was shown to
have positive effects on the akinesia of Parkinsonism.
Moreover, Cotzias1 study demonstrated not only that large
doses of L-dopa are needed and that these must be
gradually built up, but also that treatment must be
prolonged, and that unlike intravenous Laevodopa, oral
Laevodopa does not produce an immediate effect.
At a conference in Geneva, Barbeau (1970 ) reviewed
his own experience with L-dopa as a treatment for
Parkinsonism, and showed that over the years the initial
and highly favourable opinion Birkmeyer and Hornykiewicz
had formed from their pioneering work with intravenous
L-dopa in 1961, has been justified:
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Ten years of experience with L-dopa have clearly
shown that this drug is by far the most useful treatment
presently available for Parkinson's disease. It is
effective against all major aspects of the illness, but
not equally so. Hypokinesia, or akinesia, is the first
symptom to be reversed, sometimes completely. Speed in
the initiation of movements, associated movements,
postural balance are all impaired in this syndrome and
are uniformly and rapidly improved with Dopa.... On. the
other hand, other symptoms are not always completely
reversed by treatment. Rigidity is decreased in most
cases but can reappear after some months. Tremor is
usually not modified appreciably until after 2 or 3
months of continued therapy. In the first weeks of
L-Dopa, tremor can even be temporarily increased. These
observations would indicate that the effect of L-Dopa on
akinesia is a direct one, while that on rigidity and
tremor involved secondary and less specific mechanisms of
action.
How does Laevodopa produce this effect? It is
clear that the effect cannot be due to L-dopa itself, for
the amine proved to be relatively inactive (Carlsson,
1971). There is sufficient evidence to consider the
central nervous system as the site of the action (see
Hornykiewicz , 1 970 ). Any of the numerous central
metabolites of L-dopa could be the active compound, but
dopamine, serotonin, and noradrenaline, have suggested
themselves as more likely candidates. Although it is not
feasible to identify conclusively one of the three as
the decisive compound, experimental evidence suggests
that the anti-Parkinsonian action is dopamine-dependent.
Birkmeyer and Hornykiewicz (1961), for example, on the
basis of an extensive clinico-pharmacologica1 study,
showed dopamine formed in the brain from (in this case,
intravenously administered) Laevodopa to be the critical
amine. Additional support is given to this claim by
their report (corroborated by Barbeau et al., 1962) that
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the effect of Laevodopa can be increased five-fold if
patients are pre-treated chronically with a monoamine
inhibitor. Hornykiewicz, in a paper (1970) presented
to a conference in Quebec, summarised current views on
the anti-Parkinsonian effect of L-dopa. Although the
paper was read some years ago, no evidence has been
published since to gainsay his conclusions:
In spite of several questions which will remain
open..., it seems that at the moment the anti¬
parkinsonian action of L-dopa is best explained by
assuming that it is the dopamine formed in the brain
which is the active compound, and that there is a close
relationship between striatal dopamine deficiency and
parkinsonian akinesia and rigidity. This evidence is
in keeping with a large body of fairly solid evidence
obtained in animal experiments, especially in respect
of striatal dopamine metabolism in reserpined animals
and Dopa-reserpine antagonism. Therefore, it would
appear that, for the time being, we are justified to
say that in principle we have a rational basis for the
use of L-dopa in parkinsonism.
If one accepts this hypothesis that dopamine formed
in the brain from L-dopa is the active substance, how can
the therapeutic action be accounted for? In the
literature many suggestions, of varying plausibility, are
to be found. For example, a recent publication ( Anon. ,
1970) included in its list of "main possibilities" the
fol1owing :
Treatment with L-Dopa may result in the increase of
extrastriata1 dopamine. Concentrations of dopamine
throughout the central nervous system might have a
specific neurohormona1 effect in the striatum and tend
to counteract the depletion of intraneurona1 dopamine
resulting from the disease.
The metabolism of the ni gro-stri atal neuron is d i s tf\u bed
in such a way that the rate of dopamine production is
defective. If this were the case, as Cotzias has
suggested, treatment with L-Dopa acts by "saturating an
enzyme with substrate." The degeneration of the nigral
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neurons may come about either as a secondary phenomenon
or may be primary and causative of the defective dopamine
production.
Suggestions such as these., unfortunately, are open to
criticism as na'ive, reductionistic extrapolations from
limited premises. Not only is the dopaminergic system
treated in isolation, but emphasis is given to absolute
levels of amine concentration. This is perhaps not the
most profitable approach, as the development of serotonin
theories in Parkinsonism indicates.
Postmortem studies on Parkinsonian patients showed
that in addition to the dopamine depletion, there is also
a serotonin depletion (see, for example, TABLE 3). One
study found that serotonin levels in the striatum, globus
pa 11idus and substantia nigra were as much as 50% lower
in Parkinsonian patients than in controls (Bernheimer et
al., 1963). In spite of experimental findings (Poirier
et al . , 1 969a)suggesting a connection between
5-hydroxytryptamine and 'positive' Parkinson-1ike symptoms
in monkeys, serotonin depletion was' not generally
considered to be a characteristic or specific
Parkinsonian feature:
1) Taking into consideration the wide range of values
obtained in human postmortem material, the decrease in
brain serotonin in parkinsonism was mild as compared with
the severe dopamine deficiency found in the same patients.
2) A patient ... with hemi-parkinsonism did not show
a preferential decrease of striatal serotonin
contralateral to the side of the symptoms. 3) In
parkinsonian patients treated chronically with monoamine
inhibitors, the brain serotonin was markedly elevated to
above-normal levels, whereas striatal dopamine remained
virtually unchanged. In these patients the clinical
action of monoamine oxidase inhibitors on the parkinsonian
symptoms was very mild and not always consistent.
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4) Increasing brain serotonin in parkinsonian patients
by giving its precursor 5-hydroxytryptophan had no
beneficial effect on the chief symptornato 1 ogy of the
disorder (Hornykiewicz, 1971).
If, however, the focus of attention is moved away
from absolute levels of one particular amine, more
powerful and, intuitively, more plausible hypotheses are
possible. Hassler and Bak (1969), in particular, have
argued strongly that it is not the absolute amounts of
serotonin, but rather the ratio of serotonin to dopamine
i ri the striatum that is critical.
If the content of serotonin in the striatum of the
rat is increased by administration of drugs such as
harmaline, rigidity and tremor-like jerks occur. If, on
the other hand, the dopamine content of the striatum is
increased by intra-peritoneal administration of a
monoamine oxidase inhibitor such as iproniazid to block
the deamination of dopamine along with L-DOPA the rats
become hyperactive.
When a rat has undergone hemidecerebration (which
can be accomplished functionally by the brain incision...
which interrupts the fibres connecting the striatum and
the substantia nigra) slight contralateral tremor and
ipsilateral circling are seen, along with a 50 per cent
decrease in dopamine in the isolated striatum but with
no change in serotonin content. The tremor can be
amplified by increasing the striatal serotonin with
harmaline. On the other hand, combining hemidecerebration
with an increase of dopamine, by the administration of
L-DOPA and iproniazid, results in extremely high jumping
to the point of exhaustion. More detailed study of this
correlation reveals than an increase in either dopamine
or serotonin is not associated, in most cases, with a
decrease of the other or of other substances.
Both the animals with increased striatal serotonin
and normal dopamine (after harmaline administration) and
the animals with decreased dopamine but normal serotonin
(hemidecerebrated) exhibit tremor.
This is the first demonstration that it is not the
absolute value of serotonin which may be responsible for
this motor activity, but the ratio between dopamine and
serotonin. If the ratio becomes smaller than unity
rigidity and tremor-like myoclonus appear, regardless of
the means by which this ratio is altered, whether by a
simple hemidecerebration or by drug administration. If,
of the contrary, the dopamine in the striatum is increased
relative to the serotonin the rats become hyperactive and
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start to jump. In each case a relative increase of
dopamine in relation to serotonin causes hyperactivity
and a relative decrease of dopamine in relation to
serotonin gives rise to rigidity and tremor-like
movements. If in hyperactive, exophtha 1 amic, jumping
rats the dopamine-to-serotonin ratio is reversed by
harmaline administration to a value of less than unity
the motor symptoms are also reversed. Only the ratio
of these two amines in the striatum is crucial for the
motor effect.
The biochemistry of mental disorders is a rapidly
growing area, and of.late the dopaminergic system has
received increasing attention. However, Barbeau (1972),
although careful not to suggest an alternative to Brodie's
"serotonin hypothesis" and to Schi1dkrant's "noradrenaline
hypothesis" of depression, does draw attention to the role
of dopamine in Parkinsonian depression. Some
drug-induced depressions have been reversed with L-dopa
(but see Barbeau, 1972); and there is an "apparent
reversal of the state of depression (at least the
'reactive' component) in most, but not all parkinsonian
patients treated with L-dopa" (Barbeau, 1969). The
implicit relationship between dopamine and serotonin in
Parkinsonian depression adds further weight to the
importance of taking a more global view of the
biochemical aspects of the disease.
The amine-ratio suggested by Hassler and Bak, and
evidence such as that discussed above concerning the
function of serotonin, are highly pertinent to aspects of
the pathogenesis and treatment of Parkinsonism, but this
line of approach has not yet been fully explored.
Hornykiewicz considered serotonin not to be a critical
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amine since, among other reasons, increasing serotonin
concentration levels did not reduce the symptoms of the
disease. Hassler and Bak's work, however, suggests that
if the serotonin - dopamine ratio is reduced gross
hyperactivity develops. The relevance of the serotonin -
dopamine ratio to the hyperkinetic side-effects in some
patients from dopamine therapy has not been tested. If
this relationship were supported experimentally, one
would possibly be able to explain why patients develop
these side-effects, and an alternative means of treatment,
which would not necessitate reduction of dopamine therapy
with the consequent sacrifice of efficacy of treatment,
would be available.
This type of amine equilibrium hypothesis has been
used before. The hypothesis that Parkinsonian akinesia
and rigidity are due to disequilibrium between
antagonistic monoaminergic (MA) and cholinergic (ACh)
neurone systems was advanced by Barbeau (1962). Under
normal physiological conditions a delicate functional
equilibrium exists between the excitatory cholinergic and
the inhibitory dopaminergic mechanisms within the
striatum which enable it to function as a higher
regulatory centre for subcortical (1extra-pyrami da 1 1)
motor activity. In Parkinsonism, depletion of dopamine
reduces the inhibitory influence, and allows excessive
cholinergic effects. (see FIGURE 14)
The hypothesis is well supported by several clinical
and neuropharmacological observations. For example, it
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is well known that physostigmine and other centrally
acting cholinergic drugs significantly aggravate
Parkinsonian symptoms (Duvoisin, 1967). In animals
reserpine (which depresses MA activity and depletes
striatal dopamine) produces striking Parkinson-like
symptoms (Carlsson et al., 1958). Moreover, L-dopa
injected into such reserpine-treated animals restores
(albeit transiently). the striatal dopamine levels and
reverses all the symptoms induced by reserpine (Carlsson
et al., 1957). In man. L-dopa has been shown to
counteract several signs of reserpine action (Degwitz
et al., 1 960 ).
THE DISEQUILIBRIUM HYPOTHESIS OF PARKINSONISM
FIGURE 14
On the basis of experimental analysis of drug-induced
akinesia and rigidity in animals, Steg (1969) has
extended the disequilibrium hypothesis of Parkinsonism
into an extremely interesting and plausible
neurophysiological model linking peripheral and central
mechanisms:
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The central nervous system controls the muscles via
the a- and y-efferent systems. The contraction of the
skeletal muscle is controlled directly from the a-moto-
neurones. The y-motoneurones innervate the muscle
spindles and regulate the muscle length via monosynaptic
stretch reflex arc. Normal motor function requires the
participation of both of these routes of efferent muscle
control. Reserpine and physostigmine increase the a~ and
decrease the y-motoneurone activity simultaneously with
the appearance of akinesia and rigidity. L-DOPA and
atropine respectively abolish the akinesia and rigidity
and restore the normal balance between the a- and
Y-motoneurone activity.... It is suggested that the
rigidity is due to a-motoneurone hyperactivity and that
the akinesia is due to y-motoneurone hypoactivity.
The hypothesis of functional disequilibrium in
Parkinsonism is helpful. It emphasises the inter¬
relationships of the biogenic amines and it provides a
useful model for explaining the beneficial effects of the
major anti-Parkinsonian drugs presently in clinical use.
Anticholinergic drugs are efficacious because they
decrease the relative predominance of cholinergic activity
in the striatum and hence restore the dopamine -
cholinergic balance. L-dopa therapy, on the other hand,
raises the dopamine level till it balances the excessive
cholinergic level. It is clear tha't in these two cases
equilibrium is reached at different amine concentration
levels: the anticholinergic drugs can restore
equilibrium at much lower than normal levels, and L-dopa
which theoretica11y 'normalizes' striatal dopamine
establishes equilibrium at approximately the normal level.
Thus it can be expected that both anticholinergic and
dopaminergic drugs will exert, a beneficial effect and
reduce Parkinsonian symptomatology, and that dopaminergic
drugs will be far more effective than the relatively
weaker anticholinergics. (see FIGURE 15) Furthermore,
one would predict that the anticholinergic drugs, in
controlling the activity of the striatal cholinergic
mechanism, would have an observable effect ori rigidity
and tremor, whereas dopaminergic drugs, in correcting
the basic dopamine deficiency, would primarily affect
akinesia. And, as is apparent from preceeding discussion,
clinical evidence supports this pharmacotherapeutic
hypothesis.









SPEECH DISORDERS AND PARKINSONISM
A REVIEW OF LITERATURE FROM 1817 TO CIRCA 1960
SPEECH DISTURBANCE IN PARALYSIS AGITANS
"Paralysis agitans" was first described by a London
physician, James Parkinson, in his monograph An Essay on
the Shaking Ealsy (1817). Parkinson's writings show him
to be a man of astute observation and methodical approach.
Throughout his monograph he collated his observations and
drew parallels between his patients' symptoms thus
providing concise summaries of salient features of the
disease.
James Parkinson recognized disturbances of speech to
be an important feature of the disease which now bears
his name. The disturbances manifest themselves with the
passage of time and the concomitant progression of the
disease. Once the disease has progressed to involve both
halves of the body, Parkinson observed, both speech and
the intimately associated vegetative functions are
impaired. This observation is of central importance in
Parkinson's formulation of a hypothesis concerning the
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site of the responsible lesion. Although his actual
location of the lesion has since been shown to be
inaccurate, the logical sequence through which he worked
can hardly be faulted.
By the nature of the symptoms we are taught, that the
disease depends on some irregularity in the direction
of the nervous influence: by the wide range of parts
which are affected, that the injury is rather in the
source of this influence than merely in the nerves of
the parts; by the situation of the parts whose actions
are impaired, is the order in which they become affected,
that the proximate cause of the disease is on the
superior part of the medulla spinalis; and by the
absence of any injury to the senses and the intellect,
that the morbid state does not extend to the encephalon. . .
From the impediment to speech, the difficulty in
mastication and swallowing, the inability to retain, or
freely eject, the saliva, may with propriety be inferred
an extension of the morbid change upwards through the
medulla spinalis to the medulla oblongata, necessarily
impairing the powers of several nerves derived from that
portion into which the morbid change may have reached.
The nature of the speech disturbances are not
particularly well described by Parkinson himself. He
wrote of one patient's words being "scarcely intelligible";
of cases 2 and 6 having their speech "interrupted"; and
with reference to another patient, he referred to the
"impediment to speech". He did, however, include in his
monograph the full and descriptive case notes of the
Count de Lordat, which were written by Dr. Maty. It is
from these notes that a clear picture of advanced
Parkinsonian dysarthria emerges. Take, for example, this
passage:
What words he still could utter were monosyllables, and
these came out, after much struggle, in a violent
ex-piration, and with such a low voice and indistinct
articulation as hardly to be understood but by those who
were constantly with him... his senses, and the powers of
his mind jwerej unimpaired; he was attentive to,
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and sensible of everything which was said in conversation,
and showed himself very desirous of joining in it; but he
was continually checked by the impediment in his speech,
and the difficulty which his hearers were put to.
To his colleague's excellent description Parkinson
added one important feature - the temporal disturbance,
"festination". Parkinson was not the first to observe
festi nation per- se. He himself credits da Sauvage with
the term "festination" and Gaubius with being the first
to observe and describe the phenomena of hurried talking
and walking. In his monograph, Parkinson provided the
following translation of a key passage from Gaubius1
wri ti ng:
Cases occur in which the muscles duly excited into action
by the impulse of the will, do then, with an unbidden
agility, and with an impetus not to be repressed,
accelerate their motion, and run before the unwilling
mind. It is a frequent fault of the muscles belonging to
speech, nor yet of these alone: I have seen one, who was
able to run, but not to walk.
At the time when Parkinson's monograph was published,
festination was considered a syndrome in its own right,
Parkinson, however, had noted sufficient evidence of -
festination in both the speech and gait of patients to
correctly insist that festination was not a separate
entity but rather yet another manifestation of the
"shaking palsy".
Parkinson's monograph was favourably received by the
medical world. Soon after its appearance, John Cooke, in
his Treatise on Nervous Disease (1820 - 1823), considered
Parkinson's work to "be highly deserving our attention",
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arid therefore decided to "here give a short account of it,
though neurologists have not classed it among the palsies".
Although Cooke's 'account' is reasonably full, he ignored
completely the speech disturbances. In France, Charcot
introduced the eponym "Parkinson's disease", and included
the disease in his teaching syllabus. Although from
records of Charcot's lectures (see, for example, Charcot,
1887) it appears that he, too, ignored the speech
disturbances of Parkinson's disease, McHenry (1969)
recently claimed that:
Charcot would mimick the various gaits, tremors, tics,
spasms, cramps and abnormal posture or voice1 of the
patients afflicted with the disorder he was discussing.
To emphasize a point he would use any means. When he
lectured on tremors, he had three or four women brought
in who were wearing hats with long feathers, which by
their quivering made it possible to distinguish the
specific characteristics of tremors in various diseases.
It was by such means that he established the differential
disgnosis between the tremor in paralysis agitans and
disseminated sclerosis.
During the years which followed, Parkinson's
monograph continued to influence both the clinical and
the research side of neurology. Clinicians concerned
themselves with differential diagnoses, and scientists
with two aspects - locating the causal lesions, and
describing the mechanism of tremor and rigidity. No one,
however, considered the speech disturbance, and this, at
first glance, is surprising. The years that followed the
publication of Parkinson's monograph were years
characterized by the efforts to describe the neurological
substrates of communication. The work of Bouillard, Max
Writer's own italics
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Dax, and Broca provided the impetus for an unprecedented
wave of excitement and activity throughout Europe. But,
it was to the neurology of language and to the disorders
of language - aphasias, apraxia, agraphia, dyslexia,
aphonia, amusia, acalculia, and others, that attention was
directed. The dysarthrias, and particularly the
dysarthria of Parkinson's disease were for the most part
passed over.
THE TRADITIONAL VIEW OF DYSARTHRIA
The consenus of opinion concerning "dysarthria" was
that it referred, quite simply, to the articulation
produced by weakened muscles. It was easily differentiated
from other disorders of communication and its underlying
mechanism tacitly assumed to be understood.
Ironically, nowhere is the concept more explicitly
stated than in the published proceedings of a meeting
held by the Society of Neurology of Paris, held on June
11, 1908. On that day, as on two subsequent occasions,
the French neurologists met to discuss aphasia. Provoked,
as usual, by Pierre Marie's highly idiosyncratic
diagnostic categories and use of the terms "anarthria"
and "dysarthria" (co-terminous for Marie, see Marie (1906a),
footnote 10 in Marie (1906b) and footnote 9 in Marie
(1907) , Dejerine was moved to make the following
statement, - and in so doing, provided one of the clearest
descriptive definitions of the disorder:
The words dysarthria} and anarthria} have in semiology a
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special meaning admitted by everyone and signifying a
difficulty with or an impossibility for the articulation
of words. The motor asphasic in no way resembles the
dysarthric or the anarthric; indeed, when he has
conserved the faculty for pronouncing some words, in
general always the same ones, these words he generally
pronounces very correctly, sometimes emphasizing a little
bit as a child does who is learning to talk. But these
few words are the only ones which he has at his disposal,
and he is unable to pronounce any other...
How totally different is the condition of the speech
in the case of the dysarthric or the true anarthric,
whether it be a paralytic dysarthria such as the true or
the pseudobulbar, the general paralytic, or the ataxic or
spasmodic dysarthric (as in multiple sclerosis). In all
these cases only the articulation is affected. Indeed the
subject can pronounce all words but he pronounces them
badly and his language is much more incomprehensible as
his dysarthria is more advanced, to a point where - and in
the cases with a progressive form (true and pseudobulbars)
it is not easy to note - the patient becomes completely
anarthric, that is to say, it is impossible for him to
articulate any word. And in the case of these subjects —
pseudo - and true bulbars - the problems are not limited
to articulation of words but include the movements of the
lips in the act of whistling and blowing, those of the
soft palate - rhinolalia aperta of the voice and disorders
of deglutition - difficulty of the tongue - slowness and
laziness of movements. They show very well that it is a
question here of disorders of paralytic origin, ending
eventually in a more or less complete paralysis of these
different organs. But one never sees such things in the
case of a motor aphasic who has intact the functions of
the bucco-pharyngo-1aryngeal apparatus for all movements
other than those of speech.
No one at the meeting challenged Dejerine's
presentation of the traditional differentiation between
the two disorders. On that, at least, they were all in
accord. Marie, for his part, remained equally adamant
that he was not concerned with the dysarthria Dejerine
defined. "I do not see why, he insisted (1908a), "I
should be refused the right to utilize this word to
designate problems of articulation in motor aphasia... I
have given the name anarthria to disorders of articulation
which constitute all the symptomatology of the
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pathological state today called pure motor aphasia."
Later in the same discussion he returned to this point
saying: "My contradictors are moved by an erroneous
idea,... They suspect me of trying to sustain that my
"anarthria" is only a simple disorder of the peripheral
organs of articulation. - And in this they are wrong...."
The phrase 'only a simple disorder of the peripheral
organs of articulation* succinctly expresses both the
scope that the disorder was seen to have, and the
dismissive, if not contemptuous, manner with which it was
dealt. And indeed, on the surface, there seemed little
to be gained (apart from verifying Parkinson's
observations), in considering the question in more
detail. Disturbed acts of articulation and speaking are
speciously simple: if the basic vegetative functions of
breathing, of chewing, and of swallowing are disturbed
so too will be speech. Parkinson himself observed the
co-association of these disturbances. The relationship
between these functions is an intimate one, and nowhere
is it more beautifully described than in the introductory
chapter R.H. Robins wrote in 1971:
The material of speech, sounds emitted from the vocal
tract, is limited, but is range and application, nothing
less than the entire furniture of earth and heaven and
all our doings therein, is unlimited. Yet speaking is
only a by-product, an exploitation of waste: with few
exceptions, that do not alter the general picture,
speaking is simply the noisy interference with expiratory,
used, air as it passes up from the lungs through and over
the various organs of speech: glottis, tongue, palate,
teeth, lips, nasal passage, etc. Breathing out,
expiration, is a biologically essential process of ridding
the lungs of air charged with carbon dioxide. The energy
expended in additionally interfering with it to make
noise, that is, to speak, is minute. In the light of the
place taken by language (i.e. by speech) in human life as
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we know it, one may challenge anyone to name any other use
of spent material that comes anywhere near it in power
and significance. Moreover the organs of speech, as they
are called, the tongue, the teeth, and so on, are not
primarily organs of breathing and the stomach the organ of
digestion; they are organs performing a number of
functions in the economy of the human body, and speaking,
noisily and purposively interfering with spent breath, is
just one function superimposed on them.
This view of speech and its dependence on the
integrity of innervation is undeniable, but it is not
comprehensive enough to explain all the disturbances of
speech which occur in Parkinson's disease. Festination,
for example, cannot successfully be incorporated into a
simple theory of motor dysfunction.
Interest in dysarthria was rekindled in the early
part of the twentieth century, and new observations taxed
the concept of 'dysarthria' even more. Indeed, observed
phenomena were not compatible with the classical theory,
and could never have been predicted by it.
SPEECH DISTURBANCE IN POST-ENCEPHALITIC PARKINSONISM
The encephalitic epidemics that ravaged Europe and
Britain during the First World War, left their mark, in
a large proportion of patients, in the form of sequelae
resembling, in varying degrees, the symptoms of paralysis
agitans. Hall (1924) who published an erudite and
conprehensive book (based on his Lumleian Lectures
delivered before the Royal College of Physicians of London
in the preceding year) on the subject of post-encephalitic
Parkinsonism, unfortunately makes only the briefest of
passing comments on the speech disturbances. All he says
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is, "Explosive crying or laughing; repetitions of speech,
palilalia (described by Souques in 1903); torsion
movements...." European neurologists provide more
detailed discussion of speech involvement; at least half
a dozen papers were published which treat the topic in
some depth.
In the same year that Hall published his book, Leyser
provided the first serious clinical description of speech
disorders in patients with post-encepha1itic Parkinsonism.
He defined three types of speech dysfunction: palilalia,
an akinetic form and a rigid form. In addition, Leyser
made two important observations regarding the speech of
these patients. He believed the central character!stic
to be one of monotonous, weak speech with vague
articulation due to the reduced amplitude of articulatory
movements, and not, he emphasized, to rigidity, since the
facial muscles of these patients are by no means 'rigid'.
The second characteristic of their speech, is the
acceleration of speech into an unintelligible murmur.
Leyser was thus one of the first to accept akinesia as a
basis for many of the symptoms presented in the disease.
Unfortunately, however, neither the work of Leyser,
nor the concept of akinesia introduced by Kinnier Wilson
(1925) made much impact on subsequent work. Indeed, the
very next year, 1925, saw publication of a paper by
Schilling, in which 'rigor' of the vocal folds was
suggested as underlying the disturbances of speech.
Schilling's patients (1925) had one characteristic
which differentiated them from the series by Leyser: they
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all were known to have recently had the disease - from a
'few' months to a 'few' years. Schilling's findings,
reported in German, are summarized in English by Grewel
(1 957):
The regular undulations of the intermediate rest
position of the thorax during vegetative breathing are
not seen in these patients. Breathing movements are
wider in extent but more irregular than in normal persons.
Physiological division of exhalation into a fast and a
slow phase is more pronounced than in healthy people, the
slow phase being excessively slow. Breathing pauses
between the respirations are longer than normal and the
relation between thoracic and abdominal respiration is
more constant than in normal persons.
During speech the synchronisation of thoracic and
abdominal respiration is even more manifest than in
quiet breathing. According to Schilling these patients
have, during their speech, periods of increasing depth
of breathing, alternating with periods of stagnation of
respiration. During the periods of propulsivity, when
speech changes into a soft murmur, respiration, contrary
to articulation, may remain undisturbed, but in other
cases, it is shorter and shallower and may even stop.
Only rarely paradox movements of the vocal cords are
noticed. The range of the voice is considerably
decreased, the patients can no longer sing, and in
singing, as in speaking, the chest resonance is lost.
Speech melody is increasingly monotonous, especially so
because the expressive tune (pitch range and shifts of
pitch, inflections or glides, and intonation) disappears.
Objective speech, eagerness, emphasis, or strong emotions
are no longer distinguished. Moreover, rhythm does not
change; the patient is monod.ynami c-. Articulation of
vowels and consonants is insufficient owing to the
impaired movements of lips and mandible. Vowels are
pronounced vaguely and "thinly", consonants insufficiently
loud and blurred.
In 1940, Cramer published her findings of an
experimental investigation of six post-encephalitic
patients in the Phonetic Laboratory of the University
of Amsterdam. The equipment used included gramophone
recordings of the patients' speech, smoke drum recordings,
oscillograms, Wothlo's apparatus to measure exhalation,
the head-apparatus of Zwaardemaker, etc. It was a most
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thorough study of speech, using the most up-to-date
equipment available at the time. Her results are compatible
with those of Schilling.
Cramer found respiration to be shallow, with
frequent inspirations and a soft or aspirated commencement.
Very little difference was found between 'normal' or
'vegetative' breathing, deep respiration, and respiration
during reading. In comparison with 'normals', vital
capacity was reduced, and inspiration and expiration
occurred up to 1| times as frequently.
The investigations of prosody demonstrated a
reduction of pitch range during reading, similarities in
'sentence tune' between parts of the same sentence,
between items on a list of bisyllabic words. According
to Cramer a reduction in prosodic features, particularly
the downward inflection at the end of phrases or sentences
was found to be lacking. Concerning singing ability,
Cramer considered that provided due allowance for the
disturbances of respiration and articulation were made,
patients were able to sing a well-known tune 'reasonably
well'. Stress patterns were generally undisturbed
(although some deviations were observed), while timbre
was found to be altered.
Articulation was so disturbed as to reduce speech,
in some cases, to a 'murmur1. Syllables, it was found,
might be repeated, omitted, and superflous ones added.
Phonemic identification was often impossible in the
speech of patients, but when they were identified, it
was observed that certain phonemic changes occurred,
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such as explosives being substituted by fricatives
(e.g. imperfect /s/ and /z/ for /1/ arid /d/) . Cramer
believed this to be a direct consequence of the rigid
state of the articulatory muscles, and demonstrated this
using two sets of apparatus. The head-apparatus of
Zwaardemaker produces a graph representing the movements
either of the mouth or the lips. In 'normals', the
graph is characterized by variations of fluctuations that
corresponded to vowels and consonants in speech. These
f1unctuations are characteristic and easily identifiable.
In the post-encephalitic Parkinsonian patients, the graphs
were so flat as to be virtually a straight line. The
'width of mouth opening' graph was found to be so little
differentiated that the distinction between vowels and
consonants was extremely difficult, and the identification
of the different vowels impossible. A similar picture was
found in the curve depicting lip movements. The normal
excursions of the graph for articulation sounds is much
reduced in those patients, and all that is seen are
slight waves in the graph, which cannot be, with
confidence, differentiated from a graphic representation
of tremor in the muscles concerned. The second apparatus,
a smoked drum, also provided graphic representation of
movements. For this investigation, patients were
required to make sounds (e.g. 'zaa' or 'aas') or imitate
movements (e.g. yawn or grind their teeth) which
necessitated large movements of the mandible. Only a
negligible range of movement was demonstrated. Whether
in fact this indicates, as was supposed, that rigidity
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underlines the articulatory disturbances manifest by the
patients, is open to challenge. It is far more plausible
to postulate akinesia as the basis for reduced range of
movements than the rigidity adduced by Cramer.
Rate of utterance was found to be slow. This,
Cramer observed, to be due to the length of both pauses
and syllables. When smoked drum recordings were made
patients' readings, the post-encephalitic Parkinsonian
patients were shown to speak less words per unit time,
and to have more pauses than 'normals'. Furthermore,
when patients read the passage, it was found that their
'syllabic length' was 1| times greater than that of
'normals', but, interestingly, patients read a series of
unconnected words faster than the normals.
Grewel (1957) confirmed many findings made by
previous workers, and also added new observations to the
growing collection of data. He agreed with Cramer and
Schilling in their descriptions of breathing, phonation,
and articulatory disturbances. He confirmed their
findings regarding the narrowing of pitch range,
restriction of stress and intonational patterns, and on
the one point where Schilling and Cramer differ, he
supported Schilling and maintained that post-encepha1itic
Parkinsonian patients are unable to sing.
In addition, he observed that after the onset of
acute encephalitis, speech is slow and difficult. He
noticed "hyperkinetic phenomena: clonic stuttering,
logoclonic repetitions at the beginning or at the end
of a word, hyperkinesia of the tongue and the mandible
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and accelerated speaking". And in a small number of
cases there were more profound disturbances. These he
listed as "conspicuous interruptions of the speaking
drive, palilalia, and/or impulsive shrieking-, wailing-,
and howling-attacks".
He agreed with Schilling in his observation of
festination ending in dysphonic, or even in some cases,
aphonic murmurings. .But he went one step further, and
saw in the phenomenon 'compulsive' aspects: "In rare
cases this murmur continues 'automatically' for some
time, the patient being apparently unable to interrupt
this stream of abortive speech."
However, Crewel's most important contribution must
be this observation: "The patient has a growing
difficulty with the start of speech; a certain
hesitation, a slightly tonic drawing or trailing noticed
at the start, and finally it is manifestly difficult to
initiate speaking movements at all, as in the case with
any other movements in post-encephalitic Parkinsonism."
It is indeed a somewhat contradictory, and most
interesting, picture of the speech of these patients
which emerges from the literature. On the one hand there
is difficulty in starting speech which Crewel described so
well, and on the other, difficulty in stopping, noticed
by Schilling and confirmed by Grewel. Unfortunately,
Grewel comments neither upon this picture nor how it can
be subsumed under the rubric of dysarthric disturbance.
Grewel identified four factors as being responsible
for the dysarthria: the 'impaired achievement of
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intended innervations'; festination (his 'phenomenon of
propu1sivity ' ) ; rigidity and hypokinesia; and pseudo-
dysdi adok.oki nesi s . 1 Pseudo-dysdi addkoki nes is 1 is an
impairment of the subtle co-ordination of muscles, and
according to Grewel is possibly the most important factor
of al1.
A REVIEW OF LITERATURE FROM CIRCA 1950
The publication by Tretiakoff (1919) of observed
cell loss i ri the pars compacta of the substantia nigra
in the brain of Parkinsonian patients led to a
reassessment of the pathogenesis of the disease. More
recently, in the late 1 950's in particular, several
developments in the theory and method of treatment of
the disease were reported. The possibility of being
able in some way to mitigate the invariable progression
of the disease, and the prospect of being able to take
the first steps towards an understanding of the
mechanisms underlying both symptoms and disease process,
enabled the patient and his disabilities to be seen in a
n ew light.
This change in climate affected also those
disciplines which considered communication and its
disorders within their sphere of study. After 1950, an
increasing number of speech pathologists, audiologi sts,
psychologists, psychophysiologists and psych one urolo gists
investigated the function and 'dysfunction' of the basal
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ganglia, and the reports of these investigations were no
longer published solely in neurological journals. This
multidisci piinary approach lead to investigations on a
broad scale. To a problem indeterminate in concept,
classification and terminology, the behavioural
scientists brought new methods, new tools, and new
theories. While the quality of the experimentation
arising from this collaboration is often disappointing,
the collaboration itself has been most productive. In
comparison to the paucity of research prior to the 1950's,
the later period is characterised by both the wealth and
the breadth of its research.
There is no comprehensive review of this work; Calne
(1970) in his recent monograph devotes only one paragraph
to speech. This section is an attempt to fill the gap:
it is concerned primarily with the question of speech
disturbance associated with lesions of the basal ganglia,
but it shall, if in only a cursory manner, draw attention
to the scope of work as a whole that arose from the
interdisciplinary collaboration.
The modern work on speech falls into two categories.
There are studies which in essence are attempts at
scientific or objective corroboration of the descriptive
writings based on clinical observation. If any general
conclusion is to be drawn from this work it must be that
a trained ear is a reliable assessor cf speech disturbances,
and in many ways superior to equipment available at
present. The second group of studies are characterized by
an approach which satisfies at least one requirement of
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scientific experimentation. Based as they were upon
observations of behavioural changes during or after
stereotactic surgery for the relief of Parkinsonism,
they have as the identifiable and measurable independent
variable the electrical stimulation and/or an induced
lesion. However, reports similar to Marion Smith's (1967)
suggest that the location of surgical lesions is imprecise
and question both the validity and the reliability of the
method. Differences in surgical techniques used by
different neurosurgeons make assessment of reliability
difficult. Furthermore, although a new range of
experimental possibilities is offered by this method on a
practical level, investigations are restricted by ethical
considerations.
DESCRIPTIVE STUDIES
In the early 1960's, Gerald Canter, a speech
pathologist, investigated a group of seventeen Parkinsonian
patients. His work is fully documented in his PhD
dissertation (1961), and a series of three articles based
on this work (1963, 1965a, and 1965b). The work itself
falls naturally into two parts. The first is essentially
an objective (or, as Canter described it a "scientific")
description of the patients compared to an age-matched
control group. In many ways this part of Canter's work
closely parallels that of Cramer's carried out twenty years
earlier. For all the sophisticated apparatus and
laboratory expertise at his disposal, for all his care in
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establishing reliability of equipment before embarking
upon the study proper, for all the number of parameters
investigated, and for all the time spent on many of the
analyses (e.g. pitch analysis of each subject's test-
sentence took between one and two hours), Canter's work
on the whole is disappointing. Data so meticulously
collected and analysed warrants statistical treatment in
a manner more sophisticated than the mere recording of
means, medians and ranges for the 'experimental' and
'control' groups on all parameters. Nevertheless,
reported within this first part of Canter's work are
three extremely interesting findings.
Canter looked at a number of parameters which
define what he terms "physiological support" for speech.
These were chosen because they measured maximum
performance levels of the speech mechanism, and on all
parameters patients performed far less well than the
controls. Patients were found to have reduced pitch and
loudness ranges; to be unable to produce sounds as highl¬
and as low-pitched, or as loud and as soft as the controls;
to be unable to sustain phonation for as long as the
controls cauTd; and; to have lower diadokoki nesi s rates
than the controls. Canter believes his findings indicate
that patients do not utilise their "maximum function for
speech", and that the basis of this is not a reduction of
"motivation for effective communication" (as Zimmerman et
al., 1959, for example, believed), but rather, a reduction
of the "physiological support" necessary for adequate
speech. Canter believed that to improve speech in these
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patients efforts should be directed towards extending the
physiological support rather than towards increasing
"motivation".
His reasoning is most persuasive. He states that:
... many of the patients were already employing a large
proportion of what would normally be 'reserve function'
for simple continuous speech. In addition, their reserves
were so limited that even if they had employed their
maximum capacities for continuous speaking, speech would
have remained defective. Moreover, clinical experience
suggests that when an individual has to operate close to
his maximum for conversational speech, or to 'dip deeply
into his reserve', the fine control necessary for
efficient speech production is impaired even further.
On the physical parameters that correlate with what
is perceived as 'loudness', Canter found that the patients
did not appear to perform in a markedly different manner
from the controls. This finding that patients spoke as
loudly as controls is neither what Canter himself expected,
nor what one is led to believe from the literature. Canter
suggests as plausible explanation that the perceived
loudness reduction is in fact 1 istener-error. As Canter
summarises it: "It was speculated that the impression of
inadequate loudness in the speech of some of the
Parkinsonian patients might have been due to the added
perceptual effort demanded of the listener in his attempt
to understand these patients' indistinct articulation."
There is, however, another factor that Canter does not
account for. Canter's patients were all ambulatory, and
hence, were not markedly impaired in general motor
activity, nor, presumably, in speech function. It may
well be that 1istener-judgement of reduced loudness has
physical correlates measurable on current methods only in
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later stages of the disease. Production of sound for
speech is a gross motor act, requiring little of the fine
co-ordination other aspects of speech, such as articulation,
demand. It seems reasonable to expect that as the severity
of the disease progresses, mean sound-pressure levels of
patients would gradually differentiate themselves from
those of controls. Mo one to date has attempted such a
longitudinal study, although the results would be
interesting. Intuitively, the corollary would seem
plausible. If one were able to reverse the progression
of the disease in a patient whose voice was shown clearly
to be reduced in loudness, one would expect voice volume
to increase before improvements in articulation, etc.,
were apparent.
Canter found another puzzling phenomenon. When
comparing the way his patients and controls performed on
the variety of test parameters, he found that the patients
tended to differ from each other as much as they differed
from the controls. This failure to demonstrate a
consistent profile of the character!stics of Parkinsonian
speech is unexpected. It could be a product of Canter's
sampling procedure; or it may be that a trained ear is
superior to present technology for the identification of
distinctive patterns of disordered speech. For
distinctive and identifiable they indeed are. Darley et
al. (1969a, 1969b) have clearly demonstrated that their
panel of three judges were able to identify ten dimensions
which successfully differentiate the speech of
Parkinsonian patients from the speech of patients with
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other neurological involvement. This cluster of dimensions
which was empirically demonstrated to have predictive
value closely resembles the collective observations of
previous workers:
The 32 patients in the parkinsonian group presented
phenomena constituting what may be called "hypokinetic
dysarthria". . . . All four of the neurologic groups1
previously reviewed displayed mono-pitch'1 and monoloudness
but the severity of these dimensions is decidedly greater
in parkinsonism; together with reduced stress they
comprise the most striking phenomena. Related prosodic
changes distinctively present here are inappropriate
silences3 short rushes of speech3 and variable rate. It
will be seen that this is the only type of dysarthria in
which rate is not characteristically slow; it is
typically quite variable and, considering the group as a
whole, is rated as slightly fast rather than on the slow
side. Imprecise consonants is prominent, apparently being
the result of reduced excursion of the articulators rather
than simply the rate of articulation. Both harsh voice
and breathy voice are heard.
The second part of Canter's work marks a significant
change in the design of investigations. Previous work on
speech disturbances (with the notable exceptions of
Cramer's, and of course, Canter's own laboratory studies)
was based on clinical observation of patients. Canter was
the first to set up a situation in which a panel of
sophisticated listeners were re quired to make judgements
about pre-recorded samples of Parkinsonian speech. Canter
asked three judges to rate the recordings (from 'best',
Rank 1, to 'worst', Rank 17) on two parameters: clarity of
articulation, and overall speech adequacy. On the basis
of these two sets of ratings together with several
ibulbar palsy, pseudobulbar palsy, amyotrophic lateral
sclerosis, and cerebellar disorders
2names of 'dimensions' are in italics
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parameters of disease history and symptomatology, a series
of correlations were carried out. It was shown that
clarity of articulation correlated highly with judgements
of adequacy of speech, that longer duration of illness
and that disease of post-encephal1tic origin tend to be
associated with inadequate speech. However, Canter was
unable to demonstrate any relationship between adequacy
of speech and degree of tremor or rigidity.
Canter's final correlation represents a theoretical
watershed. He adduced the possibility that dysarthria
might depend on higher, or more central, neural functions.
Canter introduced the topic thus:
The importance of the left cerebral cortex in speech
and language functioning is well recognized. Little is
known concerning subcortical localization of function,
however. It was speculated that patients whose motor
impairment was predominantly on the right side of the
body, and who could therefore be presumed to have greater
involvement of the left side of the brain, might have
more severely defective speech than the patients whose
symptoms were predominantly on the left side of the body,
and whose neural involvement was presumably greater on
the right side of the brain.
The second half of this century has been
characterized by a pre-occupation with asymmetry of
functional representation in the brain. At least one
major neuropsycnological conference has taken place
dealing exclusively with this topic (see Mountcastle,
1962). It is not surprising that the question 'Does
laterality of brain-damage have an effect on speech (as
opposed to language)?' be asked at this particular point
in time. Approached from the other side, however, the
question is indeed extraordinary.
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Dysarthria has persistently been defined in a
manner most restrictive and fully consistent with the
traditional concept outlined in a preceding section of
this chapter: it was a 'disturbance of articulation'
and no more. Peacher, over two decades ago, pointed out
the need to up-date the formal definition to include more
than articulation. He believed current usage of the term
indicated an extension of the concept to include, in
addition to articulatory disturbance, disturbances of
resonance, of stress patterns, etc. (Peacher, 1950).
Grewel (1956) went further and made out a most persuasive
case for using the term in the plural form by illustrating
that the 'dysarthrias' in the various neurological
categories are sufficiently different and identifiable to
warrant this. However, neither Peacher and Grewel, nor
indeed any of the speech pathologists or neurologists who
held similar views, went any further than pressing for a
redefinition along more empirical and practical lines. No-
one challenged the basic constraint of the concept, i.e.
it was a disorder of motor, effector or peripheral
function due to paralysis or paresis of muscle. In fact
Darley et al. (1969a) are explicit on both the scope and
limits of the definition of dysarthria they subscribe to.
In an article, Patterns of Dysarthria, they explain
that they:
...will use the traditional term "dysarthria" but will use
it to encompass coexisting motor disorders of respiration,
phonation, articulation, resonance, and prosody (those
variations in time, pitch, and loudness which summate to
produce emphasis and interest in speech). However, the
term will be restricted - again in accordance with modern
usage - to speech dysfunctions that are neurogenic.
11 5
The concept of dysarthria emphasised the symptoms
and ignored completely aspects such as the site of the
lesion and the mechanism of symptom production. Even
with the amendments for which Peacher and Grewel pressed,
'dysarthria1 remained a somewhat sterile concept - a
1abel .
Canter's findings regarding laterality and speech
are disappointing. His data gave no indication that the
patients with predominantly right-sided symptoms and
these with left-sided symptoms were "systematically
different in speech adequacy". Instead, his findings
regarding patients with bilateral involvement support
both Parkinson and the traditional concept: his three
patients with bilateral affection had relatively
inadequate speech. However, the question which Canter
asked is one which will be found with increasing frequency
in subsequent research, for new techniques of
neurosurgery were introduced that lent themselves
particularly well to the investigation of laterality and
speech.
THEORETICAL CONSIDERATIONS
Traditionally all intellectual functions
including speech and language have been thought
to be located in the cerebral cortex, and more
speculations have been directed to this thin
sheet of tissue than toward any other cerebral
component. However, there are many other
structures that are demonstratably connected
with the cortex and with each other (often
only by circuitous routes). Every structure of
the brain is physiologically active and at
least some of the structures have been
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hypothesized to play a part in the same
intellectual functions that are more
frequently imputed to the cortex.
Lennebevg, 1967.
At the beginning of the century, in 1906, Pierre
Marie "startled the medical world" (Head, 1926) with
three papers in Semaine Medicale on 'Revision of the
Question of Aphasia' (Marie, 1906a, b, c). In this
aggressive manner, Marie began a dialogue, at times
extremely heated, with the champion of the orthodox
doctrines of aphasia, Dejerine. Marie's theories are
extremely interesting: it is his concept of 'anarthria'
that is particularly germane here - the interested
reader is referred to Marie's own writings and to Head
(1925) for full treatment of the theories pertaining to
aphasia. Suffice it to say here, concerning Marie's
concept of aphasia, that "...according to Marie, there
is only one true or primary aphasia, that of Wernicke,
characterized by some loss of intellectual aptitude.
When to this is added 'anarthria', we have the syndrome
known as 'Broca's aphasia'." (Head, 1926).
According to Marie, verbal communication consists of
two aspects - "interior" speech and "exterior" or
"articulated" speech. His distinction is virtually
identical to that advocated by de Saussure in his Cours
de Linguistique Generale (1916), the distinction between
"langue" and "parole" which so influenced modern
linguistics. For Marie (1908a) a disturbance of "interior"
or "articulated" speech mani fests as aphasia, - and a
disturbance of "exterior" or "articulated" speech as
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anavthvia. Anarthria does not refer merely to disturbed
articulation of sounds or words; it is a comprehensive
concept including a wide range of disorders from
phonation (Marie, 1908b) through intonation (Marie, 1906a)
to rate of speech (Marie, 1917). Of particular interest
is Marie's localization of this sensorimotor aspect of
communication. On the basis of clinical experience and
post-mortem evidence.Marie believed that sub-cortical
structures were involved: "For anavthvia, ...the lesion
p 1
is ji n | the region of the lenticular nucleus, either in
the nucleus itself, or in the anterior part and the knee
of the internal capsule, or in the exterior capsule."
(Marie, 1906a). Marie thus describes a "quadi1ateral
zone of anarthria" in a horizontal plane; he was not
able to delineate the superior and inferior limits of
his 'quadrilateral' (1906d, 1907).
It is interesting that although Marie recognized
that the right hemisphere played an equal part with the
left in the production of anarthria (1906a), he did not
elucidate why this might be so. However, he did point
out that anarthria arising from bilateral lesions in the
zones of the lenticular nuclei is more pronounced and
tended to be permanent (1906b); anarthria arising from
unilateral lesion/lesions tended to be transient and
less pronounced.
It is surprising, and not a little disappointing that
Marie did not extend his theory of anarthria to include
palilalia. Having written: "In cases where anarthria is
due to a lesion of the lenticular nuclei in the two
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hemispheres it can remain persistent, and then it often
coincides with the syndromes of pseudobulbar paralysis"
(1906a), it appears to be a small step to include
palilalia, a disorder first seen only in pseudobulbar
palsy, within the scope of his theory. Perhaps Marie
shelved the question of palilalia too long; in 1925 when
his second and last paper on palilalia appeared, (three
years after the first), Pierre Marie retired.
The second major theory concerning the role of
subcortical sturctures in communication was proposed by
Perfield, based largely on cortical electro-stimulation
studies, carried out together with Roberts. The problem
as Fenfield and Roberts saw it is explained in this
extract (1959):
It has long been assumed that the cerebral cortex
was the summit, funtiorially speaking, and that the
business of the mind was somehow transacted there. The
transactions were somehow to be carried out there by
means of "association" areas of cortex and the
transcorti cal fiber systems. According to this conception,
the visual information that came from the right half of
the visual field to the left hemisphere would have to be
made available across the hemisphere to the precentra 1
gyrus, so that appropriately patterned impulses could be
sent out to the right hand. But what about the other
hand, and the other field of vision, and what about the
plan of action?
It is obvious that the brain must have a central
coordinating and integrating mechanism. If this "machine"
is at all like other machines, there must be a place
towards which streams of sensory impulses converge. There
must be a place from which streams of motor impulses emerge
to move the two hands in simultaneous, planned action.
There must be neuronal circuits in which activity of
both hemispheres is somehow summarized and fused - circuits
the activation of which makes conscious planning possible.
In 1936, Penfield argued the case for locating this
"integrating system" within the diencepha1 on . He
believed there to be "evidence of a level of integration
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within the central nervous system that is higher than
that to be found in the cerebral cortex." Furthermore, he
believed there to be a "regional localization" of the
neuronal mechanism involved in this integration which is
most intimately associated with the initiation of
voluntary activity and with the sensory summation
prerequisite to it.... All regions of the brain may well
be invovled in normal conscious processes, but the
indispensib1e substratum of consciousness lies outside
the cerebral cortex, ... not in the new brain but in the
old... probably in the diencepha1 on .
By 1S52 Penfield had a name for his system - the
"centrencephalic system", a term he preferred to "highest
level of integration" suggested by Jackson; Penfield
disliked the connotation of Jackson's term, i.e. of a
separation between functional levels, and he disagreed
with Jackson's implication of the frontal lobes in
integration. And by 1959, Penfield had enlarged his
system
to include "the integration of varied specific functions
from different parts of one hemisphere".... The
subcortical coordinating centers... for speech are
integrating areas within one hemisphere. Thus, although
the centrencephalic system would not include the cranial
nerve nuclei of the brain stem, it would include all
those areas of subcortical gray matter (together with
their connecting tracts) which serve the purposes of
i nter-hemispheral integration and intra-hemispheral
integration.
More specifically, on the basis of three sources of
evidence - on extrapolation from research on monkeys and
apes; from his own electro-stimulation of the human
cortex; and from clinical studies - Penfield proposed the
following mechanism: the "posterior speech area", i.e.
Wernicke's, is reciprocally connected to the pulvinar and
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nucleus lateralis - posterior of thalamus; the
supra-marginal gyrus, i.e. the supp1ementary motor area,
to the pulvinar; and the "anterior speech area", i.e.
Broca's, to the centrum medianum. While accepting that
transcortical association tracts "are of importance, no
doubt", Penfield maintained that they are "certainly of
less essential importance than subcortical integration".
Penfield envisaged a "functional relationship" between
cortical areas via thalamic projections ("it is proposed,
as a speech hypothesis, that the functions of all three
cortical speech areas in man are coordinated by
projections of each part of the thalamus, and that by
means of these circuits the elaboration of speech is
somehow carried out."). Furthermore, Penfield viewed
'speech1, as opposed to 'language', as being bilaterally
represented ("There are no areas for ideational mechanisms
of speech on the non-dominant side, although the motor
mechanisms are the same as on the dominant side."). He
offered in support of his view, the observation that
stimulation of either the dominant or non-dominant "voice
control area" (in the lower portion of the precentral
gyri ) produces vocalization, and that a lesion in either
the dominant or non-dominant "voice control area"
produces "dysarthria".
The theories of Marie and Penfield, while concerned
with essentially similar areas of the brain, are
diametrically opposed. Marie sought to identify and to
distinguish between the neurological substrates of
language and of speech; Penfield sought to describe the
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substrate of all higher mental functions from speaking
to thinking, reading and writing. There are, however,
two aspects common to both theories: they both are based
on inference, and they both stress the importance of
subcortical structures in verbal activity. Marie
ascribed the function of the motor elaboration of speech
to the subcortex; Penfield ascribed the function of
mediating between cortical areas. An interesting and
critical question follows: if one were able to place
discrete lesions in specific parts of the subcortex of
man, what would result?
STEREOTACTIC SURGERY AND ITS EFFECTS ON COMMUNICATION
A common means of treatment for rigidity and tremor
in Parkinsonism is the stereotactic induction of a lesion,
usually in the ventrol ateral nucleus of the thalamus or
pallidum. The most consistent result that emerges from
the numerous reports of these stereotactic procedures is
congruent with the theoretical predictions made by both
Marie and Penfield: communication skills are closely
related to the functioning of subcortical structures.
While thalamotomy and pallidotomy undoubtedly reduce
tremor and/or rigidity, they frequently have the
unfortunate side-effects of exacerbating, and in some
cases of inducing, speech and language deficits. Cooper
(1961), for example, found that in about 10% of patients
who had undergone unilateral surgery, speech deficits
were manifest in the first two post-operative weeks.
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Bilateral surgery appeared to have an even more drastic
effect: out of 100 consecutive patients who had undergone
bilateral intervention, 18 experienced speech disturbances,
and 6 were left with "a lasting handicap, which simulated
the speech of pseudobulbar palsy". Similar results have
been reported by Waltz et al. (1966), Hermann et al.
(1966), and Spiegel et al. (1965). In 1969, Hankinson
stated that "the most persistent, troublesome, and widely
reported complication of bilateral thalamic lesions for
Parkinsonism is speech disturbances."
The first question to ask is: Are the induced
deficiencies in communication due not to the stereotactic
lesion placed in the subcortex, but, rather, to the
passage of a surgical instrument through the cerebral
areas on its way to the subcortical target?
Riklan and Levita (unpublished data reported in
Riklan and Levita, 1969) appeared to be the only ones
to have observed Parkinsonian patients during surgery
with this question in mind. Using brief tests of
language function "with an emphasis on alertness,
orientation, vocabulary, conversation, recent recall,
mental control, and the naming of common objects",
they established that
... the passage of the chemo- or cryosurgical cannula
through the cortex, the underlying white matter, and up
to the sub-cortical target area, was not associated with
any observable language or cognitive disturbance,
regardless of laterality of subsequent lesion placement
... In contrast, on occasions, apparent alterations in
linguistic fluency were associated with the passage of
the cannula through the thalamus or with the cooling of
the thalamic target following appropriate placement of
the cannula... Moreover, encephalography studies before
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and after cryosurgery lesions of the thalamus.,., suggest
that widespread edema is not a likely secondary
physiological consequence of surgery.
This finding is closely related to, and supported by
Bell's (1968) more general observation that "neurological
disorder may follow the making of a burr hole, but that
there is no recorded evidence that such a procedure has
resulted in dysphasia".
Three major types of communication disturbance are
consequent upon the stereotactic placement of subcortical
lesions: diminished voice volume; dysarthria; and
dys phasia.
Diminished Voice Volume
Allan et al. (1966), Hermann et al. (1966), and Bell
(1968) have reported that stereotactically induced lesions
lead to a diminution of pre-operative voice volume levels.
Hermann et al. (1966) found that unilateral left lesions
were more frequently followed by voice volume reduction:
67% of patients undergoing left-sided surgery exhibited
this reduction post-operatively as compared with 55% of
patients who had undergone bilateral or multiple surgery,
and 36% of patients who had had right-sided surgery.
Furthermore, they report that the lesion causing this
reduction of voice volume involved the internal capsule.
Bell (1968) however, established a clear relationship
between bilateral surgery directed towards the
ventrolateral nucleus of the thalamus, and post-operatively
diminished voice volume. In addition he found that this
diminution was relatively transient, and improved in the
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immediate post-operative period. In the case of a
dominant hemisphere lesion, however, the disorder residual
after three weeks tended to persist, whereas following a
lesion in the nondominant hemisphere in some cases voice
volume continued to improve for "some months".
Dys arthria
Speech disorders are a common sequel to subcortical
surgery. Hermann et'al. (1966) and Allan et al. (1966)
(reporting on the same group of 118 Parkinsonian patients)
suggest that the pre-operative Parkinsonian speech
disturbances are exacerbated by subcortical surgery, and
in particular, by unilateral left surgery involving the
internal capsule. Bell (1968), however, demonstrated
that the dysarthria exhibited following thalamotomy is a
product of surgery and independent of the pre-operative
Parkinsonian speech difficulties:
The pre-operative speech disorder appeared to be
exaggerated in only a few cases. The nasal intonation
of the voice of one patient was accentuated and two had
an increase in a difficulty in starting to speak. In
five cases "out of a total of 59J the diminished voice
volume and slurring present before operation were
accentuated. In other cases with a pre-operative
slurring of speech, the post-operative dysarthria was
qualitatively different, being accompanied by a marked
change in the pitch of the voice. Fourteen patients with
a post-operative speech disorder had not had a detectable
pre-operative speech disorder. The suggestion of a
relationship between the speech disorder after
thalamotomy and the pre-operative Parkinsonian speech
disorder was not confirmed on statistical analysis.
That speech difficulties are frequently consequent
upon subcortical intervention is particularly significant.
In itself this observation supports two hypotheses: one
that damage to subcortical areas interferes with speech,
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arid, secondly, that rigidity and tremor, which are
improved by surgery, are not related to speech since this
is far from improved by surgery. This latter hypothesis
is well supported by Canter's findings (1961), that
severity of dysarthria in (unoperated) Parkinsonians is
not related to degree of rigidity or tremor.
What mechanism, then, underlies both the pre- and
post-operative dysarthria? Leyser (1924) suggested
akinesia as a possibility, and the evidence, meagre as it
is, seems to bear this out. Since stereotactic surgery is
effective in reducing tremor and rigidity, but has no
beneficial effect on akinesia (Bell, 1968) it is to be
expected that the bias in selection of patients is towards
those with positive symptoms (i.e. tremor and rigidity).
That this group of patients after surgery do in fact
exhibit a disturbance of motor function qualitatively
different from either rigidity or tremor has been
demonstrated by Krayenbuhl et al. (1965). They found that
"locomotor impulses" were not always continuous nor were
they automatically integrated and coordinated following
dominant hemisphere intervention.
This finding, together with observations of
qualitative differences between Parkinsonian dysarthria
and induced dysarthria in Parkinsonian patients who have
undergone surgery, is particularly significant. In
post-operative dysarthria Bell observed increased
difficulty in the initiation of speech. Riklan and
Levita (1969) observed similar qualitative differences:
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twenty per cent of their patients after surgery exhibited
"hesitations or dysfluencies in all aspects of overt
verbal expression". All three observations - Krayenbuhl's
of disturbed motor function, Bell's of initiation
difficulties and Riklan and Levita's of dysfluencies - are
perfectly compatible with the conclusion that stereotactic
surgery exacerbates and/or induces akinesia, and that
speech disorders in Parkinsonism are manifestations of
this underlying akinesia.
Riklan and Levita's (1969) and Bell's (1968)
observation of post-operatively altered tempo of speech
relates well to reports of observation of the effect of
stimulation of subcortical structures during surgical
intervention. Electrical stimulation of deep structures
in the brain has one particularly striking effect on
speech; it alters the rate of utterance. During
stimulation of the ventro1 atera1 nucleus of the thalamus
near its junction with the internal capsule, Guiot et al .
(1961) observed that the rate with which the patients
count was either accelerated or slowed down to the point
of total arrest. This phenomenon according to Guiot et
al. "appears to be conscious and the patients are
subsequently critical of it". Van Buren (1963), however,
obtained different results: it was from stimulation of
the head of the caudate nucleus or from the adjacent white
matter of the frontal lobe and/or the frontal limb of the
internal capsule but never from within the thalamus that
he was able to produce speech acceleration or arrest.
Furthermore, in Van Buren's investigation "the patient
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never mentioned them j the speech arrestsj spontaneously
and indeed often seemed to be totally unaware that
anything out of the ordinary had occurred". An
interesting finding by both Guiot et al. and Van Buren is
that arrest or acceleration of speech appears at a lower
stimulation threshold than that for arrest of movement.
Neither of these papers appears to have taken
hemisphere dominance.into account. Hassler (1966) who
obtained similar speech results from stimulation of the
ventrolateral thalamus also ignored the question. Parigi
et al. (1964) simply reported contralateral sensations of
noise and an "inability for spontaneous language and
compulsive emission of two words following stimulation of
the ventrolateral thalamic nucleus in a Parkinsonian
patient" without reference to laterality of stimulation.
Schaltenbrand (1956) who found that stimulation of VL
produced primitive vocalization (much akin to the type of
primitive speech Penfield produced by stimulation) also
did not report whether there was a difference between left
or right hemisphere stimulation. Krayenbuhl et al. (1965),
however, added a footnote to the Guiot et al. (1961)
results: "the motor modification of speech, which
consisted in inhibition, slackening or acceleration" were
never obtained on the "non-dominant" side.
Dys phasia
The side effect of dysphasia following stereotatic
surgery directed at the ventrolateral nucleus of the
thalamus in particular is, as Bell (1968) phrases it,
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"compelling evidence for the participation of the
thalamus of the dominant hemisphere in the formulation of
speech". Unfortunately, the literature on this topic is
often unsatisfactory, and despite Bell's enthusiasm,
several issues remain unsettled.
Dysphasia is a frequently referred to side-effect.
Mundinger and Riechert (1963) reported dysphasia in all
but 5 of a series of 18 cases; Allan et al. (1966) and
Hermann et al. (1966) reported dysphasia in 9 out of 118
patients; and Bell (1968) in 9 out of 53. It has also
been described by Cooper (1961), Laitinen (1966), Lin and
Cooper (1960), Selby (1967), Spiegel and Wycis (1962),
Waltz et al . (1 966 ) and Watkins and Oppenheimer ( 1 962 ).
There are, however, reports (such as that by Markham and
Rand, 1963) which positively exclude dysphasia as a side-
effect, and reports (such as that by Bravo et al., 1966)
which, although dealing with speech disturbances consequent
upon subcortical stereotactic surgery, ignore the
possibility of dysphasia.
Most papers have disregarded the question of
hemisphere dominance. Markham and Rand (1963) and Bravo
et al . ( 1 966) stated neither the lateralization of the
lesion nor the handedness of the patients. In a
discussion of bilateral thalamotomy, Gillingham et al.
(1964) did not mention handedness, although the
occurrence of dysphasia after lesions of the dominant
hemisphere in unilateral thalamotomy had been noted in an
earlier paper (Gillingham et al., 1960); these findings
were confirmed in Hermann et al. (1966) and Allan et al.
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(1966) in which 3 of 118 patients were left handed, and
2 of these 3 exhibited post-operative dysphasia.
Of the reports that did take hemisphere dominance
into account, some found that dysphasia after thalamotomy
were more frequent with lesions in the dominant
hemisphere (Allan et al., 1966; Bell, 1968; Cooper,
1960; Selby, 1967; Hermann et al., 1966; Riechert, 1964)
1964), but others denied a correlation (Krayenbuhl et al.,
1961; Waltz et al., 1966). Dysphasia has also been
reported following dominant hemisphere pallidotomy and
pal 1iansotomy (Cooper, 1 956; Gillingham et al., 1 960 ;
Mundinger and Riechert, 1963; Spiegel and Wye is, 1962;
Svennilson et al., 1960). Hermann et al. (1966) found
that dysphasia never resulted from pure capsular lesions.
Bell (1968) has characterised the nature of the
language deficit induced by surgery particularly well:
The dysphasia varied in severity from a mild
difficulty in finding words and in naming objects to a
disorder which rendered the patient's speech almost
incomprehensible... Verbal output was reduced, there
were disturbances of rhythm and modulation of speech
even in the two cases without accompanying dysarthria,
and all patients, including those unable to emit a
meaningful sentence or proposition, had relatively
preserved comprehension of speech. Repetition was normal.
Rapid fatiguabi1ity was prominent in the more severe
disorders... In the mild cases the speech was laconic and
hesitant with periods of silence while the patient groped
for words. In all of the mild cases the patient claimed
he knew what he wanted to say. The least affected patient
was unable to name such objects as a ball-point pen and
the cord of a Venetian blind. Some patients misnamed
objects occasiona11y, and one patient in this group had
some impairment of grammar.... In only one of the mild
cases of dysphasia did the patient have some impairment
of consciousness .
The dysphasia of moderate severity was similar, but
in addition the speech was sometimes not comprehensible
because of difficulty in word finding, and the use of
paraphasias and faulty grammar.
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In cases of severe dysphasia, there were additional
difficulties. Words were "garbled" and found with
extreme difficulty. One patient, for example, six days
post-operatively, "misnamed objects, and was unable to
name the year spontaneously, but she was able to select
it and repeat it after hearing it spoken in a series of
names and dates". Another patient with extreme naming
difficulty, in his groping for words produced disjointed
explanatory phrases; for example six days post-operati vely
he referred to his operation as "cutting skull". He went
on to say: "Weekend of medicine... closed for a week
pretty well... X-ray ... local after a while. They charge
it twelve times". Patients also exhibited reading
difficulties, and perseveration. Although this group of
patients did have some impairment of consciousness, Bell
felt it was possible to distinguish their speech problems
from the paraphasic misnamings described by Weinstein and
Kahn and from "non-aphasic" misnaming by Geschwind.
The presence post-operatively of perseveration is
interesting. One of Bell's patients perseverated in both
"spoken and written speech" for "months" after his
operation. Allan et al. (1966) also observed perseveration
but as a more common post-operative feature in their
dysphasic patients. Allison and Hurwitz (1967)
demonstrated that the perseveration in dysphasia due to
thalamotomy is similar to the perseverati on in dysphasia
due to cortical lesions. This supports Allison's earlier
contention (1 966 ) that perseverati on in dysphasia
following cortical lesions indicated a disturbance of the
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speech mechanism at the subcortical level.
For Bell, this picture of difficulty in word naming,
reduced verbal output, disturbed syntax and the inability
to emit a meaningful sentence and proposition in the
presence of relatively preserved comprehension of speech
is characteristic of expressive dysphasia. Several other
authors who have observed post-operative dysphasia concur
with this. Watkins and Oppenneimer (1962) described "a
definitive nominal dysphasia but no receptive defect".
Selby (1967) found slight expressive difficulties in the
presence of unimpaired comprehension in 42.1 per cent of
126 unilateral thalamotomies of the dominant hemisphere.
Riecnert (1964) referred to "speech disturbances of the
motor aphasia type, or of subcortical aphasia type", and
Mundinger and Riechert (1963) noted a word-finding
disorder. Hermann et al. (1966) and Allan et al. (1966),
however, came to the opposite conclusion - that it was a
receptive disorder - although their brief description (see
Allan et al., 1966) nevertheless is. of a disorder
indistinguishable from that described by Bell and the
above-mentioned authors.
It is difficult to evaluate reports of general
intellectual deficits and impaired psycholinguistic and
psychomotor abilities following subcortical surgery.
Riklan and Levita (1969) suggest: "The presence of
conflicting findings in the literature may be attributed,
partly, to frequent omission of operational definitions,
to the absence of adequate control procedures, and to a
lack of objective and quantifiable data". For example,
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of 8 investigations pertinent to the question of the
psychological effects of unilateral surgical intervention,
only 3 (McFie, I960; Riklan et al., 1960; Krayenhuhl et
al., 1965) were based on statistical analysis of
standardised test data. Although quantifiable indices
were collected in another study (Fuenfgeld, 1961) the
conclusions were not derived from statistical analysis.
The 4 remaining studies (Bonduelle and Guillard, 1962;
Gillingham, 1960-61; Krayenbuhl and Yasargil, 1961;
Mueller and Yasargil, 1959) are essentially summaries of
subjective evaluations and impressionistic findings. None
of these studies made adequate use of control groups.
Pre- and immediate post-operative intervals between
evaluations varied widely, and in two studies (Gillingham,
1960-61; Krayenbuhl and Yasargil, 1961) were not even
specified. The influence of the side or laterality of
surgical intervention was defined and analysed in 3
studies only (McFie, 1960; Riklan et al., 1960;
Krayenbuhl et al., 1965). Moreover, in most cases, the
conclusions reached represent extrapolations from a
particular surgical technique and target and must
therefore be considered of limited generality. (Riklan
and Levita, 1969).
McFie (i960) studied 56 Parkinsonians before and
immediately after unilateral pallidotomy or thalamotomy
(ventro-1atera1 ), and Riklan et al. (1 960) carried out
a similar study on 71 patients. (Target area in both
studies was similar thus their results are comparable).
Left hemisphere intervention resulted post-operatively
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in significantly reduced performance on "verbal" tests
i.e. on arithmetic (McFie, 1960 and Riklan et al., 1960)
on digit span (McFie, 1960 and Riklan et al., 1960), on
similarities (McFie, 1960), and on vocabulary (McFie,
1960), subtests of the WAIS (McFie) and WBAI (Riklan).
Both studies reported that right hemisphere intervention
significantly reduced block design performance, although
McFie found also some reduction of arithmetic performance.
This reduction, however, was not as marked a reduction as
that produced by left hemisphere intervention.
Considering the reduction in performance of both left and
right groups, Riklan et al. found that the "greatest
single loss was in verbal IQ for the left brain operates
for whom the mean number of points lost was 9.1".
Riklan et al. (1 960) carried out a 11ong-range1
re-test on forty-nine of these patients. At re-test,
some nine months post-operative1y, no significant
difference was found between post-operative subtest
scores and " 1 ong-rarige" follow-up scores.
Jurko and Andy (1964) found the reverse. No
significant reduction of WAIS scores was found between
pre- and immediate post-operative assessment for a group
of twenty-one patients. At follow-up assessment of eight
patients, one to two years after surgery (posterior
ventral thalamus and subthalamic region), a significant
decrease in verbal IQ was found. (This appears to be
largely attributable to poor performance on the
'similarities' subtest). Unfortunately, however, Jurko
and Andy did not consider their results in terms of
1 34
hemisphere intervention. They attributed the disparity
between their results and the overall findings of other
workers to three major factors: a more pronounced post¬
operative morbidity following surgical techniques other
than their own; differences in the timing of follow-up
assessment (18 - 24 months for their own as compared, for
example, to 4 - 13 months for Riklan et al.); and
differences in surgical target (pallidum and VL thalamus
for McFie and Riklan et al., PL thalamus and/or
subthalamus for Jurko and Andy). There is, of course,
one more important difference to add. Jurko and Andy
tested 21 patients in the immediate post-operative period
(McFie tested 59 and Riklan et al. 71) and 8 at follow-up
(Riklan et al. tested 49).
Krayenbuhl et al. (1965) in their article "Is there
a dominant thalamus?" reported findings substantially
different to those already discussed. Ten right-handed
patients undergoing 'dominant' surgery and ten undergoing
non-dominant surgery were investigated. Surgery target
was the posterior ventrc-oral thalamic nucleus, and the
lesion was made by means of high-frequency coagulation.
Krayenbuhl et al. found no changes in intellectual
abilities after surgery. However, the two patient-groups
did react differently on other tests following surgery.
Thalamotomy of the dominant hemisphere was associated
with post-operative reduction not only of verbal memory,
but also, of the capacity for verbal learning.
Furthermore, this deficit was unchanged at the six-month
follow-up assessment. These patients undergoing
non-dominant surgery showed a significant improvement
post-operatively. Tests of general information,
'assemblage' and arithmetic reasoning "suggest an effect
of post-operative adaptation". Post-operative immediate
visual memory also improved significantly.
The two most striking post-operative dysphasic
sequelae - naming difficulties and verbal memory deficits -
may be induced by electrical stimulation of subcortical
structures. Ojeman and Ward (1971) found that stimulation
of the left 'dominant' medial central portion of the
thalamus evoked alterations in object naming ('anomia')
and perseveration. These alterations were obtained
neither from stimulation of areas directly superior,
inferior, medial or lateral to the medial central portion,
nor from stimulation of areas in the right 1non-dominant'
thalamus. 'Anomia' was defined by Ojeman and Ward as "the
inability to name objects correctly with a retained
ability to speak, usually shown by the patient being able
to say 'this is a1 even though he cound not correctly
name the object". The majority of anomic errors evoked by
stimulation were misnamings (63 per cent); the remainder
were omissions. Misnamings were 'gross errors', e.g.
"ace" for 'church'. The patients were not confused, for
the incorrect name given was not necessarily the name of
an object pictured elsewhere in the test. Similar results
had been obtained in an earlier study by Ojeman, Fedio and
Van Buren (1968). Stimulation of the pulvinar and en
passage fibres related to the centrum medianum and
dorsomedial nuclei only of the left 'dominant' hemisphere
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produced 'arsomia'. (These findings are supported by a
serial section study by Van Buren and Borke, 1969).
Ojeman, Blick. and Ward (1971) reported the effect of
stimulation of VL thalamus (medial central portions) on
a test of short-term verbal memory. Stimulation at the
time of recall, with current levels below the threshold
for changes in object naming, significantly disturbed
recall, while stimulation during the presentation of test
material to be recalled later, was associated with a
decrease in recall errors in comparison to the non-
stimulation conditions. Ojeman and Fedio (1968) noted a
similar evoked disturbance of retrieval of verbal material
from short-term memory store with stimulation of the
pulvinar at equivalent low current levels. Thus there
is an overlap between the sites from which changes in
object naming and changes in short-term verbal memory
can be evoked. Ojeman (unpublished data, cited in Ojeman
and Ward, 1971), however, has demonstrated that "this
overlap of speech and short-term verbal memory functions
at the thalamic level does not seem to be present in the
left temporal-parietal cortical area where anornia can be
evo ked".
Van Buren (1963), although they too obtained
similar results of nominal difficulties, memory deficit
and confusion when stimulating in and/or near the head
of the caudate nucleus, conclude,"...we are left with the
impression that what has been produced by stimulation
within the vicinity of the head of the caudate nucleus is
not indeed aphasia, but a more basic disturbance in which
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the impulse to speak or to continue another task has
been dulled or forgotten".
This conclusion suggests that what appears at first
glance to be a nominal or ("expressive") aphasia is, in
fact, a disturbance of a function more closely related
to the effector mechanism of speech itself than of
language. Although it is conceivable that in a test
situation where a patient is asked to name an object
correctly within a given time period, an akinetic patient
(without being "dysphasic") could indeed fail the test,
it is not possible from the limited descriptions
contained in published papers to establish whether or not
this was controlled for. It would indeed be interesting
to know whether, if given time, the patients diagnosed as
post-operative 'nominal aphasics' would still be
considered such. However, irrespective of whether or
not the diagnosis of post-operative dysphasia is a false
positive error, the suggestion by Van Buren and his
co-workers that nominal difficulties evoked by stimulation
are akinetic in nature implies an intimate connection to
the phenomena of speech acceleration and of total speech




RATIONALE AND EXPERIMENTAL HYPOTHESES
Of the numerous and varied syndromes associated
with lesions of the basal ganglia, Parkinsonism was
chosen for study. It is the commonest of the syndromes
and may reasonably be regarded as the most representative.
Furthermore, it affects both sexes from about the fifth
decade of life - long after the skills of communication
have been established.
Several types or forms of Parkinsonism have been
described. For this study two forms were selected: the
idiopathic form of the disease, i.e., 'paralysis agitans'
and the form known as 'post-encepha1itic Parkinsonism'.
The pathology of each of the chosen forms has been well
documented. Post-encephalitic Parkinsonism is associated
with greater neurological damage than is paralysis
agitans. Thus these two forms provide scope for
investigation not only of the role played by lesions of
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the basal ganglia in the disturbance of speech, but also
of possible differences between the effects of numerous
and diffuse lesions (as in post-encephalitic Parkinsonism)
and more circurnscribed lesions (as in paralysis agitans).
Intuitively one would expect greater speech disturbance
to be produced by more extensive lesions.
In the 1960's stereotactic surgery was considered
an efficacious method of treatment for Parkinsonism.
The surgical procedure involved the stereotactic
placement of additional lesions induced by high-frequency
waves, extreme cold or heat, etc., in (most commonly)
the ventrolateral nucleus of the thalamus and/or the
pallidum. There are, therefore a number of patients who,
in addition to the Parkinsonian-producing lesions, have
these induced sub-cortical lesions. Patients with a
history of previous subcortical surgery were included in
the study (provided, of course, that their basic
Parkinsonian disease was one of the two relevant forms).
Extending the hypothesis stated above that 'the more
damage to the subcortex the greater the speech
disturbance' it was predicted that patients with these
additional induced subcortical lesions would have more
disturbance of speech than patients who had not
undergone this form of treatment.
Another, and extremely important, consideration in
choosing to study these forms of basal ganglia disease,
was the advent of L-dopa. It has already been pointed
out in Chapter 4 that, the speech disturbances related to
basal ganglia lesions are independent of the two positive
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symptoms of subcortical damage, i.e., tremor and
rigidity. On these grounds alone there is a prima, facie
case for postulating a connection between speech disorders
and akinesia - the remaining symptom of the
characteri sti c Parkinsonian triad. Moreover, when one
takes into account the adverse effects of stereotactic
surgery in inducing speech disturbances in patients with
no pre-operative speech disorder, together with Fagel's
claim (1968) that this form of treatment increases
akinesia, the hypothesis gains stronger foundation. In
the past, the relationship between akinesia and speech
disturbances has been ignored - perhaps because prior to
the recent theories linking dopamine and akinesia it was
not readily testable. With the advent of L-dopa, it is
now possible to test the hypothesis that dopamine
deficiency is implicated in the production of speech
disorders in patients with lesions of the basal ganglia.
The present study began soon after Edinburgh had
become one of the centres in Britain where L-dopa was
available for clinical trial, and it was designed to
test the following hypotheses:
1. The lesions which cause akinesia are responsible
for the speech disturbance of Parkinsonian patients.
That is, the speech disturbance is a manifestation of
akinesia. The greater the extent of the lesions, the
more severe the akinesia and hence the greater the
degree of speech disturbance.
2. The lesions which occasion the speech disturbance
are biochemically mediated.. L-dopa has been shown to
141
ameliorate akinesia; it follows that the amelioration of
akinesia by this form of dopamine replacement therapy
will be reflected in a diminution of the degree of speech
disturbance.
SELECTION OF SUBJECTS
Apart from the initial decision concerning which
forms of the disease to study, the only subject-sel ection
criteria operating were two fortuitous ones. Firstly,
since L-dopa is effective in reversing akinesia all
patients admitted for L-dopa treatment (and hence all
those included in this study) were predominantly
akinetic. Secondly, the course of the treatment,
coupled with the design of the study, inevitably
selected subjects in the following way: the basic
design of the investigation was a test-revest procedure -
a procedure which has the distinct advantage of allowing
each patient-subject to serve as his own 'control1. The
experimental design thus served gratuitously to select
patients since, to be included in the study, patients had
to be tested both before treatment and after treatment,
prior to discharge. In practice this meant that those
patients who could not tolerate the gradual build-up of
dopamine had the treatment withdrawn, and thus could not
participate in the investigation. The corollary is also
true: those patients included in the study comprised
only those who were able to tolerate dopamine, and who.
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after about three to six weeks, had shown sufficient
improvement on the clinical criteria of the neurologist
in charge to be discharged from hospital.
Apart from these two unavoidable selection processes
no further selection was made. In no circumstances was a
patient s elected because he had normal or because he had
disturbed speech.
DESCRIPTION OF THE EXPERIMENTAL GROUP
COMPOSITION
A group of 70 subjects was drawn from the series of
Parkinsonian patients consecutively admitted for L-dopa
treatment to two local hospitals - the Northern General
and the Royal Infirmary. All patients were right-handed,
and all of 'normal' intelligence, as measured on the
Mill Hill vocabulary scale and Raven's matrices.
Thirty of the patients were relatively young. Of
these,twenty-seven had Parkinsonism of long standing
together with a clear, unambiguous history of
encephalitis. The remaining three had had Parkinsonian
symptoms for only a relatively short time, no clear
history of encephalitis, and, furthermore, none of the
post-encephalitic Parkinsonian symptoms, such as
oculogyric crises. The differential diagnosis of
paralysis agitans and post-encephalitic Parkinsonism,
particularly in the younger patients, is not always
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easy. (This problem was discussed in Chapter 1). For
the present study a stringent criterion of diagnosis was
adopted: only patients with an unambiguous history of
encephalitis were considered as being 'post-encephalitic 1
Parkinsonian patients.
Of the total group of subjects, just under 32% had
previously undergone stereotactic surgery. Half of them
were found to have paralysis agitans, and the other half,
post-encephalitic Parkinsonism.
The subjects were thus subdivisible according to
type of Parkinsonism and surgical history:
patients with paralysis agitans who had not
undergone surgery (subgroup 'PA', N=32);
patients with paralysis agitans who had undergone
surgery (subgroup 'PA+OP', N=ll);
patients with post-encephal i ti c Parkinsonism who
had not undergone surgery (subgroup 'PE1, N=16);
patients with post-encephalitic Parkinsonism who
had undergone surgery (subgroup 'PE+OP', N = 11) .
The composition of the experimental group reflected
well the composition of the general Parkinsonian
population. Paralysis agitans is the commonest form of
Parkinsonism. Post-encephalitic Parkinsonism, as its
name implies, is found amongst those patients who had
encephalitis during the post-war epidemics. There is,
thus, a finite, and diminishing, population of post¬
encephalitic patients. In the experimental group,
post-encephal i ti c patients were outnumbered by almost
2:1 .
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Patients with a (subcortical) surgical history are
an even more constrained population. Selection of r~ .>
patients for surgery was a careful process. Age of
patient, length of illness, and the severity of (the
positive) symptoms were critical factors. In practice
this meant that patients with paralysis agitans, because
of the relatively recent onset of their symptoms, and
patients with post-encepha1itic Parkinsonism, because of
their relatively young age, were good candidates for
surgery. Not surprisingly therefore, comparable numbers
of paralysis agitans and post-encephalitic Parkinsonian
patients had undergone surgery.
Surgery, however, appears no longer to be the first
choice of treatment for Parkinsonism. Doubts as to the
long- and/or short-term benefit of surgery, particularly
in relation to its side-effects, have been reported with
increasing frequency in recent years. The now prevalently
cautious attitude to surgery is reflected in the present
series of patients: the most recent surgical procedure
on any of these patients was carried out in 1368. On
average, surgery was undergone 11 years previously. An
equal number of left and right procedures were found to
have been carried out on the experimental group; and
only three patients had had bilateral surgery.
AGE
The average age of the group as a whole, and of the
four subgroups are summarized in TABLE 5A. Post-
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encephalitic patients were found to be significantly
younger than paralysis agitans patients; no difference
in age was found between patients who had undergone














B. ANALYSIS OF VARIANCE
SOURCE SS DF MS F
TYPE 511 . 37 1 511 . 37 10.03*
SURGERY 1 . 45 1 1 . 45
INTERACTION 1 . 76 1 1 . 76




Since the disease is progressive, 'length of illness'
is an important descriptor of a Parkinsonian population.
However, because of the very insidious onset of the
disease, it is almost impossible to determine the true
duration of the illness. A good estimate of the duration
of the illness is provided by the length of time since
the onset of the first symptoms.
The experimental group was found to have had
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Parkinsonism on average for about 15.66 years. The mean
length of illness for each of the four subgroups is
contained in TABLE 6 below. As can be seen, paralysis






GROUP AS 1 5 . 66-11.04
A WHOLE
TABLE 6
agitans patients who had undergone surgery had had
Parkinsonism for almost twice as long as paralysis
agitans patients who had not. Furthermore, the two
post-encephalitic patient groups had had Parkinsonism
for more than three times as long as the unoperated
paralysis agitans patients. As could be anticipated
from these figures, the subgroups differed significantly
in terms of the average length of illness (F-29.72;
d.f. = 3,58; p < . 01 ). Multiple comparisons of the four
means of length of illness (using Newman-Keuls testy
showed that only one pair of means did not differ
significantly: there was no difference between the
length of illness of the two post-encephalitic subgroups.
The mean length of illness for subgroup PA was
significantly shorter than that for subgroup PA+OP
(p<.01); and that both these means were shorter than the




L-dopa treatment was given to the patients after the
initial test-protocol, and other routine tests had been
carried out. The drug was administered orally, in
gradually increasing amounts until the optimal level for
each patient was reached. The optimal level for each
patient was assessed in terms of his response to the
drug. It represented the maximum dosage a patient could
tolerate without developing hyperkinesia and other
unwanted side-effects. It took, on average, four weeks
for this gradual build-up to maximum dose level to be
effected.
The optimal daily dose levels ranged from 1.5 to
10 grammes. TABLE 7 shows the mean daily dose levels.
MEAN OPTIMAL DOSE LEVEL
(GRAMS PER DAY)
SOURCE MEAN




GROUP AS 3.720*1 .84
A WHOLE
TABLE 7
Analysis of variance revealed no significant differences
between the four subgroups (F=0.4713, d.f. = 3,51, p < . 01 ) .
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EXPERIMENTAL TASKS AND MEASURES
The term 'akinesia' was introduced to neurology by
Kinr.ier Wilson. It was also Wilson who introduced the
concept of a dual motor system - a pyramidal system that
subserves 'voluntary' movement, and an extra-pyramidal
system that subserves 'spontaneous' movement. According
to Wilson (1925), 'akinesia' affects both 'spontaneous'
and voluntary movement. There is general poverty of
movement in akinetic patients, and when movement does
occur it is characterized by its slowness. Furthermore,
an akinetic patient shows a marked lack of 'spontaneity'
and 'drive'. In his 1925 article in the Lancet, Wilson
avoided actually defining his term, but, from his
descriptions of akinetic movement, it appears that
akinesia affects two aspects of movement: its
initiation is delayed and its description is slow,
laborious and minimal.
According to Wilson, all movement is affected by
akinesia. Thus speech, being a highly complex motor
sequence, should show the same two types of disturbance
(in initiation and description) as do other movements.
Simple tests were constructed to measure these two
aspects of disturbance.
Certain constraints on the choice of tasks should
be mentioned. Since a test-retest procedure was employed,
it was necessary to avoid or minimize unwanted learning
or practice effects. This was achieved by the use of
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tasks requiring only already highly-practised 'automatic'
skills. Such tasks also enjoyed the merit of not tiring
the patients and of not being too stressful, a factor of
consequence in respect of the more emotionally labile
patients .
MEASURES OF CLINICAL STATUS
BEFORE TREATMENT STATUS: On admission to hospital, and
before treatment was initiated, each patient was seen by
the neurologist in charge, who assessed the clinical
status of the patients. The degree of severity of each
of the three characteristic Parkinsonian symptoms -
tremor, rigidity and akinesia - was rated. A four-
point scale was used for tremor and for rigidity (0 = no
tremor/rigidity at all; 1 = slight tremor/rigidity;
2 = moderate tremor/rigidity; 3 = severe tremor/
rigidity). Since all patients included in this study
had some degree of akinesia, only a three-point scale
was required in the rating of severity of this symptom
(1== slight; 2 = moderate; and 3 = severe). Whether
tremor and/or rigidity was manifested bilaterally or on
only the left - or right-sided limbs was also noted.
IMPROVEMENT WITH TREATMENT: Once a patient had been
stabilized on his optimal dosage level of L-dopa, a
clinical assessment of the change in akinesia was made
by the same neurologist. Clinical improvement was
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rated on a five point scale (0 = minimal, if any,
improvement; 1 = slight improvement; 2 = moderate
improvement; 3 = marked improvement; 4 = excellent
imp ro vement).
Patients who had shown either clinical deteri orati on
or no clinical change were excluded from the present
investigation. Only those patients who were able to
tolerate large enough levels of L-dopa to effect clinical
improvement without suffering side-effects were included.
All patients rated 1 - 4 met this requirement, and an
extremely small number of patients initially considered
suitable candidates for L-dopa treatment, and hence
possible candidates for this investigation were
encountered.
MEASURES OF MOTOR ABILITY
A number of short and easy-to-administer motor
tests have been used by other workers to measure the
effects of L-dopa. These tests, however, tend to be
based on simple motor activity (for example, the digital
counting method used by Mawdsley et al. (1972)), which is
not comparable with the highly complex movements that
form the basis of speech.
Handwriting is a complex yet highly-practised motor
skill. It provides a highly appropriate material in
which to detect motor improvement since it is generally
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agreed that writing is adversly affected by akinesia.
The writing of akinetic patients is generally small, and
frequently, becomes progressively smaller, both
horizontally and vertically.
Patients were asked to write their full name,
address, some numbers (46,573,1,001) and a sentence ('Many
women went to market.') on a blank sheet of paper with a
self-sharpening propelling pencil. The instructions
followed the general form: "I want you to write your
name and address. As soon as I say'Begin!' you can
Start.". Three measures were derived from this task:
SIZE OF WRITING: The length of each word was measured
in centimetres and a mean for each patient's writing
under test and retest conditions was calculated.
TIME TAKEN TO WRITE: The time each patient took to
write his name and address was measured with a 1/100th
sec. stopwatch, taking care not to let the patient see
he was being timed. Timing started at the first stroke
the patient executed, and ended with the last full stop.
TIME TAKEN TO START WRITING: The time that elapsed
between the command 'Begin!' and the first stroke the
patient executed was also measured. A second stopwatch
(also calibrated to 1/100th sec.) was used, and care
was taken to ensure that the timing was conducted
unobtrusively.
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MEASURES OF CONTINUOUS SPEECH - PARAMETRIC
Responses for the measurement of continuous speech
were recorded on magnetic tape. The procedure for
recording was designed so as to strike a balance between
two rather different requirements. On the one hand,
recordings suitable for subsequent use with automated
analyses employing "voice keys' had to be made. On the
other hand, it was extremely desirable to obtain
realistic examples of how patients usually spoke. It
was feared that constructing too formal a recording
session in the only available sound-proofed laboratory
which was situated some miles from the hospital perhaps
would influence patients to talk uncharacteristically
well, and produce loud, over-articulated, laborious
speech. It was, therefore, decided to make the
recordings at the hospital, in a room near the wards,
and that the sessions be structured in as informal a
manner as possible with minimal attention being drawn
to the process of recording.
A Revox (model A77) tape recorder was used. Only
clean, new tapes (3ASF low-noise SP5Z) were employed.
The recordings were made at 7| inches per second, and
only one of the two available tape-tracks (the lower)
was used, to avoid any cross-image due to tape
deterioration. Input was through a boom-mounted headset-
microphone (Sharpe, Mark II LM) to ensure a standard
mouth-microphone distance even in patients with severe
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head tremor.
The microphone used was uni-directiona1 . The use
of this type of microphone was well rewarded. It
effectively failed to record not only any general
background noise of the hospital, but also the rustles
and noises produced by tremulous limbs. Later
oscillographic analysis showed that the recordings made
under the hospital conditions had a signal-to-noise
ratio of at least lOdb, and that the recordings were not
appreciably worse than those made under laboratory
condi ti ons .
The procedure for calibration of input level to the
tape recorder was similar to that used by Canter (1S 6 6) .
A standard acoustic stimulus was recorded just prior to
the speech recording for each subject was made. The
1,000 cps output of an Advance signal generator was fed
into the tape recorder. The voltage was 0.1 volts,
measured on a Marconi valve voltmeter. The tape recorder
gain control was set so that the input signal gave a
reading of zero on the VU meter built into the tape
recorder. The input tone was recorded for 30 sees. The
tape recorder gain control was not altered throughout
the recording session of a given patient. The procedure
was repeated for each individual recording session.
TASK: CONVERSATION
This was the first speech sample that was recorded.
It was initiated by general questions from the examiner,
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and usually was confined to topics such as the patient's
family (frequently concerning grandchi1dren), occupation,
particular interests, or, as a last resort, how the
patient spent his time in hospital. In general, the
experimenter tried to keep her contribution to the
conversation to a minimum while at the same time
eliciting fairly long, uninterrupted samples of the
patient's speech. It was not a difficult situation to
engineer - once an appropriate topic was found, the
patients proved quite loquacious.
The purpose of this task was twofold: to minimize
the inhibitions attendant on the test and recording
situation, and to obtain a sample of conversational
speech which would later be used by the judges for
eva1uation.
TASK: AUTOMATIC SPEECH
Patients were asked to recite the alphabet, the
names of the days of the week and t'he months of the
year. They were also asked to count from 1 to 10. The
instructions for this task were non-commita1. No
reference to either rate or loudness of utterance was
made. Patients were merely told, for example: "I want
you to count from 1 to 10. As soon as I say 'Begin!',
you can start."
Two measures of temporal aspects of speech, both
requiring similar analyses, were based on the recordings
of the patients' counting. The reasons for choosing this
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particular activity for analysis are several: In
counting from 1 to 10, the number names, with the sole
exception of 7, are monosyllabic. Counting is a
universally familar activity, and it conforms to
Hughlings Jackson's 'inferior' or 'automatic' speech.
It is, therefore, virtually free of those hesitations
consequent upon the formation of 'superior' or
'propositional ' speech which has been extensively
studied by Goldman Eisler (1968). Furthermore, in the
act of counting, syntactical and other paralinguistic
markers do not constrain the rhythm of speech.
The speech samples were played into a signal



















beginning of phonation and off by the cessation of
phonation. The output of the detector was fed to a
chart recorder (Bryans modal 27000) and a graph of the
on/off activity of the detector was obtained. In order
to monitor that the detector was responding to as much
of the phonation as was possible, outputs from both the
tape recorder and signal detector were fed to a two-
channel storage oscilloscope. The gain controls on the
tape recorder and signal detector were adjusted so that
the detector could be seen (on the oscilloscope) to
respond to the extreme beginning and end of each
phonation. This required delicate adjustments of the
gain controls. In general, the most satisfactory
results were obtained when the output gain from the tape
recorder was set relatively high, and the input gain to
the signal detector relatively low. The controls were
adjusted for each speech sample that was analysed.
PERIODICITY OF PAUSE AND PHONATION: The length of
phonation for each of the ten digits (i.e. the length of
the "on" phase of the signal detector) and the length of
the nine intervening pauses (i.e., the length of the
"off" phase of the signal detector) was measured directly
from the chart recordings. When, as occasionally
occurred, two phonations ran together without detectable
pause, the total phonation time was halved and this value
was allotted to each digit. Means and standard deviations
for the duration of phonation and pause were calculated
for each patient under test and retest conditions.
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REGULARITY OF SPEECH: For this analysis, the counting
activity was considered as a sequence of 'word pause'
units. If speech were of even pace or rhythm, each unit
would be of comparab 1 eduration. In festinant speech,
the units later in the sequence would be shorter than
units earlier in the sequence. The digit 'ten' was
excluded from the analysis. The length of each unit
(i.e., each word and its following pause) was measured
from the chart recording.
TIME TAKEN TO START 'AUTOMATIC' SPEECH: The time that
elapsed between the command 'Begin!' and the beginning
of the utterance of the first unit in the sequence -
digit, name of weekday, name of month, letter of the
alphabet, were all measured using the voice key and
chart recorder. A mean initiation time based on all
four measures was calculated for each patient under
both test and retest conditions.
TASK: READING
The passage chosen for this task was 'Arthur the
Rat'. The passage is a narrative, and is characterized
by a predominance of high-frequency vocabulary. It was
felt that these two factors were an advantage and
would perhaps produce less errors in reading than, say,
the highly descriptive more abstract 'Rainbow Passage'
developed by Fairbanks.
The patients were first given the printed copy of
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the reading passage to look over. When they were
satisfied it presented no difficulty, they were asked
to read the passage aloud. (To ensure that the patients
were not unduly hurried, the experimenter would give the
patient the printed copy, and instead of sitting, clearly
waiting for the patient to finish looking over the
passage, the experimenter used this time to fill in
details of the patient's case history from his case
notes . )
The instruction for the task, as advocated by
Johnson et al. (1963), were non-commita1: patients
were merely asked to read 'as you ordinarily would'. No
more detailed instructions were given.
Two measures were based on this reading task:
RATE OF READING: The time taken to read the passage
was measured using a 1/I 00th sec . "stopwatch . The
number of words read per minute was calculated for each
patient under both test and retest conditions.
VOICE VOLUME: The reading sample was used for the
voice-volume measures. "Loudness" is a psycho-accoutic
concept, and unfortunately as yet there is neither a
satisfactory nor a standard means of adequate
quantification. In this study the basic technique
suggested by Mr. Antony of the Linguistics Department
(Edinburgh Univ.) and used by Allan et al. (1966), and
Hermann et al.(1966) was used, with seme modification.
Antony's technique involves feeding a speech sample into
a simple form of sound level meter with a scale in
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decibels instead of volts. The meter thus measures
amplitude of the input signal, at 5 sec. intervals. For
this study, the input-level of the signal was
standardized by means of the calibration tone preceding
each recording. The output gain of the tape recorder
was adjusted so that when the recorded tone was played
through a chart recorder (Bryans) a linear excursion of
comparable amplitude for each recording was obtained.
Once the gain was satisfactorily adjusted, it was not
altered and, on this gain setting, the reading sample
was played into the sound level meter. Mean db measures
for each patient under both test and retest conditions
were calculated.
TASK: SUSTAINED PHONATION
For this item the patient was required to say the
sound "ah" for as long as possible, without undue strain.
After a demonstration by the investigator, the test was
carried out, measuring the length o'f the phonation with
a 1/10th second stop watch. This test was performed at
three stages of the test-session - at the beginning,
middle, and end; a mean-length of phonation was
calculated.
MEASURES OF CONTINUOUS SPEECH - NON-PARAMETRIC
The recorded samples of the patients' conversation,
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'automatic' speech sequences and reading were played to
two judges for evaluation. Both judges were experienced
in assessing disturbed speech.
Construction of the rating-scales.
The judges, together with the writer, selected five
variables, which, on the basis of their clinical
experience were believed to comprehensively cover those
aspects of speech disturbance relevant in Parkinsonism.
The variables were agreed by all three to have the
following scope of reference:
'INTELLIGIBILITY': a measure of the adequacy of speech
for everyday communication;
'DYSARTHRIA': a measure of the clarity, precision and
to some extent, the speed of articulation:
'PROSODY': a measure of stress and intonational
patterns;
'FESTINATION': a measure of that temporal disorder
peculiar to Parkinsonism - the hurrying at the end of
an utterance; and,
'PHONICS': a measure of vocal quality based on such
factors as pitch, timbre, and, to some extent, loudness
of voice.
It was agreed that each parameter would be
represented by a five-point scale of severity of
disturbance. A seven-point scale would call for
unnecessarily fine, and perhaps impossible,
discrimination, while a three-point scale would involve
too gross and inflexible a classificatory model. A
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rating-score of '1' represented 'slight impairment1;
'3', 'moderate impairment': and, '5' 'marked or severe
impairment'. Rating scores of '2' and '41, represented
intermediate degrees of impairment. If no disturbance
was heard by the judge/s, the sample received no rating-
s core.
Procedure
The speech samples were randomly assigned in groups
of ten recordings. The samples were not re-recorded;
the original recordings were played to the judges for
evaluation so that no difficulties with artificial
re duction of the signal-to-noise ratios of the tapes
would be encountered.
One group of ten speech samples was played at each
rating-session. The same Revox tape recorder that the
tapes had been made on was used. The playback volume
was kept constant throughout each and every session.
(The volume control knob was set to level 7). The
rating-sessions lasted roughly 1 -'I| hours. The judges
were not told the name of the patient whose recording
was being played, nor did the judges have information as
to whether they were listening to a 'before' or 'after'
treatment recording. Judges were free to ask for the
recording under consideration to be replayed as many
times as necessary for them to make their evaluations;
they were not allowed to hear the previous recordings
for comparison. There was no collaboration or discussion
between judges during the rating-sessions.
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Reliability of assessments
Ten speech samples had, unknown to the judges, been
presented twice for evaluation. The differences between
the two sets of ratings each judge had awarded these
samples were tested to provide a measure of rating
consistency, or 'intra-judge reliability '. Wilcoxon's
matched-pairs signed-ranks test was used for this
purpose. In no case did the difference between two sets
of ratings even approach significance at the .05 level,
indicating a high degree of intra-judge reliability.
A high degree of inter-judge agreement on each scale




T Z T Z
'OVERALL' 0.717 6.859 0.677 6.479
'DYSARTHRIA' 0.631 6.036 0.751 7.188
'PROSODY' 0.743 7.110 0.663 6.345




Kendall's rank order test together with their
associated z-scores. A z-score of 1,64 is associated
with the .05 level of probability. As can be seen from
TABLE 8 a highly significant level of agreement was
revealed in the assessment of speech, on all five scales.
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MEASURES OF INITIATION
Two of the three measures of the time taken to begin
a complex sequence of movement - TIME TAKEN TO START
WRITING and TIME TAKEN TO START 'AUTOMATIC' SPEECH
SEQUENCES - have already been described. The third
measure, described below, was based on performance of a
confrontation naming task.
The Oldfield & Wingfield Object Naming Test (1965)
was used. The test materials comprise 36 cards each
bearing an outline drawing of an object. (see FIGURE 17
EXAMPLES OF STIMULUS MATERIAL (REDUCED IN SIZE)
FIGURE 17
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for four examples of the drawings used in the test). The
dep i ctedobjects were chosen by the test constructors so
that the frequencies of their name-words, as given in the
Thorndike-Lorge (1944) word count, were spread through a
wide range, i.e., from 'AA1 words with a frequency of
occurrence of >100 per million down to words with a
frequency of <1 per million. Ten of the outline drawings
are for practice, although the subject does not know
that his responses to them will be ignored.
The test was administered as advocated by Oldfield
and Wingfield (1965): The subject was told he would be
shown a series of cards, and that each card had on it a
drawing of an object. He was instructed to name the
object as quickly as he could, giving its common name
without qualification or further description. To
illustrate the instructions, he was given three examples
of naming common objects in the experimental room ('bag';
'window';'door'). Before the test began it was once
again stressed that he was to respond as quickly as
pos sible.
The following procedure was used: with the
experimenter seated opposite the subject at a table, each
card in the pack was flicked over while an electronic
timer (Advance TC 14) was started at the same instant.
As soon as the subject responded with the correct name
the timer was stopped. Response-1atency was measured
in msecs. , and verbatim records of the patients'
responses were made.
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The cards were presented to the patients in one of
the three (random) orders described by Oldfield and
Wingfield (1965), with the constraint that no patient
be exposed to a particular order more than once.
MEASURES OF ABILITIES WITH POSSIBLE RELEVANCE TO
CONFRONTATION NAMING
A number of standard psychological tests were
administered to the experimental group. The tests were
chosen for their relevance to measure those psychological
functions that one intuitively believes to be related to
the functions or abilities involved in a confrontation
naming task. The tests used were:
BLOCK DESIGN: The Block Design subtest of the Wechsler
Intelligence Scale was used. In this task, derived from
Kohs' Block test, which was intended to measure
intelligence (Kohs, 1923), the subject is asked to copy
a red and white patterned drawing using three-dimensional
blocks. Time limits are set and time bonuses can be
gained for the more difficult nine-block designs. A
pilot study revealed that even severely akinetic
Parkinsonian patients were capable of completing the
more difficult items within the time limits required to
earn maximum time bonuses. There are six four-block and
four nine-block designs. The maximum score is 48. Since
performance on this test is influenced by the age of the
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subject, the raw scores were corrected for age according
to the tables supplied with the W.A.I.S. ana these age-
corrected scores formed the basis of all result analyses.
SPAN OF APPREHENSION: The 'digit span' subtest of the
Wechsler Memory Scale was used. The scale offers two
versions (Forms A and B), and thus is suited for use in
a test-retest experimental design. The test resembles
closely the 'digit span' subtest of the W.A.I.S. It
comprises two parts - the first requires the subject to
repeat an increasing series of digits in the order of
presentation ("Digits Forwards"); and, the second, to
repeat an increasing series of digits in a reversed
order ("Digits Backwards"). The maximum number of
digits presented under each condition is eight; the
maximum score on the test is thus 16. Since the
performance on this test is influenced by the age of
the subject, the raw scores were corrected for age
according to the tables supplied with the W.A. I.S., and
these age-corrected scores formed the bases of all
result analyses .
STORY RECALL: The "Logical Memory" Subtest of the Wechsler
Memory Scale (Forms A and B) was used. This subtest
comprises two short narrative stories. The subject is
instructed to listen carefully to the stories which are
read aloud by the experimenter. Immediately after both
stories had been read, the subject is asked to recall as
much of each story as he could. ('SHORT-TERM' MEMORY).
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An hour later, without prior warning, the subject was asked
once again to recall each story ('DELAYED RECALL1). Half
of the subjects were given Form A before treatment and Form
B after treatment; the other half vice versa.
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CHAPTER 6
RESULTS I: CLINICAL STATUS AND RIOTCP. PERFORMS
In this chapter the status of the experimental group
both before and after treatment is considered. Two
bodies of data are presented: ratings of the clinical
status of each patient, by the neurologist in charge, and
measures of motor performance, based on handwriting. The




The clinical ratings of severity for each of the
three characteristic Parkinsonian symptoms - tremor,
rigidity and akinesia - provided a picture of the before
treatment status. Each of these sets of data was
analysed to see whether different degrees of subcortical
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damage (represented by the four subgroups) v/ere
associated with different degrees of severity of symptoms.
A four-point scale had been used in rating the severity of
tremor and rigidity. However, it was not possible to
subject the data to x2 analysis in the form of 4 x 4
matrices (i.e. four degrees of severity x 4 subgroups).
For the x2 test to be reliable no more than 20% of the
cells may have an expected frequency of less than 5
(Siegel, 1956). Neither of the two sets of ratings met
this requirement. Consequently the data had to be
conflated, in both the row and the column classifications,
into 2x2 contingency tables. The experimental
hypotheses, and the nature of the information, determined
the way in which the data was conflated.
Of chief interest were a) whether paralysis agitans
patients were less affected than post-encephalitic
patients and b) whether unoperated patients were less
affected than operated patients. Two separate x2 tests
were thus required. For one test the rows of the
contingency table comprised the patients grouped
according to type of Parkinsonism (i.e. PA and PA+OP
subgroups versus PE and PE+OP subgroups). For the other,
the rows represented patients grouped according to
surgical history (i.e. PA and PE subgroups versus PA+OP
and PE+OP subgroups). In each test the columns comprised
the four degrees of severity conflated to produce two
groups of patients rated either as 0 ('no symptom at all')
or 1 ('slight'), and as 2 ('moderate') or 3 ('severe').
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The situation was slightly different for akinesia.
Since all patients in the experimental group were
admitted to hospital specifically for L-dopa treatment,
it was only to be expected that all patients would have
some degree of akinesia. A rating category of 0 was
therefore not applicable in respect of this symptom.
Only three degrees of severity were required to describe
the patients (1 = 1 slight', 2='moderate1, 3='severe').
As was the case with tremor and rigidity, the data
did not meet the statistical requirements for expected
frequencies so that once again a 2 x 2 contingency table
was used. The classification of patients in the rows
remained the same as that described above for tremor and
rigidity. The column classification, however, represented
the data as follows: in one column were grouped all
patients rated 1 ('slight') or 2 ('moderate') and in the
other all those rated 3 ('severe'). Thus, when the data
on akinesia was subjected to the two x2 tests, the
relative proportions of severely akinetic patients to
slightly or moderately akinetic patients was tested.
The data collected from the assessment of clinical
improvement was also based on a four-point scale
(l='slight' improvement, 2='moderate' improvement,
3='marked' improvement, 4='excellent' improvement). This
data, too, did not meet the requirements for expected
frequencies and had to be conflated for the two x2 tests.
In each case the row classification was the same as that
used in treating the data on severity of symptoms, as
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described above. The column classification, however,
reduced the data as follows: in the one column the total
number of patients showing a slight to moderate
improvement was recorded, and in the other the total
number of patients showing a marked to excellent
improvement. On the basis of these tests it was possible
to establish whether either of the types of Parkinsonism
and whether either of the kinds of surgical history were
associated with greater degrees of improvement.
PARAMETRIC DATA
The analysis of the three measures of motor function
are also contained in this chapter. These measures are:
TIME TAKEN TO START WRITING, TIME TAKEN TO WRITE and SIZE
OF WRITING. All three sets of measures were parametric
in nature, and were analysed according to the following
methods:-
In order to see (both before $nd after treatment)
whether the degree of subcortical damage (represented by
the four subgroups) was associated with different levels
of performance, the data was subjected to analysis of
variance. A two (fixed) factor model of analysis was
used so that it was possible to test the effect both of
type of Parkinsonism and of surgical history. Where
appropriate a similar two factor analysis of covariance
was conducted in which the after treatment data was
adjusted in terms of the before treatment data. Direct
inter-group comparisons were carried out where necessary.
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One tailed t-tests for independent samples were used.
The differences between the before and after
treatment data were tested by means of t-tests (for
paired samples). It was predicted that dopamine
replacement therapy would improve performance; one-
tailed tests were therefore used.
CLINICAL STATUS
SEVERITY OF SYMPTOMS BEFORE TREATMENT
On admission to hospital each patient was seen by
the neurologist in charge who rated the severity of the
patient's tremor, rigidity and akinesia.
DISTRIBUTION OF RATINGS OF TREMOR
DEGREE OF DISTURBANCE
' none' 'slight' 'moderate 1 ' marked'
PA 1 7% 33% 40% 10%
PE 36% 36% 28% -
PA+OP 66% 1 7% 1 7% -
PE + OP 6 6% 1 7% 17% -
GROUP AS 32% 30% 30% 6%
A WHOLE
TABLE 9
TABLE 9 shows the distribution of ratings for tremor.
The median of the ratings for tremor for the group as a
whole was 1.09, representing 'slight' degree of tremor.
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The medians for the four subgroups were also calculated:
subgroup PA=1.5, subgroup PE=0.88, subgroup PA+0P=1.00,
subgroup PE+OP = 1 .00. All four medians represent a 'slight'
degree of tremor. Not surprisingly, neither of the x2
tests to which this data was subjected revealed
significant inter-subgroup differences. Paralysis agitans
and post-encephalitic patients had similar degrees of
tremor (x2= .0219; d.f.=l; p>.05). Operated and
unoperated patients were also shown not to differ in
terms of severity of this symptom (x2=.2995; d.f.=l;
p> . 05 ] .
The distribution of ratings for degree of rigidity
is contained in TABLE 10. The group's median rating for
DISTRIBUTION OF RATINGS OF RIGIDITY
DEGREE OF DISTUR3AN CE
1 none' 'slight' 'mo derate' 'marked'
PA 2 33 1 7% 4 3% 1 7%
PE 35% 35% 28% -
PA + OP 25% - 75% -
PE+OP 50% - 25% 2 5%
GROUP AS 2 9% 18% 41% 12%
A WHOLE
TABLE 10
rigidity was 1.5, representing a 'moderate' degree of
rigidity. For subgroup PA the median rating was found to
be 1.93 ('moderate'], subgroup PE, 0.88 ('slight'],
subgroup PA+OP, 1.85 ('moderate'], and subgroup PE+OP, 2.0
('moderate']. No significant difference was found
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between the severity of rigidity shown by paralysis
agitans patients and by pest-encephalitic patients
(x2=2.1039; d.f.=l; p>.05) nor between operated and
unoperated patients (x2=0.0565; d.f.=l; p>.05).
The question of laterality of tremor and rigidity
was considered. The majority of patients had bilateral
tremor and/or rigidity. The patients with only unilateral
'positive' symptoms were about equally divided as
between left-sided and right-sided symptoms. The
relative proportions of patients with unilateral left- or
right-sided symptoms were similar in all four subgroups.
Thus, although the patients are subdivided into four
subgroups according to type of Parkinsonism and surgical
history, it was found that:
a) the proportions of patients with bilateral, with
left- and with right-sided tremor and/or rigidity were
similar in all four subgroups;
b) in general, the patients had only a 'slight' degree
of tremor. No differences in degree of tremor were
found between the two types of Parkinsonism or the two
surgical histories;
c) the patients had a 'moderate' degree of rigidity.
No differences in degree of rigidity were found between
the two types of Parkinsonism nor between patients who had
and those who had not undergone surgery.
Although it is extremely gratifying, from the point
of view of experimental design, that the experimental
group, selected in as random a manner as possible,
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provided four subgroups so homogeneous in clinical
features, this very homogeneity in degree of the 'positive'
symptoms, i.e. tremor and rigidity, is itself of intrinsic
interest. Since stereotactic surgery is performed
specifically to 'relieve' or 'reduce' rigidity and tremor,
one would have expected patients who had undergone this
form of treatment to have a less marked degree of tremor
and/or rigidity than patients who had not undergone
surgery. However, since both paralysis agitans and post¬
encephalitic Parkinsonism are progressive degenerative
diseases, in evaluating the significance of the findings
one must take cognisance of both the length of illness at
the time of surgery and the length of illness at the
beginning of this investigation.
When this is done, it is seen that paralysis agitans
patients confirmed expectations. At the time when
paralysis agitans patients underwent surgery, they had, on
average, had the disease for roughly 6.1 years. The
unoperated paralysis agitans patients had had the disease
for an average of 8.25 years . Thus the two paralysis
agitans groups are roughly comparable in these terms.
When the investigation began, operated paralysis agitans
patients had had the disease for an average of 16.1 years.
This is almost twice as long as the unoperated patients.
(As pointed out in Chapter 5, the difference in length of
illness between these two paralysis agitans groups is
significant.) The findings, then, that operated and
unoperated patients have similar degrees of rigidity and/or
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tremor appears to support Gillingham's assertion (1969):
"... there is no longer any serious doubt, if we study
patterns of daily activity before operation and during
follow-up of 10 years or more, that in an increasing
number of patients the progress of the disease appears to
have been greatly slowed down or even halted."
The results from the two post-encephalitic groups,
however, are quite different. Subgroups PE and PE+OP had
had the disease for a comparable length of time (see
Chapter 5) when this investigation began. Since subgroup
PE+OP patients had undergone surgery eleven years
previously, that is, after having had the disease for
15.29 years, one would have expected these patients to
have a less marked degree of tremor and/or rigidity than
their unoperated counterparts, subgroup PE, who had had
the disease for 28.38 years. However, no such difference
was found. Operated and unoperated patients were found to
have symptoms of like severity.
Two explanations could be advanced for this finding:
that surgery does not benefit post-encephalitic
Parkinsonism, or that the effects of surgery wear off.
However since studies have shown that surgery does, if
only in the short-term, reduce symptoms of post¬
encephalitic Parkinsonism, the first explanation cannot
be sustained. The second explanation, that the effects of
surgery are of limited duration, appears the more
attractive of the two. Hypothesising that paralysis
agitans and post-encephalitic Parkinsonian patients
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respond differently to surgery is not unreasonable: the
two forms of the disease are known to be of different
pathogenesis and their clinical pictures differ in many
respects. A differential response to treatment would
therefore not be surprising.
What is particularly interesting, however, is the
implication regarding the therapeutic nature of surgery.
On the basis of follow-up studies of patients 10 years
after surgery, Gillingham noted (1969) a sustained
reduction in the severity of the positive symptoms of his
operated patients. He interpreted these results as an
indication that induced pallidal and/or thalamic lesions
(at best) halt or (at least) slow down the progression of
the disease process. However, the present results from
comparisons between operated and unoperated patients after
a similar period suggest that some modification of this
view of the therapeutic nature of surgery is required. On
comparing only post-encephalitic patients, matched in
terms of age and date of onset of t"he disease, no
difference in the severity of the symptoms was found
between patients who had undergone surgery 11 years
previously and unoperated patients. These results suggest
that rather than affecting the progression of the disease,
the induced lesions have the effect of suppressing the
positive symptoms. Once the potency of the induced
lesions abates the symptoms manifest with a degree of
severity compatible with the stage of development of the
disease process. This point clearly needs further
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investigation .
The distribution of ratings for degree of akinesia is
contained in TABLE 11. The median rating for the group as
DISTRIBUTION OF RATINGS OF AKINESIA
DEGREE OF DIST URBANCE
'slight' 'moderate ' 'marked'
PA 3% 2 9% 68%
PE 8% 38% 54%
PA+OP 1 7% - 83%
PE+OP - 17% 8 3%
GROUP AS 5% 2 7% 68%
A WHOLE
TABLE 11
a whole was 2.84 which represents a 'severe' degree of
akinesia. The median rating for subgroup PA was 2.76
('severe'), for subgroup PE, 2.57 ('severe'), for subgroup
PA-i-OP, 3.5 ('severe'), and for subgroup PE+OP, 3.5
('severe'). Paralysis agitans and post-encephalitic
patients were found to have similar degrees of akinesia
(x2=0.5263; d.f.=l; p>.05). Operated patients, however,
were found to be more severely akinetic than unoperated
patients (x2=5.6821; d.f. = l; p < . 05 ) . This finding
strongly supports Fagel's claim (1968) that stereotactic
surgery has the undesirable effect of increasing akinesia.
It is particularly interesting that this effect is still
so evident eleven years after surgery had been undergone.
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CLINICAL IMPROVEMENT WITH TREATMENT
Once a patient, had been stabilized on his optimal
dosage level, a clinical assessment of his condition was
carried out by the neurologist in charge. TABLE 12 shows
DISTRIBUTION OF RATINGS OF CLINICAL IMPROVEMENT
DEGREE OF IMPROVEMENT
'slight' 'moderate' ' marked' ' exce11ent1
PA 10% 30% 5 3% 7%
PE 59% 2 5% 8% 8%
PA+OP 14% 5 7% 1 5% 14%
PE+OP 50% 37% - 13%
GROUP AS 26% 33% 32% 9%
A WHOLE-
TABLE 12
the distribution of ratings of improvement for the group
as a whole, and for the four subgroups (in percentages).
The medians for these ratings were calculated. The group
as a whole were found to have made a 'moderate' improvement
(median = 2.21). The median for subgroup PA was 2,56, for
subgroup PE, 1.36; for subgroup PA+OP, 2,33; and, for
subgroup PE+OP, 1.50, Of the four subgroups, the paralysis
agitans patients were found to have shown greater
improvement than the post-encephalitic patients (x2=6.6842;
d.f.=l; p<,01). Surgery, however, did not appear to limit
the degree of improvement : operated patients showed a
degree of improvement similar to that shown by non-
operated patients (x2 = 2.4494; d.f.= l; p > , 0 5 ) .
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MEASURES OF MOTOR PERFORMANCE
TIME TAKEN TO START.WRITING
The latency for writing on command was taken for
each patient. The mean value of these latencies for the
group as a whole was 1.27±.69 seconds. TABLE 13A
contains the mean latencies for the four subgroups.
Analysis of variance showed that the magnitude of
the latency for writing on command did not vary with
surgical history. Operated and unoperated patients
responded comparably. A significant variation, however,
was found with type of Parkinsonism (F = 5 .39; d.f. = l; 30,
p < . 05 ). Paralysis agitans patients responded far quicker
than post-encephalitic Parkinsonian patients (TABLE 13B).
After treatment, the mean latency for the group as a
whole was 1 .01± 41 seconds. These mean latencies for the
four subgroups are also contained in TABLE 13A. Analysis
of variance after treatment showed -that although the
magnitude of latency did not vary with surgical history,
it did vary significantly with type of Parkinsonism.
Paralysis agitans patients still responded quicker than
did post-encephalitic patients (TABLE 13C).
Comparisons between the before and after treatment
latencies for writing on command were carried out by means
of t-tests for dependent (paired) samples. It was found
that the group as a whole was considerably faster after
treatment (t=3.499; d.f.=37J p<.005). As can be seen
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TIME TAKEN TO START WRITING
A. COMPARISON OF SCORES BEFORE AND AFTER TREATMENT
PRE POST
DF T





























GROUP 1.27 0.69 1 .01 0.41 37 3.4490**
B. ANALYSIS OF VARIANCE BEFORE TREATMENT
SOURCE SS DF MS F
TYPE 2.7416 1 2.7416 6 .3547*
SURGERY 0.2372 1 0.2372 0.5498
INTERACTION 0.0097 1 0.0097 0.0225
ERROR 14.6685 34 0 .4314
C. ANALYSIS OF VARIANCE AFTER TREATMENT
SOURCE SS DF MS F
TYPE 2.4952 1 2 .4952 7.1570*
SURGERY 1 .1207 1 1 .1207 3.2145
INTERACTION 0.1991 1 0.1991 0.5711
ERROR 1 1 .8537 34 0.3486
D. ANALYSIS OF COVARIANCE
SOURCE SS DF MS F
TYPE 0.3859 1 0.3859 3.3181
SURGERY 0.4803 1 0 .4803 4.1298*
INTERACTION 0.0001 1 0.0001 0 .0009
ERROR 3.8387 33 0.1163
TABLE 13
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from the last column in TABLE 13A, only the two
unoperated subgroups, i.e. subgroup PA and subgroup PE,
showed a significant change with treatment. In each case,
the patients responded faster after treatment. The two
operated subgroups, however, showed no significant change
with treatment.
These results suggest that change in performance
with treatment is strongly dependent on surgical history.
To confirm this, the before and after treatment latencies
were subjected to an analysis of covariance (TABLE 13D).
It was found that when a linear adjustment is made for the
effect of variation due to differences in latencies prior
to treatment, as measured by the covariate, there -is a
statistical difference between the amount of change shown
by unoperated and operated patients. However, no
statistical difference was also found between the amount
of change shown by paralysis agitans and post-encephalitic
patients .
From these results two conclusions may be drawn. On
the one hand it is apparent that the magnitude of the
latency for writing on command varied significantly with
type of Parkinsonism. Paralysis agitans patients respond
significantly faster than do post-encephalitic patients.
Furthermore, this differential effect of type of
Parkinsonism is evident both before and after treatment.
On the other hand, it is apparent that a diminution of the
magnitude of the latency for writing on command is
observed with L-dopa treatment. However, not all four
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subgroups show this improvement. Only unoperated patients
are faster in responding after treatment. Patients with a
surgical history show no significant change in response
speed; they are neither faster nor slower with treatment.
SIZE OF WRITING
Before treatment, the average size of words written
was 4,2 cms. long, for the group as a whole. The mean
sizes of writing for the four subgroups are contained in
TABLE 14A. Analysis of variance of the before treatment
data revealed no difference in size of writing between
the paralysis agitans and the post-encephalitic patients.
A significant difference, however, was found between the
size of writing of the operated and unoperated patients
(F=7.3729; d.f.=l,36; p<.05). (See TABLE 14B). Patients
who had not undergone surgery wrote significantly larger
than patients who had. In the case of post-encepha 1itic
patients this difference was parti c.ul arly striking:
unoperated patients wrote almost twice as large as operated
patients. This difference is highly significant
(t=+3.0024; d.f.=13; p<.002).
Comparisons between the before and after treatment
measures of size of writing revealed that for the group
as a whole there was a significant increase in the size of
writing following treatment (t= -3.0544; d.f.=39;
p<.005). Each of the four subgroups reflected this
increase (see TABLE 14A), although in only the two
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SIZE OF WRITING
A. COMPARISON OF SCORES BEFORE AND AFTER TREATMENT
PRE POST
-MEAN STD DEV. MEAN STD.DEV.
ur 1
PA 4.4725 1.6686 5.0150 1.8781 1 9 -2.2178*
PE 4.8956 1.6578 5.6611 1.3870 8 -2.1429*
PA+OP 3.7600 0.9607 4.1000 0.8718 4 -1.2981
PE+OP 2.6333 0.9201 3.0833 1.3801 5 -1 .2529
GROUP 4.2027 1.6357 4.7562 1.7732 39 -3.0544*
B. ANALYSIS OF VARIANCE BEFORE TREATMENT
SOURCE SS DF MS F
TYPE 1 .0793 1 1 .0793 0.4692
SURGERY 16.9604 1 16.9604 7.3729*
INTERACTION 3.4932 1 3.4932 1.5185
ERROR 82.8135 35 2.3004
C. ANALYSIS OF VARIANCE AFTER TREATMENT
SOURCE SS DF MS F
TYPE ,0.3823 1 0.3823 0.1449
SURGERY 22.2429 1 22.2429 8.4317**
INTERACTION 5.0276 1 5.0276 1 .9058
ERROR 94.9683 36 2.6380
D. ANALYSIS OF COVARIANCE
SOURCE SS DF MS F
TYPE 0.0688 1 0.0688 0.0682
SURGERY 1 .2353. 1 1 .2353 1 .2255
INTERACTION 0.4339 1 0.4339 0 .4304
ERROR 35.2801 35 1 .0080
TABLE 14
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larger subgroups did the change reach at least the .05
per cent level of significance. (PA: t= -2.2178;
d.f.=19; p<.025 and PE: t= -2.1429; d.f. = 8*, p<.05).
Analysis of variance of the after treatment measures
showed that there was no significant difference between
the size of writing of paralysis agitans patients and
post-encephalitic patients. A significant difference,
however, was found between patients who had undergone
surgery and those who had not. (See TABLE I4C).
Operated patients wrote smaller words than did unoperated
patients.
Since both before and after treatment it was found
that operated patients wrote smaller than unoperated
patients a difficulty in interpretation of the results
arises. Do the patients, irrespective of surgical
history, respond comparably to treatment? In other words
is the after treatment difference in the size of writing
merely a reflection of the before treatment difference
or "bias" in performance? Or, dces'a surgical history
limit the degree of improvement? Is the difference in
size of writing after treatment a reflection of different
degrees of response to treatment? Do unoperated patients
(who happen to write larger) improve more or, indeed, less
than do operated patients (who happen to write smaller)?
To resolve this difficulty, the data was reanalysed
using an analysis of covariance in which the after
treatment data was adjusted in terms of the before
treatment data. As can be seen from TABLE 14D which
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contains the results of this analysis, when the adjustment
is made no differences of significance are found either
between the two types of Parkinsonism studied, or, more
pertinently, between the patients who had and those who
had not previously undergone subcortical surgery. These
results quite clearly reveal comparable degrees of increase
in the size of writing amongst the patients, irrespective
of surgical history, and of type of Parkinsonism.
TIME TAKEN TO WRITE
Before treatment the group took, on average, 40.38±
16.83 seconds to write their names and addresses. The
mean writing times for the four subgroups are contained
in TABLE 15A. Analysis of variance of these before
treatment measures revealed significant differences
between patients who had and those who had not undergone
surgery (F = 5.9619; d.f. = l, 30 4, p < .05). The patients who
had not undergone surgery took less, time to write their
names and addresses than the patients who had. Type of
Parkinsonism, however, was not found to be a significant
factor (see TABLE 15B).
After treatment, the group took on average 35.04+
12. 42 seconds to write their names and addresses. The
mean writing times for the four subgroups are contained in
TABLE 15A. Although inspection of this table reveals an
after treatment reduction in both mean times and standard
deviations for the group as a whole and for the four
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TIME TAKEN TO


























GROUP 40.3808 16.8330 35.0388 12.4238 33 1 .9190
B. ANALYSIS OF VARIANCE BEFORE TREATMENT
SOURCE SS DF MS
TYPE 13.9570 1 13.9570 0 .0541
SURGERY 1538.8203 1 1538.8203 5.9619*
INTERACTION 54.5352 1 54.5352 0.2113
ERROR 7743.2656 30 258.1086
C. ANALYSIS OF VARIANCE AFTER TREATMENT
SOURCE SS DF MS F
TYPE 54.3125 1 54.3125 0 .4274
SURGERY 1145.0391 1 1145.0391 9.0100**
INTERACTION 81.6992 1 81.6992 0 .6429
ERROR 3812.5508 30 127.0850
D. ANALYSIS OF COVARIANCE
SOURCE SS DF MS F
TYPE 41 .3186 1 41 .3186 0 .3603
SURGERY 480.6089 1 480.6089 4.1909*
INTERACTION 55.7153 1 55.7153 0 .4858
ERROR 3325.6980 29 1 14 . 6792
TABLE 15
188
subgroups, none of the t-tests comparing before and after
treatment measures reached significance. The time taken
to write the same sample did not change with dopamine
replacement and the consequent reduction of akinesia.
Not surprisingly, therefore, analysis of variance of
the after treatment writing times provided a picture very
similar to that found before treatment. As can be seen
from the tabulation of results in TABLE 15C, type of
Parkinsonism was once again found not to be a significant
factor, while surgical history was again found to be a
significant factor. Operated patients wrote far slower
than unoperated patients.
These results are interesting, particularly in the
context of the ascertained increase in size of writing
with treatment. Clearly there is evidence of writing more
rapidly after treatment: the patients wrote substantially
larger words after treatment in about the same time as it
had taken them to write micrographically before treatment.
Furthermore, there is clear indication that stereotactic
subcortical surgery had an adverse and lasting effect on a
highly-practiced complex motor activity such as writing.
Although surgery did not limit the degree of improvement
with dopamine replacement, both before and after treatment




The group of patients selected for the present study
were predominantly akinetic. Although all four subgroups
were found to have 'severe' akinesia, analysis of the
clinical ratings revealed that patients with a surgical
history were more profoundly akinetic than patients who
had not undergone subcortical stereotactic surgery. Mo
difference in degree of akinesia was found between
paralysis agitans and post-encephalitic Parkinsonian
patients .
The group as a whole was found to have only 'slight'
tremor and 'moderate' rigidity. The degree of these
'positive' symptoms varied significantly neither with
surgical history nor with type of Parkinsonism.
The question of the efficacy of surgery in reducing
positive symptoms was considered. It was found that when
length of illness before surgery and length of illness
when this investigation commenced are taken into account,
efficacy of surgery is found to vary with type of
Parkinsonism.
Ratings of clinical improvement with L-dopa treatment
showed that although all patients made at least some
improvement, paralysis agitans patients showed
significantly more improvement than post-encephalitic
Parkinsonian patients. Clinical improvement did not vary
with surgical history: no difference was found in degree
of clinical improvement between operated and unoperated
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patients .
Findings from measures of the size of writing and
time spent writing showed that both size and time of
writing varied significantly with surgical history. Both
before and after treatment it was found that unoperated
patients wrote larger words and spent less time writing
these larger words than operated patients. With treatment
all patients showed an increase in size of writing and a
decrease in writing time. However, not all patients
showed the same amount of improvement. Unoperated patients
were found to have made significantly greater improvement
on both these tasks with treatment than did operated
patients .
The latency for writing on command both before and
after treatment varied significantly with type of
Parkinsonism. Paralysis agitans patients were faster than
post-encephaIitic Parkinsonian patients. On comparing
before and after treatment latencies it was found that the
group as a whole was significantly faster after treatment.
Not all subgroups reflected this increase however. Only
unoperated patients improved with treatment. Analysis of
covariance confirmed that reduction in response latency
varied significantly with surgical history. Type of
Parkinsonism did not appear to limit the degree of
improvement on this task.
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CHAPTER 7
RESULTS II: EVALUATION OF SPEECH DISTURBANCE IN PATIENTS
WITH LESIONS OF THE BASAL GANGLIA
Previous workers in the field of Parkinsonian
dysarthria have for the most part ignored the role of
akinesia. It was therefore necessary to proceed
aprioristically in order to arrive at basic information
essential to the rest of the investigation. Fundamental
questions were asked: What is the prevalence, severity
and nature of the speech disturbance in a group of
predominantly akinetic Parkinsonian patients? Is the
disturbance in speech related to the degree of subcortical
damage? Is this speech disturbance modified by the
reduction in akinesia consequent upon administration of
L-dopa?
Answering questions such as these involves making
normative judgements. Speech samples of forty-three
Parkinsonian patients were recorded on magnetic tape (see
Chapter 5) before treatment with L-dopa had commenced
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('test') and again ('retest') once the neurologist in
charge was satisfied that each patient was on his own
maximal dosage level of L-dopa and was showing clinical
improvement in general motor ability. The forty-three
patients comprised twenty paralysis agitans patients
with no history of subcortical surgery (subgroup PA);
eight paralysis agitans patients with a history of
subcortical surgery•(subgroup PA+OP); nine post¬
encephalitic Parkinsonian patients without a relevant
surgical history (subgoup PE) and six with such a
history (subgroup PE+OP). The eighty-six recorded
speech samples were played to two judges experienced in
evaluating disordered speech. The judges were asked to
direct their attention to five parameters of speech,
defined for this study by the rating-scales. They were
required to decide, for each speech sample, whether
there was disturbance on any of these parameters and, if
so, to rate the severity of this disturbance on a five-
point scale. (Maximum severity was 5). The scales were:
INTELLIGIBILITY, DYSARTHRIA, PROSODY, FESTINATION and
PHONIC. The construction of the scales, the procedure
followed in obtaining the judges' evaluations and the
reliability as between the judges' ratings have been
discussed in Chapter 5.
METHODS OF ANALYSIS
The two sets of data (i.e. the before treatment or
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'test1 data and the after treatment or 'retest1 date)
were non-parametric in nature and were subjected to
similar methods of analysis. Basically two different
sets of analysis of variance tests were used. In the
first set of analyses each of the five rating-scales was
considered independently. The Kruskal-Wal 1 i s test was
employed to ascertain whether, on each scale, the
severity of impairment varied across the four subgroups.
Where necessary, comparisons between individual subgroups
were carried out using Mann Whitney tests. In the second
set of analyses each subgroup's degree of impairment on
all five scales was considered. Friedman's analysis was
used to test (for each subgroup) the variance of severity
of impairment across the five scales. This was followed
up by calculating and testing the concordance amongst
the rating scores of sub-group members. Kendall (1948)
has suggested that when there is significant concordance
the ranked entities (in this case the rating-sea 1es) may
be ordered in terms of their respective sums of the
poo 1ed-ordered scores. The rating-sca1es may thus be
considered in terms of their contribution to the total
pattern of impairment for each subgroup. By this method,
therefore, it is possible to see whether patterns of
impairment differ according to type of Parkinsonism
and/or surgical history.
To see whether L-dopa treatment had any effect on
speech, the differences between test and retest ratings
were tested by means of Wilcoxon's matched-pairs signed-
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ranks tests. In three cases where n was too small for
the test to be valid, the binomial test was used.
Where appropriate, one-tailed tests were used. The
hypothesis underlying all these tests was: The greater
the neurological damage, the greater the speech
disturbance. Thus the following distribution of
disturbance was predicted: PA<PE; PA+0P<PE+0P and PA<PA
+0P; PE<PE+0P. Moreover, if the hypothesis that
Parkinsonism is a dopa-deficiency syndrome is correct,
it would follow that test > retest.
SPEECH DISTURBANCE BEFORE TREATMENT HAD COMMENCED
INCIDENCE OF SPEECH DISTURBANCE
INTELLIGIBILITY
Three patients (7%) out of the total group of forty-
three were found to have no impairment at all on the
scale INTELLIGIBILITY. A further three patients (7%)
were considered by the judges to have perceptible, yet
minimal, disturbances (within normal limits, i.e. being
given an average of 0.5 points by the judges). Thus
only 14% of the patient group had speech that the judges
considered acceptable, and 86% had some impairment in
intelligibility. As FIGURE 18A illustrates, the
impairment scores for these patients ranged from 1 to
4.5, are negatively skewed with a mode of 4.0. The
median for the total group of forty-three patients was
2.66.
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Just over a quarter of the total patient group (26%)
were found to have articulation of speech within 'normal'
limits. Of these, 14% were without any dysarthria, and
a further 12% had preceptible, yet minimal articulatory
disturbance. The remaining 74% of the group had
dysarthria of varying degrees. The rating-scores given
these patients ranged from 1 ('mild') to 4 ('moderate-
to-severe1), were positively skewed in distribution with
a mode of 1.5. (See FIGURE 18B). The median for the
whole group was 1.53.
PROSODY:
Only 9% of the forty-three patients had no
disturbance at all in prosodic features. A further 7%
had perceptible but minimal disturbance. Thus only 16%
of the group were considered to have adequate or 'normal'
speech on this scale, and 84% to have some disturbance.
As can be seen from FIGURE 18C, the degree of
disturbance of ratings was skewed marginally to the left
with a mode at 2.0. The median for the group as a whole
was 1.94.
FESTINATION:
In marked contrast to the other disturbances,
festination was seen in only approximately one third of
the forty-three patients. Moreover, even among the 35%
affected, it was not a particularly marked disturbance.
Festination was rated between 1 ('mild') and 2 ('mild
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to moderate'). The distribution of scores is positively
skewed, with the mode at 1.0 (See FIGURE 18D). The
median for the group as a whole was.0.5.
PHONIC:
Of forty-three patients 19% were considered to have
speech within normal limits on this parameter, This
segment of the group comprised 7% with no disturbance at
all, and a further 12% with perceptible yet minimal
impairment. The 81% of patients who were considered
impaired on this rating-scale were found to have 'slight'
(1) to 'moderate' (3) impairment (See FIGURE 18E). The
distribution of impairment scores is skewed positively,
with a mode of 2.0. The median for the group as a whole
was 1.63.
DEGREE OF SPEECH IMPAIRMENT
The degree of impairment on the scale INTELLIGIBILITY
varied significantly with patient group (H=8.830,d.f.=3,
p<.05). Patients with paralysis agitans who had no
history of subcortical surgery were significantly more
intelligible than paralysis agitans patients who had
previously undergone subcortical surgery (U = 37 .0,p= . 025)
and post-encephalitic patients with no surgical history
(U=45.5, p<.025). No significant difference was found
between the two postencephalitic groups, nor between
the two groups who had undergone surgery. Clearly,
Parkinsonism of encephalitic origin and/or previous
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surgical history is associated with greater impairment in
intelligibility.
The degree of dysarthria varied significantly with
patient subgroup (H=11.0710, d.f.=3, p<.01>.001).
Subgroup PA had significantly less dysarthria than
subgroup PA+OP (U=30.5, p<.01>.001), and subgroup PE
(U=48.5, p<.05> . 025 ) .
No s igni fi cant ' vari ati on in degree of impairment
between subgroups was found on the other scales, PROSODY,
F EST I NAT ION and PHONIC- See TABLE 16.
ANALYSIS OF VARIANCE T0F DEGREE OF SPEECH
IMPAIRMENT BEFORE TREATMENT AMONGST THE
FOUR SUB-GROUPS
RATING SCALE H D.F. P
INTELLIGIBILITY 8.8830 3 < . 0 5 > . 0 2
DYSARTHRIA 11.0710 3 < . 02 >.01
PROSODY 5.6800 3 >.05
FESTINATION 7.0123 3 >.05
PHONICS 4.0220 3 >.05
1Kruskal-Wallis analysis of variance
TABLE 16
PATTERNS OF SPEECH IMPAIRMENT
A significant variation in degree of impairment
across the five scales was found within the group as a
whole and within the four subgroups (See TABLE 17A).
There was, in addition, significant concordance between
group-members and between subgroup-members in their
ratings on the five scales. (See TABLE 17B).
Kendall (1948) has suggested that when there is
significant concordance amongst several sets of rankings,
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'PATTERNS' OF SPEECH BEFORE TREATMENT
A. ANALYSIS OF VARIANCE1 OF DEGREE
OF DISTURBANCE ACROSS FIVE
RATING-SCALES
SOURCE d.f. Xr2 p
PA 4 32.6800 <.001
PE 4 22 . 7556 <.001
PA+OP 4 22.8000 < .001
PE+OP 4 17.4333 <.01
GROUP AS 4 84.9814 <.001
A WHOLE
1Fr-Cedman ' s
B. DEGREE OF CONCORDANCE AMONGST
SUB-GROUP MEMBERS
SOURCE k W P
PA 20 0.4085 <.01
PE 9 0.6321 < .01
PA+OP 8 0.7125 <.01
PE+OP 6 0.7264 < .01
GROUP AS 43 0.4941 < .001
A WHOLE
TABLE 17
the ranked entities (in this case the rating-scales) may
be ordered scores. Ranking the scales in this way
succinctly indicates the relative 'weight' or predominance
of each scale in the total pattern of speech impairment.
In descending order of predominance, the scales rank as
fo11ows :
For the group as a whole:
INTELLIGIBILITY, PROSODY, DYSARTHRIA, PHONIC, FESTINATION.
200
For subgroup PA:
INTELLIGIBILITY, PROSODY, PHONIC, DYSARTHRIA, FESTINATION.
For subgroup PA+OP:
INTELLIGIBILITY, DYSARTHRIA, PROSODY, PHONIC, FESTINATION.
For subgroup PE:
INTELLIGIBILITY, DYSARTHRIA, PROSODY, PHONIC, FESTINATION.
For subgroup PE+OP:
INTELLIGIBILITY, DYSARTHRIA, PROSODY, PHONIC, FESTINATION.
The patterns are similar in a number of respects:
in all cases INTELLIGIBILITY is at the top of the list,
FESTINATION at the bottom, and PROSODY always preceeds
PHONIC. The difference in patterns is attributable
solely to the position of DYSARTHRIA in the rankings. In
subgroup PA, DYSARTHRIA is penultimate while for the
other sub-groups it is second. This is not totally
unexpected. In the preceeding section, it was shown that
there was a significant variation in the degree of
DYSARTHRIA across the four subgroups. PA was
significantly less dysarthric than the other subgroups
and these other subgroups were equally disturbed in
articulation.
However, similar significant variations were found
on the scale INTELLIGIBILITY. PA was significantly more
intelligible than the other subgroups, while these
subgroups, PA+OP, PE, PE+OP, did not differ amongst
themselves in the degree of impairment in intelligibility.
One could argue that despite this significant variation
across the subgroups, since INTELLIGIBILITY is
consistently the scale showing the most impairment, it is
a global or super-ordinate scale reflecting the composite
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disturbances of the four more 'specific' scales. The
argument could be extended to exclude INTELLIGIBILITY
from the ranking lists altogether. Indeed, on omitting
this scale and re-analysing the data from only the
'specific' scales, precisely the same ordering of scales
is obtained for the group as a whole and for the four
subgroups.
The pattern of .'PROSODY, PHONIC, DYSARTHRIA,
FESTINATION' that was obtained for paralysis agitans
patients who have no previous surgical history is in
keeping with the study by Darley et al. (1969a, 1969b).
In that study, three judges were able to differentiate
patterns of dysarthria associated with a variety of
neurological diseases. Parkinsonian patients
constituted one of the groups of patients involved in
this study. The parameters the judges found most useful
in distinguishing Parkinsonian speech from the other
types of speech disorder were those relating to prosodic
features - "MONOPITCH" (defined as lacking in "normal
pitch and inflectional changes"); "REDUCED STRESS"
(reduction of "proper stress or emphasis patterns");
and "MONOLOUDNESS" (lack of "normal variations in
loudness"). The next most useful parameter was
"IMPRECISE ARTICULATION OF CONSONANTS". This was
followed by three parameters relating to speed of
utterance: "INAPPROPRIATE SILENCES", "SHORT RUSHES" (of
speech): and "VARIABLE RATE" ("festination").
The relative predominance of dysarthria in the other
sub-groups is not totally unexpected. Cramer (1940)
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emphasised the role of dysarthria in the pattern of
speech impairment in the six post-encephalitic patients
she studied and the effect of stereotactic surgery on
the speech of "Parkinsonian" patients, according to
Allen et a 1 . (1966), Herman et al. (1966), and Bell
(1968) is to increase dysarthria. What is surprising,
is that no significant difference in the degree of
dysarthria was found, amongst these three groups. One
would have predicted that since paralysis agitans
patients who have undergone surgery have (in comparison
to unoperated paralysis agitans patients) an overlay of
dysarthria, the same would hold true of post-encephaiitic
patients. Those post-encephalitic patients with a
surgical history might be expected to have more severe
and marked dysarthria than those with no surgical
history. This, however, was not found to be the case.
SPEECH DISTURBANCE AFTER TREATMENT HAD COMMENCED
INCIDENCE OF SPEECH IMPAIRMENT
After treatment, a larger proportion of the patients
in the study were considered by the judges to have speech
within 'normal' limits.
INTELLIGIBILITY:
After L-dopa treatment had been stabilized in each
patient, 23% of the group, a proportion 9% larger than
on previous testing, were found to have speech within
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'normal' limits. This group comprised 9% who were
without any impairment at all, and 14% with perceptible,
yet minimal, impairment. The scores of the remaining 77%
of the group (who had impairment of intelligibility)
although of a slightly larger range than previously, were
no longer negatively skewed in distribution. As
FIGURE 19A illustrates, the distribution of impairment-
scores assumes a shape closer to a normal distribution.
This is reflected in the values of the mode (2.75) and
the median (2.45) of these scores.
DYSARTHRIA:
On retest, 37% of the patients were found to have
either minimal or no dysarthria. This was an
improvement of 11%. The 63% of patients with dysarthria
had scores ranging from 1 ('mild') to 5 ('severe') with
a mode of 2 and a median of 1.38. The distribution of
scores (See FIGURE 19B) was positively skewed.
PROSODY:
On retest, after L-dopa treatment had commenced, 7%
more of the patients had speech with 'normal' prosodic
features than on first testing. The 23% of the group
with 'normal' prosody comprised 7% with no disturbance
at all, and 16% with perceptible yet minimal disturbance.
Disturbance in prosodic features was found in 77% of the
group. The severity of disturbance was found to range
from 1 ('slight') to 3 ('moderate'). The distribution of
impairment-ratings was negatively skewed, with a mode of
2.5, and a median of 1.63. See FIGURE 19C.
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F EST I NAT 10 N:
On retest, a slight increase in the number of
patients with festinant speech was found. Whereas before
treatment 35% of patients had festination, on retest 41%
were rated as disturbed on this parameter. (As will be
shown later, this anomaly is largely attributable to one
group viz. PE+OP.) The degree of disturbance, however,
was over the same range as before treatment, from 1
('mild') to 2 ('mild to moderate'). The mode of these
disturbance ratings was 1.0 and the median 0.63. See
FIGURE 19D.
PHONIC:
An increased proportion of patients were considered
to have speech within normal limits, on this rating-
scale, after treatment. As can be seen from TABLE 1.5,
on retest 7% more patients were found to have a
perceptible yet minimal disturbance than on first
testing. On retest, the range of disturbance-ratings
was found to be smaller (See FIGURE 19E). The mode of
disturbance-ratings was 1.5, and the median 1.39.
DEGREE OF SPEECH IMPAIRMENT
INTELLIGIBILITY:
The degree of impairment varied significantly with
patient group (H=23.0706, d.f. = 3, p< .001 ) . Unoperated
patient groups were significantly more intel1igibi1e
than their operated counterparts (PA<PA+OP0. p < . 0 01 ;
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?E<PE+OP: U = ll, p<.05>.025 ). Furtherrnore, the two
unoperated groups were significantly different; subgroup
PA was more intelligible than subgroup PE (U=53, p<.05
>.025). No difference of significance was found between
the two patient subgroups with previous surgical history.
DYSARTHRIA:
The degree of dysarthria varied significantly with
patient subgroup (H=18.8830, d.f. = 3, p < . 0 01 ) . Patients
with no previous surgical history were significantly less
dysarthric than their operated counterparts (PA<PA+OP:
U = 11 . 5 , p < 0 01 ; PE<PE+OP: U = 11 , p<.05). Paralysis agitans
patients without surgical history had markedly less
dysarthria than post-encephalitic patients without
surgical history (U=53, p<.05>.025). However, paralysis
agitans patients who had a history of subcortical
surgery were not less dysarthric than post-encephalitic
patients with a history of subcortical surgery.
PROSODY:
Analysis of retest scores showed that the degree of
impairment varied significantly with patient group
(H=14.1041, d.f.=3, p<.001). Patients without previous
surgical history had significantly less prosodic
disturbance than their operated counterparts (PA<PA+OP:
U = 22 .0 , p< . 01> . 001 ; PE<PE+OP: z = 1 . 9331 , p<.0268). No
significant difference was found between the two forms
of Parkinsonism in this study, neither between the
groups without a history of previous surgery (PA,PE),
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nor between those groups which had previously undergone
surgery (PA+OP, PE+OP).
FESTI NATION:
A significant variation in degree of impairment on
this scale was found according to patient subgroup
(H=9.7213, d.f.=3, p< . 05>.02 ). Unoperated paralysis
agitans patients had significantly less festination than
operated paralysis agitans patients (U=25, p< .01> .001 ) .
The difference between unoperated and operated post¬
encephalitic patients just failed to reach significance
(PE<PE+OP: z=1.555, p=.0594). No difference was found
between subgroups PA and PE, or subgroups PA+OP and
PE+OP.
PHONIC:
The degree of disturbance varied significantly with
patient subgroup (H=14.2958, d.f.=3, p<.01>.001).
Patients who had no history of surgery, irrespective of
type of Parkinsonism, were significantly less impaired
on this rating-scale on retest than those who had
previously undergone surgery (PA<PA+OP: U=33.5,
p<.01> . 001; PE<PE+OP: U = 6.5, p<.01>.001).
CHANGES IN SPEECH DISTURBANCE: test-retest comparisons
INTELLIGIBILITY:
The group as a whole was significantly more
intelligible after treatment (T = 31, n =24, p<.005). The
two unoperated subgroups were found to have improved
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significantly (PA: T=0, n = 10, p < .001; PE: (on binomial
test), x^O, n =5, p=„031) but the two subgroups with a
previous surgical history showed no significant change.
DYSARTHRIA:
The group as a whole was found to be significantly
less dysarthric after treatment had begun (z=1.6366,
p<.05). Both subgroups without surgical history showed
a significant improvement (PA: T = 10, n=ll, p<.025>.01;
PE: T=0, n=7, p<.01>.001). The two other subgroups,
PA+OP and PE+OP, showed no significant change.
PROSODY:
A significant reduction in disturbance of prosodic
features was found for the group as a whole after
treatment had begun (z=2.0048, p<.023>.022). However,
only one subgroup, subgroup PA, showed a significant
improvement on this scale (T=8, n=13, p<.003).
FEST I NAT 10 N:
No significant change was found for the group as a
whole on this scale. However, when considering the
subgroups individually, a significant change was found
in one of the subgroups. Subgroup PE+OP was significantly
more impaired on this scale after treatment (x = 0, n=5,
p=.031).
PHONIC:
The group as a whole showed a significant improvement
on this scale after treatment had commenced (T=81, n=25,
p<.025>.01). Of the four subgroups, however only
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subgroups PA and PE showed significant reduction in
phonic disturbances [PA: T=12, n = 12, p<.025>.01; PE:
(binomial test) x =0, n = 5, p=.031). The two subgroups
with previous surgical history did not change
significantly.
These findings are clearly in direct contrariety to
the editorial comments: on the limitations in treatment
of Parkinson's disease made by Schwab (1968): "Still
further future hopes are needed to help cases with
difficulty in speech and handwriting that many patients
have At present... L-dopa can not do very much
for either." However, the improvement in speech with
L-dopa treatment reported herein is in clear accordance
with the two studies published after this investigation
had begun. Rigrodsky and Morrison (1970) compared the
speech performances before and after L-dopa treatment
of a group of twenty-one Parkinsonian patients. On only
one of the four rating-scales used was a significant
change found (a=.05). This scale, -the "time factor in
speaking", was a measure of the "overall rate of
speaking, the appropriateness of phrasing and pauses,
the rhythm and fluency of speech". The three other
scales ("overall adequacy", "clarity of articulation",
and "nasal resonance"), however, did reveal a "trend in
the direction of improved speech during L-dopa therapy".
Nakano et al. (1973), in a double-blind crossover study,
found that when their eighteen patients "with
Parkinson's syndrome" were on L-dopa (as opposed to a
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placebo or procyclidine hydrochloride) the
"Intelligibity" of their speech was much improved. They
believed this improvement to be attributable to the
"improvement in the articulation" of their patients.
PATTERNS OF SPEECH IMPAIRMENT
After treatment, despite the significant reduction
in impairment seen for the group as a whole (on all
scales except FESTINATION) a significant degree of
variation across the rating-scales was found. When the
scales are ranked in terms of their relative contribution
to the overall picture of impairment, FESTINATION - the
one scale on which no improvement (or deterioration) was
observed - remained the least predominant disturbance.
The order of scales, from most to least predominant is:
(INTELLIGIBILITY), PROSODY, PHONIC, DYSARTHRIA,
FESTINATION. It appears that L-dopa treatment affects
speech impairment in two ways: it reduces the severity
of impairment in terms of intelligibility, articulation,
prosodic features and vocal quality; and it alters the
overall pattern of disturbance. After L-dopa treatment,
dysarthria is a less predominant feature.
For all the four subgroups, degree of impairment
varied across the five scales (See TABLE 18A). There
was also a significant degree of concord within each
group (See TABLE 18B). The four subgroups, however,
were not all affected similarly by L-dopa.
Subgroup PA appears to have been affected only in
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'PATTERNS' OF SPEECH AFTER TREATMENT
A. ANALYSIS OF V A RI A N C E 10 F DEGREE
OF DISTURBANCE ACROSS FIVE
RATING-SCALES














































terms of a reduction in quantity of disturbance. The
quality was unaffected: the relative amounts each scale
contributed to the overall pattern of impairment is
almost identical before and after treatment despite
significant reductions in degree of disturbance on all
scales except FESTINATION.
In subgroup PE, however, treatment affected both
the quantity and quality of speech impairment. After
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treatment the relative amounts each scale contributed to
the overall pattern of impairment differed from those
before treatment. After treatment, in order of
predominance, the scales rank as follows:
(INTELLIGIBILITY), PROSODY, DYSARTHRIA, PHONIC,
FESTINATION. Some change could, perhaps, have been
expected since this subgroup improved on INTELLIGIBILITY,
DYSARTHRIA and PHONIC but remained unaffected on PROSODY
and FESTINATION. However, what is particularly
interesting is the way in which the scales are ordered
after treatment. PROSODY and not DYSARTHRIA is now the
predominant disturbance. In this respect subgroup PE
resembles subgroup PA more closely than the operated
counterpart PE+OP. This closer affinity to the other
unoperated Parkinsonian group, and the widening of
differences from operated post-encephalitic patients is
in accordance with the changes in degree of disturbance
already discussed.
Patients who had previously undergone surgery
remained largely unaffected by treatment. DYSARTHRIA
was still the predominant disturbance, and even though
post-encephalitic patients with a surgical history
increased in their amount and degree of festination, the
order in which the scales contribute to the overall




Before treatment, predominantly akinetic Parkinsonian
patients have a high incidence of speech disturbance.
Over 80% have reduced intelligibility, disturbances of
prosody and of phonic quality. Furthermore, over 70% are
dysarthric. Festination, however, was not found to be a
marked disturbance - only one out of every three patients
exhibited this temporal distortion.
The degree of impairment on INTELLIGIBILITY and
DYSARTHRIA before treatment varied significantly between
the four subgroups. In each case unoperated paralysis
agitans patients were less impaired than the three other
subgroups.
Some variation between the subgroups was observed in
the relative importance of the five- parameters. Before
treatment paralysis agitans patients without previous
surgical history were predominantly a-prosodic while the
three other subgroups were predominantly dysarthric.
After treatment, the intensity of disturbance on
each of the five parameters varied significantly between
the subgroups. Unoperated patient subgroups were
generally less impaired than their operated counterparts;
and on INTELLIGIBILITY and DYSARTHRIA PA proved less
impaired than PE.
Within subgroup PE a notable change in the nature of
speech disturbance was observed. Whereas before treatment
the speech of this subgroup was undifferentiab1e from the
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two subgroups with surgical history, after treatment the
speech of subgroup PE resembled more closely that of
subgroup PA. After treatment, the speech of the two
unoperated subgroups was characterized by a relative
predominance of prosodic disturbances and that of the
operated groups by dysarthria disturbances.
Test-retest comparison showed that for the group as
a whole, there was significant improvement on four of
the five scales. The only scale on which no reduction
(and indeed, no increase) was demonstrated was
FESTINATION. Of the four subgroups, PA showed a
significant reduction in disturbance on all five
parameters. Subgroup PE showed a significant
improvement on all scales except PROSODY and FESTINATION.
The two other subgroups, however, fared less well. Of
these two subgroups with a history of subcortical
surgery, only PE+OP showed any significant change.




RESULTS ill: THE DESCRIPTION OF SPEECH
The speech samples that had been played to the
judges for evaluation were also subjected to analysis in
an attempt to obtain parametric, 'objective' measures
character!* s ti c of the samples. A number of standard
measures were taken such as rate of reading and voice
volume. In addition, the samples w-ere subjected to
certain novel methods of analysis. The purpose of these
was to investigate the fine temporal changes in speech
that occur with Parkinsonism and that are possibly
reversed by dopamine replacement therapy. These analyses
provided quantification of the periodicity of words and
pauses, and of the regularity of speech.
The results will be presented in two sections. The
first, Vocal Characteristics, covers mean voice volume,
variation in voice volume, and sustained phonation. The
second section. Temporal Characteristics, covers rate of




The results presented in this chapter are from
parametric tests based on interval data. The choice of
statistical techniques was governed by the two basic
experimental hypotheses.
The first hypothesis related the degree of
subcortical damage to the degree of speech disturbance
and predicted that the larger the extent of the lesion/s
the greater would be the speech disturbance. The
differences before treatment in degree of disturbance
between the four subgroups (each of which represented a
different degree of subcortical damage) were tested using
an analysis of variance with two fixed factors - type of
Parkinsonism and surgery. The same ANOVA was used on the
after treatment scores unless significant differences
were found in the before treatment scores, in which case
an analysis of covariance with the same two factors was
used. The effect of this technique was to 'adjust' each
after treatment score in terms of the before treatment
score. Where appropriate, inter-subgroup comparisons
were made using the t-test (for individual samples).
The second hypothesis proposed a connection between
the speech disturbance and the dopamine concentration
levels of the striatum. It was hypothesised that
dopamine replacement would be reflected in a diminution
of speech disturbances. To test this hypothesis, one-
tailed t-tests for 'paired samples' were used, with each




Voice volume measures were based on the recordings
of the patients reading the standard passage "Arthur the
Rat". Measures were taken at five second intervals
throughout the reading (see Chapter 5). For each patient,
both before and after treatment, the means and variances
of these measures were calculated and subjected to
statistical analysis.
MEAN VOICE VOLUME
Before treatment the group of patients was found
to have an average voice volume level of 63.3+ 6.26 dB.
Subgroup PE + OP spoke the softest (60.02+ 4.32 dB) and
subgroup PE the loudest (64.39+ 6.05 dB). (see TABLE 19A).
Analysis of variance revealed no significant differences
between the subgroups: neither type of Parkinsonism nor
surgical history was of importance as far as voice volume
levels were concerned, (see TABLE 19B).
The finding that operated patients spoke no softer
than unoperated patients is particularly interesting. In
1966 two studies of the effect of surgery on voice volume
were published. The results contained -in these two
studies (Allan et al., 1966, and Hermann et al., 1966)
are directly comparable with the findings of the present
study since similar methods of data collection and of
218
MEAN VOICE VOLUME
A. COMPARISON OF SCORES BEFORE AND AFTER TREATMENT
PRE POST
DF T





























GROUP 63.3092 6.2619 66.4069 5.9937 42 -3.9036**
B. ANALYSIS OF VARIANCE BEFORE TREATMENT
SOURCE SS DF MS F
TYPE 10,.2500 1 ID..2500 0 .2552
SURGERY 20,.8:25 1 20,.81 25 0,.5182
INTERACTION 49,.3750 1 49 .3750 1 . 2293
ERROR 1 565,.4375 35 40 .1651
C. ANALYSIS OF VARIANCE AFTER TREATMENT
(ADJUSTED SUMS OF SQUARES OF MAIN EFFECTS)
SOURCE SS DF MS P
TYPE 0.6515 1 0.6515 0 .0200
SURGERY 225.7 40 1 225 .7140 6.9246*
INTERACTION 5.0360 1 5.0350 0.1545
ERROR 1271.2500 39 32.5961
TABLE 19
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measuring "voice volume" were used. The Allan and the
Hermann studies both found that stereotactically induced
subcortical lesions lead to a significant dimi nution from
pre-operative voice volume levels. In 1958 Sell confirmed
that in the immediate post-operative period patients do
speak much softer than they had prior to surgery.
However, Bell also found that during the first three
weeks after surgery the voice volume of his patient group
gradually increased. In some cases voice volume had
returned to its pre-operative level. The present finding
that eleven years after surgery operated patients speak
as loudly as unoperated patients appears to support Bell's
view that the diminution in voice volume seer, in the
immediate post-operative period is transitory.
After treatment the mean voice volume level for the
group as a whole was 66.41+ 5.99 dB. The mean voice
volume levels of the four subgroups are shown in TABLE 19A.
Analysis of variance of these after treatment measures
revealed that surgery was a highly significant factor
(F=6.9246, d.f.=l,39; p<.05). Operated patients spoke
far softer than their unoperated counterparts. No
difference in voice volume, however, was found between
paralysis agitans and post-encephalitic patients. (See
TABLE 19C).
The before and after treatment voice volume measures
were compared to ascertain the effect of L-dopa treatment.
With treatment, the group as a whole showed a significant
increase in voice volume (t= -3.9036; d.f.=42; p<.005).
However, when the group was divided into its constituent
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parts it was clear that not all the four subgroups
reflected this change. Only the unoperated subgroups,
i.e. PA and PE, showed a significant increase in voice
volume. Of the unoperated subgroups, PE+OP tended to
speak marginally louder and PA+OP marginally softer after
treatment. Taken together, the operated subgroups
showed no change at all (see TABLE 19A).
On the basis of these results it is clear that the
effect of stereotactic surgery in depressing voice
volume levels is not completely 1transitory ' . When the
voice volume levels of patients who had undergone surgery
eleven years previously are compared with the voice
volume levels of unoperated, severely akinetic,
Parkinsonian patients, no statistically significant
difference is found. However, when operated and
unoperated patients are on maximal dosages of L-dopa, only
unoperated patients are seen to benefit. Voice volume
levels of unoperated patients increase substantially with
treatment, while operated patients show no such
improvement. Clearly, stereotactic subcortical surgery
doas have an important and a lasting effect on voice
volume level: it reduces the capacity for improvement.
VARIATION IN VOICE VOLUME
According to Darley et al. (1 968b) 'monoloudness ' is
one of the characteristic disturbances in the speech of
Parkinsonian patients. The degree of monoloudness is
reflected in the variance of the voice volume measures.
These variances were analysed to see whether the degree
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VARIATION IN VOICE VOLUME






PA 2.4715 1.1515 2.5520 1 .1424 18 -0 .5395
PE 1 .7398 1 .2183 2 .1650 0.9331 7 -1 .2862
PA+OP 2.1930 0.6908 2.7718 0.9386 5 -1.8545
PE+OP 1.9358 1 . 2698 2.6766 1 .0246 5 -1 .0142
GROUP 2.1962 1.416 2 .5256 1 .0446 38 -2 .0179
B. ANALYSIS OF VARIANCE BEFORE TREATMENT
SOURCE SS DF MS F
TYPE 3..0279. 1 3 .0279 2 .3701
SURGERY 0,.3010 1 0 .3010 0 .2356
INTERACTION 0,.1845 1 0 .1845 0 .1444
ERROR 44,.7153 35 1 .2775
C. ANALYSIS OF VARIANCE AFTER TREATMENT
SOURCE SS DF MS F
TYPE 0..4362 1 0,.4362 0,.3895
SURGERY 0..6839 1 0 .6839 0 .6107
INTERACTION 0 .4340 1 0 .4340 0,.3876
ERROR 39,.1943 35 1 .11 98
TABLE 20
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of subcortical damage and/or whether dopamine
replacement therapy had any influence on monoloudness .
Before treatment, no significant variation in the
magnitude of voice volume variances was found either
between operated and unoperated patients, or between
paralysis agitans and post-encephalitic Parkinsonian
patients. The results of this analysis of variance are
shown in TABLE 20A.
The after treatment data presented a similar picture.
As can be seen from TABLE 20B surgical history and type
of Parkinsonism were not associated with significantly
different degrees of monoloudness.
When the before and after treatment voice volume
variances were compared, it was clear that for the group
as a whole there had been a significant increase in the
variability of loudness. Furthermore, as can be seen in
TABLE 20A the spread of these measurements had decreased.
The four subgroups all reflected these changes (see
TABLE 20C) despite the fact that none of the changes
reached the 5% level of confidence.
From these findings it may be concluded that neither
before nor after treatment does the degree of variability
in loudness vary significantly with the degree of
subcortical damage. However, variability in loudness is
affected by dopamine level. Once replacement therapy
had reached an optimal level (as defined on clinical
criteria) a significant increase in the variability of
loudness was seen. All patients, irrespective of type of
Parkinsonism or surgical history, showed this improvement.
223
SUSTAINED PRONATION
Before treatment had begun the group as a whole were,
on average, able to sustain phonation for 7.227+ 3.79
seconds. TABLE 21A shows the length of time for which
each of the four subgroups could sustain phonation.
Canter (1961) found a "marked reduction in this aspect of
physiological support for speech" in his group of
seventeen (unoperated) paralysis agitans patients. They
could sustain phonation for about 11.6 seconds while his
control group averaged 20.6 seconds. The patients in the
present study appeared even more impaired on this task
than Canter's patients had been. It seems, however, that
Canter's patients were also only slightly to moderately
affected in other respects. As was mentioned in
Chapter 4, although he did not assess the severity of
akinesia in his patients, Canter did mention that they
were all fully mobile and able to walk to his laboratory.
In the present study all the patients were found by the
neurologist in charge to be severely akinetic. Perhaps
the disparity between Canter's measurements and the
present study's findings is a reflection of this
difference in degree of general or 'clinical' impairment.
Analysis of variance of these before treatment
measures of sustained phonation revealed that neither
type of Parkinsonism nor surgical history was an
important factor. The length of sustained phonation did
not vary significantly with either of these two factors.
(See TABLE 2IB ) .
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SUSTAINED PRONATION
A.COMPARISON OF SCORES BEFORE AND AFTER TREATMENT
PRE POST
DF F
MEAN STD.DEV. MEAN STD.DEV.
PA 7.3535 3.8182 9.3580 4 .5308 1 9 -1 .9803*
PE 5.7755 3.0228 8.1548 2 .9535 8 -2 .8039**
PA+OP 7.3512 4.5885 8.6587 3.6931 7 -2.6176**
PE+OP 8.8167 3.7736 9.8317 3.1105 5 -0.9036
GROUP 7.2270 3.7899 9.0421 3 .8349 42 -3 .0308**
B. ANALYSIS OF VARIANCE BEFORE TREATMENT




















C. ANALYSIS OF VARIANCE ,AFTER TREATMENT




















D. ANALYSIS OF COVARIANCE






















After treatment had reached an optimal level for
each patient, the group of patients as a whole were able
to sustain phonation, on average, for 9.042+ 3.83
seconds. (See TABLE 21A above for the mean values of
sustained phonation for the individual subgroups.)
Analysis of variance showed that after treatment the
length of sustained phonation did not vary significantly
either with type of Parkinsonism or with surgical
history. (See TABLE 21C).
When the before and after treatment measures of
sustained phonation were compared, it was seen that the
group as a whole was able to sustain phonation
significantly longer after treatment (t= -3.0308,
d.f.=42; p<.005). The four subgroups all reflected
this increase (see TABLE 21A), although in the smallest
subgroup (PE+OP) the increase did not reach significance.
Analysis of covariance confirmed that the degree of
improvement did not vary with either type of Parkinsonism
or surgical history. (See TABLE 21D.)
From these results it may be concluded that the
ability to sustain phonation is not affected either by
type of Parkinsonism or by surgical history. With
treatment, all four subgroups show similar degrees of
improvement. After treatment, the ability to sustain
phonation does not vary significantly with either type




Before treatment the group of patients read, on
average, 152.79 words per minute. The standard
deviation of this mean was found to be 35.76 w.p.m. This
relatively large variation in reading speed is not
totally unexpected. Darley et al . (1968b), for example,
found, in their investigation of dysarthrias, that their
group of (untreated) Parkinsonian patients was considered
by the three judges to contain both slow and fast
speakers. Canter, in his extensive study (1961) of the
speech characteristics of (untreated) Parkinsonian
patients, included 'rate of reading' amongst his test
parameters. He found that although the median reading
rate of his 17 patients was 172.6 w.p.m. and that of his
17 age-matched controls was 177.6 w.p.m., the range of
reading rates for his patients was three and a half times
larger than that for his controls. Although Canter
himself does little more statistically with his carefully
collected data, he does provide complete records of his
results. From his records the average reading rate for
his patients was calculated by the present writer to be
154.88+ 46.11 w.p.m. and that of his controls to be
180 . 66+ 15.27 w.p.m.
Out of interest, Canter's data and the data from the
present investigation were compared. Cochran's
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t-approximation was used in preference to the usual t-test
for independent samples for a number of reasons. The
two sets of data were based on different standard reading
passages (Fairbank's "Rainbow Passage" by Canter, the
British version of Johnson's "Arthur the Rat" by Gamsu).
All sets of data were collected and analysed by different
investigators, etc. The advantage of Cochran's t is that
it is more conservative than the Behrens-Fisher solution
(Snedecor and Cochran, 1956) and is robust enough to be
used with samples from even markedly skewed populations.
Using Cochran's t, it was found that there was no
significant difference between the reading rate obtained
from Canter's patients and the untreated patients in the
present study (Cochran's t= .16, t(0.05) = 2.0927).
Furthermore, Canter's control group read significantly
faster than his own patients (Cochran's t = 2.1883,
t(0.05) = 2.11) and the untreated patients in the present
study (Cochran's t = 3.7693, t(0.05) = 1.5556). FIGURE 20
shows Canter's patient and control data together with the
data from the present investigation.
The mean reading rates obtained for each of the four
subgroups before treatment are contained in TABLE 22A.
Analysis of variance showed that rate of reading varied
significantly neither with type of Parkinsonism nor with
surgical history. (See TABLE 22B.)
After treatment, the group of patients as a whole
read, on average, 167.33 w.p.m. A standard deviation of
36.70 w.p.m. was obtained. The value of this deviation
is remarkably similar to the standard deviation obtained
228
RATE OF READING: COMPARISON OF DATA BY CANTER (1961)
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A. COMPARISON OF SCORES BEFORE AND AFTER TREATMENT
PRE POST
DF T
MEAN STD DEV. MEAN STD.DEV.
PA 161.7363 33.1058 1 71 .1863 38.3924 1 5 -1 .4301
PE 149.3943 34.5000 1 72 .6686 24.8100 6 -2 .6500**
PA+OP 159.0583 37.4720 168.9833 32.1501 5 -0.9473
PE+OP 1 21 . 3600 42.9975 145.4980 51.5134 4 -2.4437*
GROUP 152.7850 36.7600 167.3250 36.7000 33 -3.4000**
B. ANALYSIS OF VARIANCE BEFORE TREATMENT
SOURCE SS DF MS F
TYPE 4212.6952 1 4212.6952 3.2355
SURGERY 1918.6032 1 1918.6032 1.4736
INTERACTION 404.9595 1 404.9595 0.3110
ERROR 39060.4596 30 1 302 .01 53
C. ANALYSIS OF VARIANCE AFTER TREATMENT
SOURCE SS DF MS F
TYPE 662.6385 1 662.6385 0.4779
SURGERY 1322.0576 1 1322.0576 0.9534
INTERACTION 852.3182 1 852.3182 0.6147
ERROR 41598.5477 30 1386.6183
TABLE 22
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before treatment. Analysis of variance carried out on
the after treatment reading rate revealed that rate of
reading did not vary significantly with either of the two
factors. (See TABLE 22C).
On comparing the before and after treatment reading
rates for the group as a whole, a significant increase in
rate was found (t= 3..4526; d.f.= 33; p<p.0025 ). All
four subgroups showed an increase in reading rate although
in only two subgroups (PE and PE+OP) did this increase
reach at least the 5% level. (See TABLE 22A). Of
particular interest is the comparison between treated
patients and Canter's control group. As reported above,
before treatment the group of patients as a whole were
found to read significantly slower than Canter's control.
After treatment, however, these same patients read as
fast as Canter's controls. (Cochran's t= .9667,
t(0.05)= 2.0928). (See FIGURE 20).
PERIODICITY OF SPEECH
The results concerning the length of pauses and
phonations in unoperated paralysis agitans patients have
been discussed elsewhere (Mawdsley and Gamsu, 1971 - see
appendix). In that study only a few post-encephalitic
and a few operated patients were included. It appeared
from those results, however, that unoperated paralysis
agitans patients differ from post-encephalitic and
operated patients in respect of the parameters in question.
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The corpus of data on which the paper was based has
therefore been extended to include more patients in these
latter categories. The corpus now presented comprises
data from all four subgroups, that is, PA, PE, PA+OP and
PE+OP. This extended corpus of data will be discussed
from three viewpoints - the length of phonations, the
length of pauses, and the ratio between phonations and
pauses .
LENGTH OF PHONATIONS
Before treatment the mean length of words for the
group as a whole was 353- 113ms. TABLE 23A contains the
mean value for the phonations of the individual subgroups.
Analysis of variance revealed no differences of
significance between paralysis agitans and post¬
encephalitic patients or between operated and unoperated
patients. (See TABLE 23B).
After treatment the group's mean length of phonations
was 3511 83ms. The mean length of phonations for the four
subgroups are contained in TABLE 23A. Analysis of
variance after treatment revealed, once again, that
neither type of Parkinsonism nor surgical history affects
the length of phonations. (See TABLE 23C).
On comparing the length of phonations before and
after treatment for the group as a whole, no significant
change was found (t= 0.1048; d.f.=33; p>.05). When the
group was divided into its constitutent parts it was seen
that in only one subgroup, subgroup PA, was there a
significant change in length of phonation. (See TABLE 23A).
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MEAN LENGTH OF PHONAT IONS
A. COMPARISON OF SCORES BEFORE AND AFTER TREATMENT
PRE POST
DF T

















GROUP 353 113 351 83 33 0.1048
B. ANALYSIS OF VARIANCE BEFORE TREATME NT
















C. ANALYSIS OF VARIANCE AFTER TREATMENT


















The length of phonation for subgroup PA was significantly
shorter after treatment (t = 2.5079; d.f.=13; p<.05).
The other subgroups, however, both individually, and when
grouped together failed to show a significant change.
The variability of each patient's phonations was
also considered. Before treatment the standard
deviations for individual patients gave a mean value of
2.17-839 ms. TABLE 24A contains the mean values for the
subgroups. Analysis of variance revealed no significant
variation in the size of this deviation with either type
of Parkinsonism or surgical history (see TABLE 24B).
After treatment, the standard deviations of individual
patients gave a mean value for the group as a whole of
2.03+ 593 ms. The mean values after treatment for the
subgroups are contained in TABLE 24A. Analysis of
variance after treatment also revealed no significant
variation with either type of Parkinsonism or surgical
history (see TABLE 24C). On comparing the before and
after treatment standard deviations of the group as a
whole no significant change in the magnitude of
deviations was found (t=0.7914; d.f.= 33; p>.05). Of
the four subgroups, subgroup PA was the only subgroup to
show a significant change. The standard deviations for
subgroup PA were significantly reduced after treatment
(t=2.3565, d.f.= 13: p<.05). The three other subgroups,
however, showed no change in the variability of their
phonation times.
LENGTH OF PAUSES





IN LENGTH OF PRONATIONS
SCORES BEFORE AND AFTER TREATMENT
PRE POST
- DF T
MEAN STD DEV. MEAN STD.DEV.
PA 2.5914 0. 8272 2 .0329 0.4459 13 2.3565*
PE 1.7511 0. 7065 1 . 7533 0.3998 8 -0.0074
PA+OP 1.9750 0. 9590 2.4700 0.8621 5 -1.3182
PE+OP 1.9880 0. 5625 1 .9660 0. 7325 4 0.0512
GROUP 2.1715 0. 8387 2.0262 0.5928 33 0.7914
B. ANALYS IS OF VARIANCE BEFORE TREATMENT
SOURCE SS DF MS F
TYPE 0.5905 1 0.5905 0.9446
SURGERY 2.6830 1 2.6830 4.2922*
INTERACTION 1 .1 858 1 1 .1858 1 .8970
ERROR 18.7530 30 0.6351
C. ANALYSIS OF VARIANCE AFTER TREATMENT
SOURCE SS DF MS F
TYPE 0.7480 1 0.7480 2 .3072
SURGERY 0.9226 1 0.9226 2.8458
INTERACTION 0.2000 1 0 .2000 0.6169
ERROR 9.7258 30 0 .3242
TABLE 24
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before treatment was 408± 244ms. The mean length of
pauses for the four subgroups are contained in TABLE 25A.
Analysis of variance revealed no significant variation in
pause length with either type of Parkinsonism or surgical
history. (See TABLE 25B).
After treatment the mean length of pauses for the
group as a whole was. 3721 247 ms . The mean length of
pauses for the four subgroups are contained in TABLE 25A.
Analysis of variance showed that the length of pauses
did not vary significantly with either type of
Parkinsonism or surgical history. (See TABLE 25C).
On comparing the length of pauses before and after
treatment for the group as a whole, no significant change
was detected. When the four subgroups were considered
individually, however, it was seen that subgroup PA did
undergo a significant change. After treatment the length
of their pauses had increased significantly (t= -3.2292;
d.f.= 13; p<.001). Subgroup PE and subgroup PA+OP were
shown to have made no significant change. Subgroup PE+OP,
however, did change with treatment. With treatment the
length of the pauses had almost halved. This change just
failed to reach the .05 level of significance (t= 2.7546;
d.f.= 4; p> .05 . t(. 05) = 2.776) .
The variability of individual patient's pauses was
also considered. The standard deviation from each
patient in the group provided a mean value of 124+ 66ms.
The mean values for the four subgroups are contained in
TABLE 26A. The magnitude of standard deviation did not
vary with either type of Parkinsonism or surgical history.
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MEAN LENGTH OF PAUSES
A. COMPARISON OF SCORES BEFORE AND AFTER TREATMENT
PRE POST
DF T

















GROUP 408 244 372 247 33 0.0500
B. ANALYSIS OF VARIANCE BEFORE TREATMENT
















C. ANALYSIS OF VARIANCE AFTER TREATMENT


















VARIATION IN LENGTH OF PAUSES
A. COMPARISON OF SCORES BEFORE AMD AFTER TREATMENT
PRE POST
DF T
MEAN STD DEV. MEAN STD.DEV.
PA 2.5829 1.4076 2.4186
PE 2.4622 0.7627 1.7256
PA+OP 2.6500 2.1498 2.0433













GROUP 2.4874 1.3146 2.0924 0.8616 33 2 .2100*
B. ANALYSIS OF VARIANCE BEF ORE TREATMENT
















C. ANALYSIS OF VARIANCE AFT"ER TREATMENT


















(See TABLE 26B). After treatment, the standard deviation
obtained from each patient provided a group mean value of
105± 43ms. On comparing the before and after treatment
measures of variability, it was found that the group as a
whole showed a significant decrease in variability with
treatment. All four subgroups showed similar reductions
in variability although only the reduction shown by
subgroup PE reached significance. (See TABLE 26A). As
can be seen from the subgroup means in TABLE 26A,
paralysis agitans patients tended to vary the length of
their pauses more than post-encephalitic Parkinsonian
patients. On analysis, however, this difference did not
reach the 5% significance level. As is shown in TABLE 26C,
analysis of variance found that the magnitude of the
standard deviation of pauses varied significantly neither
with type of Parkinsonism, nor with surgical history.
RATIO OF PHONATIONS TO PAUSES
In addition to the length of phonations and the
length of pauses, the ratio between these two measures was
also considered. The phonation-pause ratio was
calculated for each patient in the group. The mean value
of these ratios for the group was found to be 1.1982* .78.
The mean values for the four subgroups are contained in
TABLE 27A. Analysis of variance of these measures showed
that the magnitude of the ratio did not vary significantly
with either type of Parkinsonism or surgical history.
(See TABLE 27B).
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RATIO OF PHO NAT IONS TO PAUSES
A. COMPARISON OF SCORES BEFORE AND AFTER TREATMENT
PRE POST
DF
MEAN STD DEV. MEAN STD.DEV.
PA 1 .4414 0.9780 0.8386 1.5610 13 2.9849*
PE 0.9140 0.5520 1 . 3267 0.8377 8 -2 .7083*
PA+OP 1 .0733 0.5922 1 .421 7 0 .6721 5 -1.4735
PE+OP 1 .1860 0.6693 2.3240 1 .3653 4 -2.3727
GROUP 1 .1982 0.7803 1 .2891 0.9135 33 -0.5655
B. ANALYSIS OF VARIANCE BEFORE TREATMENT
SOURCE SS DF MS F
TYPE 0..0833 1 0 ,.0883 0 , . 1 438
SURGERY 0.,8561 1 0..8561 1 ,.3944
INTERACTION 0,,725 7 1 0 , . 7257 1 , . 1 81 9
ERROR 18.,4210 30 0,.6140
C. ANALYSIS OF VARIANCE AFTER TREATMENT
SOURCE SS DF MS F
TYPE 4.7892 1 4.7892 7.4738*
SURGERY 3.6897 1 3.6897 5.7580*
INTERACTION 0.1640 1 0.1640 0 .2559
ERROR 19.2232 30 0.6408
TABLE 27
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After treatment the mean phonation to pause ratio for
the group as a whole was found to be 1.2891± .91. The
mean values for the four subgroups are contained in
TABLE 27A, Analysis of variance after treatment showed
that the magnitude of phonation to pause ratios varied
significantly with both surgical history and type of
Parkinsonism. (See TABLE 27C). Paralysis agitans
patients were found to have smaller phonation-pause
ratios than post-encephalitic patients. This indicates
that paralysis agitans patients, compared to post¬
encephalitic patients, have shorter phonations separated
by longer pauses. Similarly, unoperated patients were
found to have smaller phonation-pause ratios than
operated patients, i.e., that unoperated patients had
shorter words and longer pauses than operated patients.
On comparing the ratios obtained before and after
treatment it was found that no significant change had
occurred for the group as a whole. Subgroup PA, however,
showed a significant decrease in phonation-pause ratios
(t= 2.9849; d.f.= 13; p<.05). Of the three other
subgroups, however, only subgroup PE and subgroup PA+OP
showed significant changes. In both cases it was found
that the ratios had increased significantly. Subgroup
PE+OP however did not show a significant change, although
this group too showed an increase in phonation-pause
ratios. Not surprisingly, therefore, when these three
groups, that is PE, PA+OP and PE+OP, are considered
together, a significant increase in phonation-pause ratios
is obtained (t= -3.5361; d,f.= 19; pc.Ol).
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THE REGULARITY OF SPEECH
The recordings of the patients counting from 1 to 10
were further analysed to see whether the recited numbers
were evenly spaced in time, or whether counting speeded
up towards the end of the sequence, i.e. whether there
was evidence of f es t.i nati on .
For this analysis the lengths of both words and
pauses were taken into account. The times that elapsed
between the first phonemes of the successive words (i.e.
numeral-names) were measured. These measures thus
comprised the time taken to say a number plus the pause
following it, before the next number was begun. Nine such
measures were obtained; "ten" had to be omitted since, as
it was the last word in the sequence, no estimate of the
pause succeeding it could be made.
The nine word-pause units from the before and after
treatment recordings of the patients' counting were
subjected to similar analyses of variance using a 2x2x9
model, where the first factor (A) is surgery; the second
(B), type of Parkinsonism; and, the third (C), the nine
word-pause units .
Before treatment neither surgery (F=.0003;
d.f.= 1.31) nor type of Parkinsonism (F=.0725; d.f.= 1.31)
affected the length of word-pause units. Furthermore,
there was no significant interaction between surgery and
type of Parkinsonism (F=.0389; d.f.= 1.31). A highly
significant main effect for factor C (i.e., length of the
nine word-pause units) was found (F= 4.9623; d.f.= 8.248;
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MULTIFACTOR REPEATED MEASURE ANALYSIS OF VARIANCE OF THE
BEFORE TREATMENT WORD - PAUSE DATA
SOURCE DF SS MS F
Between subjects 34 9760 .4608
A (surgery) 1 0.8731 0.8731 0 .0003
B (type of Parkinsonism) 1 239 .3295 239.3295 0.0725
AB 1 128.3799 128.3799 0.0389
Error between subjects 31 9391.8783 302.9681
Within subjects 280 2096 .4372
C(Word - pause units) 8 266.1794 33 .2724 4 .9623*
AC 8 70.9710 8.8714 1 .3231
BC 8 51 .3180 6.4148 0.9567
ABC 8 45.1306 5.6413 0.8414
Error within subjects 248 1662.8282 6.7050
ANALYSIS OF LINEAR TREND
Within subjects 35 526.4931
C 1 233.2000 233.2000 25.7673*
AC 1 8.3646 8.3646 0.9242
BC 1 3 .4442 3.4442 0.3806
ABC 1 0 .9274 0 .92 75 0.1025
E r ro r within subjects 31 280 .5569 9 .0502
ANALYSIS OF QUADRATIC TREND
Within subjects 35 301 .1 240
C 1 5.1255 8.1255 0.5577
AC 1 0.8881 0 .8881 0.0966
BC 1 8.5045 8.5045 0 .9254
ABC 1 1.7179 1.7179 0.1869
Error within subjects 31 284.8880 9.1899
TABLE 28
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p <.0i). This is clear indication of a marked
discrepancy between these nine units. Hence the analysis
indicated that before treatment the patients' counting
is far from evenly spaced. None of the interactions with
factor C is statistically significant, indicating that
the shapes of the acceleration curves are essentially
similar for operated.and unoperated groups, and for
paralysis agitans and post-encephalitic groups.
These findings are in accord with the judges'
evaluations of speech recordings. As was reported in
Chapter 7, the judges found that the patients' speech was
characterized by festination and that there were no
differences in degree of festination amongst the four
subgroups .
The nature of this variation among the nine word-
pause units was investigated. The results of this
analysis of trend are summarized in TABLE 28. As can be
seen, 87.61% of the sum of squares for factor C
(ss=266.1974) are accounted for by the sum of squares for
the linear component (ss=233.2000). Not surprisingly,
this linear regression was found to be highly significant
(F = 25 .7673; d.f.= 1,31; p < . 01) . The linear component on
which this sum of squares is based was negative, indicating
a downward trend, i.e., the lengths of the word-pause
units grew progressive1y shorter throughout the sequence
of nine units. No significant degree of curvature was
found in this negative regression (F=0.5577; d.f.= 1,31).
After treatment, results were obtained that are
essentially similar to those obtained from the before
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MULTIFACTOR REPEATED MEASURE ANALYSIS OF VARIANCE OF THE
AFTER TREATMENT WORD-PAUSE DATA
SOURCE DF SS MS
Between subjects 35 8745.3636
A (surgery) 1 58.9517 58.9517
B (type ) 1 74.4980 74 .4980
AB 1 5 .4763 5.4763
Error between subjects 32 8606 .4376 268 .9606
Within subjects 288 1 658 .2533
C (word-pause units) 8 129.5513 I 6 .1939
AC 8 48.1159 6.0145
BC 8 1 9 .8457 2 .4807
ABC 8 78.0681 9 .7585
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ANALYS I C AC f> 11O U 1 1 ''1UADRATIC TREND
Within subjects 36 108.3028
C 1 2 .9750 2 .9750
AC 1 0.0209 0 .0209
BC 1 1 .0976 1 .0976
ABC 1 0 .4087 0 .4087








treatment analysis. No differences in overall length of
word-pause units was found. Neither factor A (surgery) nor
nor factor B (type of Parkinsonism) appeared to have a
significant effect on the overall length of word-pause
units. Moreover there were no significant interactions
between these two main factors. (See TABLE 29).
A significant variation in length among the nine
word-pause units was found (F=2.9983, d.f.=8,256; p < .01 ) .
Thus, after treatment, as had been the case before
treatment, a marked discrepancy in the lengths of the
nine word-pause units was found. On testing the effect
of the other main factors (A and B) on word-pause length
(Factor C), no significant interactions were found. Thus,
neither surgery nor type of Parkinsonism affected the
variation in word-pause length. However, when the large
overall interaction between surgery, type of Parkinsonism
and word'pause units (i.e. "ABC") was tested, it failed to
reach significance (F(.05) 1.93). The magnitude of ABC was
not completely unexpected. It will be remembered that the
judges rated the degree of festination shown by operated
post-encephalitic patients more severely than any of the
other three groups. As pointed out in Chapter 7, the
variation in these ratings of festination after treatment,
varied significantly with both type of Parkinsonism and
surgical history. The present findings are cleariy
consonant with the judges' impressions.
On further analysis it was found that 85.66% of the
sums of squares for factor C (ss= 129.5513) was accounted
for by the linear component (ss= 110.9760). As can be
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seen in TABLE 29, this linear regression was highly
significant. As had been the case before treatment, the
linear component on which this sums of squares is based
was negative. This shows that even after treatment, the
patients' speech was festinant. The length of the word-
pause units grew progressively shorter throughout the
sequence of nine word-pause units. This finding is in
keeping with the judges' evaluations of the speech
recordings of these patients (see Chapter 6). No
significant degree of curvature was found in the negative
regression of factor C (F= 0 . 91 7L., d . f .= 1,32).
in order to assess whether L-dopa treatment had any
effect on festination, the slopes of the before and after
treatment linear regressions were calculated and compared.
Linear regressions were fitted to the mean length of the
word-pause units by the least squares method. (Regression
lines for only the group as a whole were fitted since the
previous analyses had revealed no significant variation
with type of Parkinsonism or surgical history). The
analyses of variation in TABLE 30 summarize the results
of fitting lines to the data. The slope of the before
treatment regression was found to be -11.69; and the slope
of the after treatment regression was found to be -8.16.
The difference between these slopes, however, was not
found to be significant. (t=1.6923, d.f.= 14, p>.05).
This finding corroborates the judge's opinion of no
decrement in the degree of festination.
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ANALYSES OF VARIANCE: LINEAR REGRESSION OF LENGTH
OF WORD PAUSE UNITS ON SERIAL POSITION
SOURCE OF VARIATION SS DF
Before treatment








DEVIATIONS DUE TO REGRESSION 3995.1360 1
DEVIATIONS FROM REGRESSION 668.7090 7
41 .8208




RESULTS IV: THE INITIATION OF SPEECH
In Chapter 5 it was postulated that akinesia affects
not only the description of movement, but also its
initiation. The previous two chapters dealt with
experimental findings related to the description of a
complex motor-sequence such as speech. This chapter is
concerned with the initiation of speech. Reported here
are the results of tests of the initiation of 'automatic'
speech sequences and of confrontation naming. Also
reported are the results from a small battery of standard
psychological tests.
ic ic k
As Oldfield and Wingfield pointed out in their
description of the Object Naming Test, their Test is a
useful technique, but it is not a standardized test. No
set of norms exists for confrontation naming. For this
reason, a small group of males, matched for age and I.Q.
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with the patients, were used as "controls". The group
were all volunteers, drawn from the pool of servitors at
Edinburgh University. (All thirteen of the men refused
payment for their participation). The group were
screened for neurological disorders. They were all
right-handed and English was their mother-tongue. (None
in fact was bilingual). The test was administered in the
same way with the controls as with the patients.
METHODS OF ANALYSIS
The measurements of the initiation of 'automatic'
speech sequences were analysed using the same methods as
those used on the data discussed in the preceding chapter.
Briefly, this involved subjecting the before and after
treatment data to analyses of variance to test whether
type of Parkinsonism or surgical history, i.e. different
degrees of subcortical damage, were- associated with
different levels of performance. The differences between
the before and after treatment data was tested by means of
t-tests (for paired samples) in order to see whether a
reduction in akinesia after treatment is reflected in a
reduction of latency in the initiation of 'automatic'
speech s equences .
The data from the confrontation naming test was
analysed by different methods. Four aspects of the
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initiation of responses were considered:-
1. Success in naming test items: The number of test-
items correctly named by each subject {"success score")
was calculated and x2 tests were used to test whether
patients were as successful as the controls, both before
and after treatment. The purpose of this analysis was to
ascertain whether a reduction in word-availability was
associated with Parkinsonism.
2. Error analysis: The types of error made both by
patients and controls were analysed using x2 tests to see
whether patients and controls differed both in terms of
gross number of errors made and in terms of the relative
proportions of the different types of error. Similar
analyses were carried out to see whether type of
Parkinsonism, surgical history and/or L-dopa treatment
affected the gross number and/or the type of errors made
by the patients .
3. Speed of response: The speed with which patients and
controls responded to the twenty-six test items was
compared. It was of interest to find out whether
untreated patients were slower than the controls in naming
objects; whether patients responded faster after treat¬
ment than they had previously, before treatment; and
whether, after treatment, patients responded as fast as
did the controls. Also of interest was whether type of
Parkinsonism and/or surgical history affected the patients'
speed of response (before and after treatment).
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The twenty-six items of the Object Naming Test fall
naturally into seven classes. These classes are defined
by the frequency of occurrence of the object name
(according to the Thorndike-Lorge listing). The mean
response latency for each of these classes was calculated
for the group as a whole and for the four subgroups, under
both the test and re-test conditions. Means were also
calculated for the controls. Had the data been
homogeneous, it would have been suitable for treatment by
t-tests. However, this was not the case (see later). A
normal transformation cf the data was necessary, and the
difference between the magnitude of the various sets of
means was tested using a u-statistic. This transformation
and statistic is explained more fully when the results of
the analysis are presented.
4. The nature of the disturbance to the initiation of
motor sequences: The basic hypothesis of the present
investigation is that speech disorders consequent upon
basal ganglia lesions are akinetic in nature. Akinesia,
it is further hypothesized, is non-specific and affects
the initiation (and description) of all motor sequences.
Thus it will affect speaking, writing, walking, playing
the piano, and so on. Furthermore, it will affect all
forms of these activities. For example, in speech,
akinesia will delay the initiation of any utterance, be it
'automatic1 or highly prepositional in character.
The Oldfield Wingfield Object Naming Test provides
data eminently suitable for testing this hypothesis. As
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explained above, the test comprises twenty-six outline
drawings of objects. The objects depicted include both
common and rare items. A number of workers (for example,
Howes, 1964; Rochford and Williams, 1965) have
demonstrated a temporal relationship between response
availability and frequency of occurrence of the name of
the depicted object; commonly used words are 'retrieved'
faster than rarely used words. Furthermore, Oldfield and
co-workers have shown that a linear relationship subsists
between the response latency and the logarithmic frequency
of the object name. Thus, if akinesia does in fact effect
a constant delay in the initiation of all responses to the
Object Naming Test, and if L-dopa treatment does ameliorate
or reverse this effect, then it may be predicted that:-
a. the slopes of the linear regressions obtained from
the controls, from the group of patients as a whole before
treatment, and from the group of patients after treatment
will be similar;
b. the intercepts of these three regressions will differ.
Furthermore, it may be predicted that i) the before
treatment intercept will be significantly larger than the
after treatment intercept and the control intercept (i.e.,
before treatment patients respond slower over the whole
test than they do after treatment, or than the controls
do); ii) the after treatment and the control intercepts
will not differ significantly (i.e., with treatment,
patients will respond as fast to the whole test as do the
controls ) .
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Since the data was found to be non-homogeneous,
weighted linear regressions were fitted (see later for a
more detailed description of the weighting), and the
regressions were compared using an analysis of covariance
(similar to that described by Snedecor and Cochran, 1967).
Similar analyses were also carried out in which the
performance of each of the four subgroups both before and
after treatment was compared with that of the controls.
INITIATION OF 'AUTOMATIC' SPEECH SEQUENCES
Both before and after treatment the patients were
asked to recite a number of "automatic" speech sequences -
counting from "1" to "10", the names of the days of the
week, the months of the year, and the alphabet. The time
between the command to begin and the beginning of the
first word in each sequence was measured. Average
"initiation times" were calculated for each patient , one
for before treatment, the other for after treatment.
Before treatment, the group of patients as a whole
took 1.245-492 ms. to begin these "automatic" sequences.
As Table 31A shows, the mean initiation times for the
four subgroups ranged from 1.377-479 ms. (for subgroup PE)
to 1.174-867 ms. (for subgroup PE+OP). Analysis of variance
revealed no significant differences between the subgroups:
neither type of Parkinsonism nor surgical history was
associated with slower or faster initiation of 'automatic'
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INITIATION OF 'AUTOMATIC' SPEECH SEQUENCES
A. COMPARISON OF SCORES BEFORE AND AFTER TREA TMENT
PRE POST
DF T
MEAN STD DEV. MEAN STD.DEV.
PA 1.2123 0.4209 0 .6771 0.2422 1 7 4.1 585**
PE 1.3770 0 .4786 0.7885 0.1757 6 '0 .4255
PA+OP 1.2307 0.4366 0.8394 0.2224 6 2.2354*
PE+OP 1.1736 0.8667 1.0130 0.1841 4 0. 7394
GROUP 1.2453 0.4918 0.7743 0.2416 37 3.2782*
B. ANALYSIS OF VARIANCE BEFORE TREATMENT
SOURCE SS DF MS F
TYPE 0.0564 1 0.0564 0.2188
SURGERY 0.0258 1 0.0258 0.1001
INTERACTION 0.1031 1 0.1031 0.3999
ERROR 8.7670 34 0.2578
C. ANALYSIS OF VARIANCE AFTER TREATMENT
SOURCE SS DF MS F
TYPE 0..1432 1 0.1432 2 . 9224
SURGERY 0 .2724 1 0.2724 5 ,.5591**
INTERACTION 0,.0630 1 0.0630 1 .2857
ERROR 1 . 61 78 33 .0490
TABLE 31
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sequences. (See TABLE 31B).
Analysis of variance after treatment revealed that
surgical history was highly significant. Patients who had
undergone surgery were far slower than patients who had
not. Whether patients were diagnosed as having paralysis
agitans or post-encephalitic Parkinsonism was irrelevant
as far as speed of initiation was concerned: no
significant difference was found between the two types of
Parkinsonism. (See TABLE 31C).
On testing the difference between the before and
after treatment initiation times it was found that the
group of patients as a whole responded significantly
faster after treatment (t=3.2782 d.f.="37; p< .01)-
Although all four subgroups responded faster after
treatment, only in the case of the two paralysis agitans
subgroups did this reach significance (PA: t=4.1585,
d.f. = 17, p< .01 ; PA+OP: t=2.2354; d.f.=6; p< .01. . In
the two post-encephalitic subgroups the "improvement"
shown did not reach the .05 per cent level for the one-
tailed tests. (See TABLE 31 A).
THE NAMING OF OBJECTS
. SUCCESS IN NAMING OBJECTS
The number of test-items correctly named by a subject
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DISTRIBUTION OF 'SUCCESS SCORES'
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constituted a 'success score'. The distributions of these
scores for the patients before and after treatment are
shown in FIGURE 21. Also shown is the distribution of
scores for the controls.
The median score of the control group was 21.00 and
this was used as a cut-off point to classify the
distribution of patients' scores. Before treatment no
significant differences were revealed either between the
four subgroups, or between the patients and the controls.
Similarly, after treatment no significant differences in
distribution were detected between either the four sub¬
groups, or between the patients and the controls.
It may therefore be concluded that the patients, both
before and after treatment, were as successful as the
controls in correctly naming test-items. Furthermore,
from these findings it may be inferred that on retest,
once L-dopa treatment had reached an optimal level, there
was no significant change in the patients' performance;
they were as successful after treatment as they had been
before treatment in correctly naming test-items.
ERRORS IN NAMING OBJECTS
The erroneous responses were classified according to
whether the stimulus was mi sidentified, misnamed or not
known. Mi sidentification was scored if the subject
described the stimulus as another object (XYLOPHONE stable).
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A misnaming error was scored if the subject described
the function of the stimulus-item (GYROSCOPE + "oh1, it's
for checking balance . ...it's used on ships to steady
them..."); if a subject produced a response which
morphologically approximated to the correct response
(OCTOPUS + "octopoctopus"); or, if the subject produced
a response standing in the semantic relationship of
synecdoche (OCTOPUS -> "tentacles") or of metonymy
(TUNINGFORK -> "pitch") to the s ti mul us-i tern . When the
subject said he did not know what the object was, the
error was scored as 'not known'..
The distribution of the three types of error
(represented as percentages) for the four subgroups
before and after treatment, and for the controls are
shown in TABLE 32. No significant differences in the
relative proportions of types of error were found between
DISTRIBUTION OF TYPES. OF ERROR
BEFORE TREATMENT AFTER TREATMENT
SOURCE
Misnaming MisidcnIification Not known Misnaming Misidantification Not known
(%) <%> (%) (%) (%) (%)
PA 24 38 38 26 31 43
PE • 32 48 20 35 35 30
PA+OP 24 38 38 23 37 40
PE+OP 24 41 35 39 44 1 7
CONTROLS 33 33 34
TABLE 32
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the four subgroups and controls, either before (x2=5.2217,
d.f.=8) or after treatment (x2=7.O603, d.f.=8). From these
sets of results it may be inferred that no significant
change occurred in the relative proportions of types of
error of the patients before and after treatment.
Error analysis of this kind has previously been
successfully used in differentiating between patients with
language disorders and controls. Newcombe et al. (1971)
in a study of patients with chronic, focal brain lesions
due to missile injury tested their subjects on the same
Object Naming Test (using the same procedure). The errors
made by subjects were analysed using the same criteria of
classification. They found significant differences in the
relative proportions of types of error between patients
and controls. Moreover, they found over 10% of errors
made by patients with left temporal" 1obe lesions were
misnaming errors. Misidentification errors were far less
common, and tended to occur more frequently in their
bilateral group patients with lesions of the occipital
a re as of the brain.
In the present study, the similarity of the relative
proportions of error types between patients and controls
is interesting. It tends to rule out both qualitative
language disturbance in untreated patients, and qualitative
change with treatment. Furthermore, it is particularly
interesting that patients who had previously undergone
subcortical surgery did not stand out from the other
patients. Previous studies (reviewed in Chapter 4) have
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reported dysphasia and anomia following subcortical
surgery. The present results, in failing to reveal any
deficit, clearly indicate that if these patients had
suffered adverse effects from surgery, these effects were
transitory and left no detectable residual anomia.
The relationship between stimulus item and the
number of errors was also considered. TABLES 33 to 37
show the distribution of errors according to stimulus item.
DISTRIBUTION OF ERRORS ACCORDING TO STIMULUS ITEM FOR
SUBGROUP PA
















xy1ophone 7/ 2 3 2 10 1 8 1
gyros cope 10 3 0 7 10 2 1 7
metro nome 10 1 2 7 11 1 3 7
syringe 4 0 2 2 5 0 2 3
stethes cope 4 0 3 1 5 0 2 3
tuningfork 9 2 4 3 8 2 2 4
octopus 5 2 3 0 7 4 2 1
hors es hoe 1 0 1 0 0 0 0 0
an vi 1 4 1 0 3 3 1 0 2
di ce 2 0 2 0 2 0 2 0
microscope 8 3 2 3 7 4 0 3
windmi11 1 1 0 0 0 0 0 0
typew riter 1 1 0 0 0 0 0 0
s c rew 5 1 4 0 1 1 0 0
anchor 1 0 1 0 3 3 0 0
basket 1 1 0 0 0 0 0 0
book 1 0 1 0 0 0 0 0
74 18 28 28 72 19 22 31
TABLE 33
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DISTRIBUTION OF ERRORS ACCORDING TO STIMULUS ITEM FOR
SUBGROUP PE
















xylophone 4 0 2 2 3 0 2 1
gyroscope 5 1 0 4 5 0 0 5
metronome 5 1 2 2 3 0 2 1
syringe 3 T 1 1 0 0 0 0
stethescope 5 0 4 1 3 0 2 1
tuningfork 4 2 0 2 3 1 1 1
bagpipe 1 0 0 1 0 0 0 0
octopus 2 2 0 0 2 2 0 0
horseshoe 1 0 1 0 0 0 0 0
anvil 1 0 0 1 1 0 0 1
di ce 4 0 4 0 4 1 3 0
micros cope 3 0 1 2 2 0 0 2
windmi11 1 1 0 0 1 1 0 0
typewri ter 1 1 0 0 2 1 1 0
screw 2 1 1 0 1 1 0 0
42 10 16 16 30 7 11 12
TABLE 3*4
DISTRIBUTION OF ERRORS ACCORDING TO STIMULUS ITEM FOR
SUBGROUP PA+OP
















xylophone 4 0 2 2 4 0 3 1
gyroscope 5 4 0 1 4 3 0 1
metronome 5 2 2 1 4 1 1 2
syringe 1 0 1 0 0 0 0 0
turn* ngfork 0 0 0 0 2 0 1 1
octopus 2 2 0 0 2 2 0 0
hors es hoe 0 0 0 0 1 0 1 0
anvi 1 2 1 0 1 2 1 0 1
di ce 2 0 2 0 1 1 0 0
micros cope 4 0 3 1 4 0 2 2
screw 4 0 4 0 1 1 0 0
drum 1 1 0 0 1 0 1 0
tap 1 0 1 0 0 0 0 0
book 1 0 1 0 0 0 0 0






















xylophone 1 0 0 1 1 0 0 1
gyroscope 3 2 0 1 2 1 1 0
metro nome 3 1 2 0 2 1 1 0
syringe 2 0 1 1 1 0 1 0
stethes cope 1 0 0 1 1 1 0 0
turn" ngfork 1 0 0 1 1 1 0 0
octop us 0 0 0 0 1 1 0 0
dice 1 0 1 0 2 0 2 0
typew riter 1 0 0 1 1 1 0 0
s crew 1 1 0 0 0 0 0 0
tap 1 0 1 0 0 0 0 0
book 2 0 2 0 0 0 0 0
1 7 4 7 6 12 6 5 1
TABLE 36
DISTRIBUTION OF ERRORS ACCORDING TO
STIMULUS ITEM FOR THE CONTROLS
Total Mis¬ Misidcn- Not
STIMULUS ITEM no*. naming tificaiion known
gyros cope 9 2 1 6
micros cope 7 4 0 3
s tethes cope 6 0 4 2
octopus 4 3 0 1
xylophone 5 4 0 1
metronome 10 2 5 3
tuningfork 9 4 2 3
syringe 1 0 0 1
anvil 3 0 1 2
typewriter 1 1 0 0
drum 2 2 0 0
bagpipes 2 0 2 0
screw 2 1 0 1
61 23 15 23
TABLE 37
263
Kendall's coefficient of concordance (W) was calculated
to reveal the extent of agreement across groups concerning
the degree of difficulty presented by individual test-items.
The before treatment data gave a W of .7150. This
corresponds to a x2 of 89.375 with 25 degrees of freedom,
indicating an extremely high degree of concordance (p< .001) .
Similarly, the after treatment data gave a W of .7769,
corresponding to a x2 of 77.693 with 25 degrees of
freedom (p < .001) . Rank order correlations for the overall
difficulty of the twelve most difficult items were
calculated for all groups ar\d subgroups. (See TABLE 38).
RANK ORDER CORRELATION (KENDALL1 S) BETWEEN NUMBER OF
ERRORS AND LOGARITHMIC FREQUENCY OF THE STIMULUS ITEM
PRE POST
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Both before and after treatment the patient group as a
whole and the four subgroups showed high and significantly
positive correlations. The less frequent the name of the
depicted object, the greater the failure rate. Similar
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results were obtained for the controls.
It may therefore be concluded that success or failure
on this Object Naming Test is strongly dependent on the
nature of the test-item. Failure to name objects was not
dependent on whether the subject was a patient or a
control since both patients and controls experienced
similar difficulty with the less frequent test-items.
LATENCY IN NAMING OBJECTS (CORRECTLY)
The latency measures of the (correct) responses were
grouped into seven categories according to the Thorndike
Lorge count of the stimulus item which elicited them (the
method employed by Newcombe et a!., 1965). Means and
variances were calculated for each of the seven categories
for all groups and subgroups. The variances of responses,
however, were found to differ significantly across the
seven categories within all groups ana subgroups (In all
cases, Bartlett's test, p<.01). Furthermore, the
variances were significantly different between the
controls and patient groups and subgroups (Snedecor's
F-test, p< .05). Comparisons between mean response latencies
for controls and patients were therefore made using the
standard normal deviate of the differences between the mean
latencies for each frequency category. Summing these
normal deviates over all the categories (g = 7) a statistic
U is obtained which can be used to test the null hypothesis
265
that there is no difference between the controls' and
patients' mean latencies - i.e. the hypothesis that U comes
from a normal distribution with a mean 0, and a variance g,
N(0,g) .
Using this technique a significant difference was
found between the mean latencies for the controls and for
the group of untreated patients. Similar significant
differences were found between the controls and the PRE
mean latencies for all four subgroups. (See TABLE 39).
STANDARD NORMAL DEVIATES: PRE vs CONTROLS
SOURCE U-STATISTIC HYPOTHESIS P
PA 1 5 .7286 N(0,7) < .01
PE 13.1200 N(0,7) < .01
PA+OP 11 .3816 N (0 , 7 ) < .01
PE+OP 7.3641 N(0,7 ) < .01
GROUP AS 16.6777 N(0,7) < .01
A WHOLE
TABLE 39
In all cases the U statistic obtained was positive. This
indicates that in all comparisons, the controls were
significantly faster in responding to the stimulus items
than were the patients.
Comparisons were also made between the controls'
mean latencies and the patients' mean latencies after
treatment. It was found that after treatment the group of
patients as a whole were still significantly slower in
responding than the controls. However, as TABLE 40 shows,
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STANDARD NORMAL DEVIATES: POST vs CONTROLS



















5.3900 N(0,7 ) < .05
TABLE 40
this is entirely attributable to subgroup PE+OP. All three
other subgroups responded as fast as did the controls;
subgroup PE+OP, however, remained significantly slower.
From the results contained in TABLES 39 and 40 it can be
inferred that all patients except post-encephalitic
Parkinsonian patients who had previously undergone
subcortical surgery improved with treatment on this task.
After treatment they were as fast as the controls in
response.
RESPONSE LATENCY AND FREQUENCY OF OCCURRENCE OF STIMULUS
ITEM
Wingfield (1966) and Oldfield and Wingfield (1964)
demonstrated that a linear relationship subsists between
the response latency and the logarithmic frequency of
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occurrence of the words in the Object Naming Test. Since,
in the present study, in each and every group and subgroup
the variance of mean response latencies for all twenty-six
test-items were found to differ significantly (Bartlett's
test, p<.01), weighted linear regressions were fitted.
ni
The weights were calculated by the formula p001ed variance'
where ni is the number of responses in the group to the
th object, and the pooled variance is estimated from all
the patients' responses to the object.
Regression lines were fitted to only part of the test
♦
items. Arbit et al . ( 1 970) have shown that only tests
above a certain level of difficulty reveal psychological
deficit in Parkinsonian patients. Since psychological
functions are not of particular interest in this part of
the analysis of performance, difficult test items were
avoided. Thus the possibility of any psychological
deficits clouding the issue was carefully avoided. "Easy
items" were operationally defined as those items which had
elicited more than 95% correct responses. This
established a cut-off point at the frequency level of 10
per million, and defined fourteen such "easy items". These
included items such as "SHOE"; "BASKET"; "GLOVE"; and,
"SCREW". The cut-off point proved felicitously stringent.
Newcombe et al . (1 976) had shown that test-items with a
log. frequency of 10~5.10 were particularly sensitive to
the psycholinguistic effects in patients with brain
lesions. The cut-off point adopted in the present'study
lies well within the 'non-sensitive' area of the test.
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Comparisons between the regression lines of the
controls and the patients (as a whole) before and after
treatment were made using analyses of covariance. These
results are presented in TABLE 43. The table shows
clearly the series of successive analyses that were
carried out. Initially three regression lines, one for
each set of data, were fitted (TABLES 41, 42 and 43A).
Parallel lines were then fitted to the same data sets and
the difference between the fitting of separate and of
parallel lines was tested. This, in effect, is a test of
the differences in slope of the three lines. As TABLE 43B
shows, no significant difference was found. The data sets
could be described equally well by either separate or
parallel lines. It is apparant therefore that, for the
group as a whole, neither Parkinsonian lesion/lesions nor
L-dopa treatment have qualitative effects on the
confrontation naming of "easy" objects.
Next, quantitative differences between the three lines
were considered. One line was fitted to the three data sets
and the difference between the fitting of one line and the
fitting of parallel lines was tested. This is a test of
the differences in intercepts of the three regression lines.
If all three lines were of comparable height, no difference
should be found between the fitting of one line or of two
parallel lines. As TABLE 43C shows, the fitting of one
line to all three data sets did make a considerable
difference; the three lines clearly do not represent
similar levels of performance.
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ANALYSES OF VARIANCE: FITTING WEIGHTED LINEAR REGRESSIONS
OF RESPONSE LATENCY ON LOGARITHMIC FREQUENCY OF THE OBJECT
NAME FOR THE GROUP AS A WHOLE BEFORE AND AFTER TREATMENT
AND FOR THE CONTROLS.
SOURCE OF VARIATION DF SS F
For The GROUP AS A WHOLE BEFORE TREATMENT:
DUE TO REGRESSION ONLOG. FREQUENCY 1 109.7778 33.8956**
DEVIATION FROM REGRESSION 12 38.8645
TOTAL VARIATION OF RESPONSE LATENCY 13 148.6423
For The GROUP AS A WHOLE AFTER TREATMENT:
DUE TO REGRESSION ON LOG. FREQUENCY 1 58.3368 14.2160*
DEVIATION FROM REGRESSION 12 49.2429
TOTAL VARIATION OF RESPONSE LATENCY 13 107.5797
For The CONTROLS:
DUE TO REGRESSION ON LOG. FREQUENCY 1 46.8913 20.6079**
DEVIATION FROM REGRESSION 12 27.3044
TOTAL VARIATION OF RESPONSE LATENCY 13 74.1957
* p < . 0 5
** p< . 01
TABLE 41
WEIGHTED LINEAR REGRESSION FOR THE GROUP OF PATIENTS AND
THE CONTROLS
SOURCE REGRESSION
GROUP OF PATIENTS BEFORE TREATMENT y 100<3-III 0 .56x
GROUP OF PATIENTS AFTER TREATMENT y = -0.99 - 0 .42x
CONTROLS y ii o • CT) 0 .35x
TABLE 42
270
ANALYSIS OF COVARIANCE: COMPARISONS OF WEIGHTED LINEAR
REGRESSIONS FROM THE GROUP AS A WHOLE BEFORE TREATMENT,
AFTER TREATMENT, AND FROM THE CONTROLS.
SOURCE OF VARIATION DF SS MS F
A. FITTING THREE LINES
DEVIATIONS FROM 3 LINES





WITHIN GROUP 39 330.4177
B. FITTING // LINES
IMPROVEMENT OVER 3 LINES
DEVIATIONS FROM 3 LINES
1 206.8123 206.8123 64.5099**
2 8.1 936 4.0968 1 .2779
36 1 1 5 .41 18 3.2059
WITHIN GROUPS 39 330.4177
C. FITTING ONE LINE 1 205.5811 205.5811 63.2013**
IMPROVEMENT OVER // LINES 2 74.2781 37.1391 11.4176**
DEVIATIONS FROM // LINES 38 123.6054 3.2528
TOTAL 41 403.4646
D. FITTING // LINES 1 206.8123 206.8123 63.5798**
DEVIATIONS FROM // LINES 38 123.6054 3.2528
BETWEEN GROUPS:-
PRE : POST+CONTROLS 1 66.1354 66.1354
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Finally, multiple comparisons between the three
intercepts were carried out. It was found that there was
no difference between the intercepts of the regression
lines for the patients after treatment and for the controls.
This clearly indicates that treated patients respond just
as fast as the controls. There was, however, a significant
difference between the intercept of the line for the treated
patients plus the controls. (See TABLE 43D). The inter¬
cept of the regression line for the untreated patients was
far larger than the intercepts of the other two lines.
Thus the performance of the patients before treatment was
considerably worse than their performance after treatment
and worse than the performance of the controls.
From this series of analyses the following
conclusions may be drawn:
a. Over and above the effect that log. frequency of the
test-item has on the response latency, Parkinsonian lesions
exert a constant, quantitative effect on the confrontation
naming of "easy" objects. (Untreated) Parkinsonian patients
are significantly slower in responding.
b. L-dopa treatment effects a uniform reduction in the
latency of response to confrontation naming without
ajjar-tiag the rate of increase of the latency of response c
with the logarithmic frequency of the item.
In short, as predicted in the basic hypothesis of this
investigation the results show that Parkinsonism and L-dopa
have quantitative, and not qualitative, effects on the
performance of subjects in a confrontation naming test.
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Similar analyses were carried out in which the before and
after treatment performances of each of the four subgroups
were compared with that of the controls. These analyses
are summarized in TABLES 44 through to 55. From these
tables it may be seen that:-
a. in each and every set of data a linear relationship
subsisted between response latency and logarithmic
frequency of the object name (TABLES 44, 45; 47, 48; 50,
51; 53, 54).
b. no significant difference in the slope of the
regression lines was found. Thus, it may be concluded
from these findings (TABLES 46B, 49B 52B, 55B) that the
nature of the behaviour tested was not affected by type of
Parkinsonism and/or surgical history and/or L-dopa
treatment.
c. significant differences in the intercept of the
regression lines were found (TABLES 46C, 49C, 52C, 55C).
It was also found that the four subgroups did not all
perform comparably; subgroup PE+OP once again, stood out.
The after treatment intercepts for subgroups PA, PE,
PA+OP were found to be similar to the control intercept.
Their before treatment intercepts, however, were found to
be significantly larger than their after treatment inter¬
cept and that of the controls. These findings indicate
that before treatment each of these three groups did
display impairment in a confrontation naming task. The
impairment is shown to be a uniform increase in response
latency. With treatment a uniform reduction in response
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ANALYSES OF VARIANCE: FITTING WEIGHTED LINEAR REGRESSIONS
OF RESPONSE LATENCY ON THE LOGARITHMIC FREQUENCY OF THE
OBJECT NAME FOR SUBGROUP PA BEFORE AND AFTER TREATMENT
AND FOR THE CONTROLS.
SOURCE OF VARIATION DF SS
For SUBGROUP PA BEFORE TREATMENT:
DUE TO REGRESSION ON LOG. FREQUENCY 1 67.3213
DEVIATION FROM REGRESSION 12 32.7659
TOTAL VARIATION OF RESPONSE LATENCY 13 100.0872
For SUBGROUP PA AFTER TREATMENT:
DUE TO REGRESSION ON LOG. FREQUENCY 1 37.5846
DEVIATION FROM REGRESSION 12 49.1383
TOTAL VARIATION OF RESPONSE LATENCY 13 86.7229
For CONTROLS:
DUE TO REGRESSION ON LOG. FREQUENCY 1 46.8913
DEVIATION FROM REGRESSION 12 27.3044







WEIGHTED LINEAR REGRESSION FOR SUBGROUP PA AND THE CONTROLS
SOURCE REGRESSION
SUBGROUP PA BEFORE TREATMENT y = -1 .48 - 0 .56x
SUBGROUP PA AFTER TREATMENT y = -0.99 - 0 .42x
CONTROLS y = -0.76 - 0.35x
TABLE 45
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ANALYSIS OF COVARIANCE: COMPARISONS OF WEIGHTED LINEAR
REGRESSIONS FROM SUBGROUP PA BEFORE TREATMENT, AFTER
TREATMENT, AND FROM THE CONTROLS.
SOURCE OF VARIATION DF SS MS F
FITTING THREE LINES 3 151.7972 50.5991 16.6796**
DEVIATIONS FROM 3 LINES 36 109.2086 3.0336
WITHIN GROUPS 39 261 .0058
FITTING // LINES 1 142.3776 142.3776 46.9335**
IMPROVEMENT OVER 3 LINES 2 9.4196 4.7098 1.5525
DEVIATIONS FROM 3 LINES 36 109.2086 3.0336
WITHIN GROUPS 39 261 .0058
FITTING ONE LINE 1 143.9153 143.9153 46.1001**
IMPROVEMENT OVER // LINES 2 33.7784 16.8892 5.4101**
DEVIATIONS FROM // LINES 38 118.6282 3.1218
TOTAL 41 296.3219
FITTING // LINES ii 1 42 .3776 1 42 .3776 45.5075**
DEVIATIONS FROM // LINES 38 118.6282 3.1218
BETWEEN GROUPS
PRE : POST+CONTROLS 1 34.6692 34 .6692 1 1 .1055**
POST : CONTROLS 1 0.6469 0.6469 0 .2072




ANALYSES OF VARIANCE: FITTING WEIGHTED LINEAR REGRESSIONS
OF RESPONSE LATENCY ON THE LOGARITHMIC FREQUENCY OF THE
OBJECT NAME FOR SUBGROUP PE BEFORE AND AFTER TREATMENT AND
FOR THE CONTROLS.
SOURCE OF VARIATION DF SS F
For SUBGROUP RE BEFORE TREATMENT:
DUE TO REGRESSION ON LOG. FREQUENCY 1 39.8707 33.1207**
DEVIATION FRUM REGRESSION 12 14.4453
TOTAL VARIATION OF RESPONSE LATENCY 13 54.3160
For SUBGROUP PE AFTER TREATMENT:
DUE TO REGRESSION ON LOG. FREQUENCY 1 12.2349 6.1961*
DEVIATION FROM REGRESSION 12 23.6957
TOTAL VARIATION OF RESPONSE LATENCY 13 35.9306
For CONTROLS:
DUE TO REGRESSION ON LOG. FREQUENCY 1 46.8913 20.6079**
DEVIATION FROM REGRESSION 12 27.3044
TOTAL VARIATION OF RESPONSE LATENCY 13 74.1957
* p<.05
** p <.0 1
TABLE 47
WEIGHTED LINEAR REGRESSIONS FOR SUBGROUP PE AND THE CONTROLS
SOURCE REGRESSION
SUBGROUP PE BEFORE TREATMENT y == -2.24 -- 0.76x
SUBGROUP PE AFTER TREATMENT y == -2.18 -■ 0 .4 7 x
CONTROLS y == -0.76 -■ 0 .35x
TABLE 48
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ANALYSIS OF COVARIANCE: COMPARISONS OF WEIGHTED LINEAR
REGRESSIONS FROM SUBGROUP PE BEFORE TREATMENT, AFTER
TREATMENT, AND FROM THE CONTROLS.
SOURCE OF VARIATION DF SS MS F
FITTING THREE LINES 3 98.9969 32.9990 18.1523**
DEVIATIONS FROM 3 LINES 36 65.4454 1.8179
WITHIN GROUPS 39 164.4423
FITTING // LINES 1 89.0601 89.0601 48.9906**
IMPROVEMENT OVER 3 LINES 2 9.9368 4.9685 2.7330
DEVIATIONS FROM 3 LINES 36 65.4454 1.8179
WITHIN GROUPS 39 164.4423
FITTING ONE LINE 1 86.2477 86.2477 43.4782**
IMPROVEMENT OVER // LINES 2 52.0792 26.0396 13.1268**
DEVIATIONS FROM // LINES 38 75.3822 1.9837
TOTAL 41 213.7091
FITTING !! LINES 1 89.0601 89.0601 44.8950**
DEVIATIONS FROM // 38 75.3822 1.9837
BETWEEN GROUPS:-
PRE : POST+CONTROLS 1 44.2034 44.2034 22.2833**





ANALYSES OF VARIANCE: FITTING WEIGHTED LINEAR REGRESSIONS
OF THE RESPONSE LATENCY ON THE LOGARITHMIC FREQUENCY OF
THE OBJECT NAME FOR SUBGROUP PA+OP 3 EFORE AND AFTER
TREATMENT AND FOR THE CONTROLS.
SOURCE OF VARIATION DF SS F
For SUBGROUP PA+OP BEFORE TREATMENT:
DUE TO REGRESSION ON LOG. FREQUENCY 1 7.4326 18.9752**
DEVIATION FROM REGRESSION 12 4.7002
TOTAL VARIATION OF RESPONSE LATENCY 13 12.3828
For SUBGROUP PA +OP AFTER TREATMENT:
DUE TO REGRESSION ON LOG. FREQUENCY 1 5.9282 8.1994*
DEVIATION FROM REGRESSION 12 8.6755
TOTAL VARIATION OF RESPONSE LATENCY 13 14.6037
For CONTROLS:
DUE TO REGRESSION ON LOG. FREQUENCY 1 46.8913 20.6079**
DEVIATION FROM REGRESSION 12 27.3044
TOTAL VARIATION OF RESPONSE LATENCY 13 74.1957




WEIGHTED LINEAR REGRESSION FOR SUBGROUP PA+OP AND CONTROLS
SOURCE REGRESSION
SUBGROUP PA+OP BEFORE TREATMENT y ii i 0 en 00 1■ 0 .34x
SUBGROUP PA+OP AFTER TREATMENT y 1LOoIII - 0.31 x
CONTROLS y = -0 .76 -- 0 .35x
TABLE 51
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ANALYSIS OF COVARIANCE: COMPARISONS OF WEIGHTED LINEAR
REGRESSIONS FROM SUBGROUP PA+OP BEFORE TREATMENT, AFTER
TREATMENT, AND FROM THE CONTROLS.
SOURCE OF VARIATION DF SS MS
FITTING THREE LINES










FITTING // LINES 1 60.1477 60.1477
IMPROVEMENT OVER 3 LINES 2 0.1044 0.0522
DEVIATIONS FROM 3 LINES 36 40.6801 1.1 300
WITHIN GROUPS 39 100.9322
53.2281**
0 .0462
FITTING ONE LINE 1 59.5777 59.5777 55.5085**
IMPROVEMENT OVER // LINES 2 15.3750 7.6875 7.1625**
DEVIATIONS FROM // LINES 38 40.7845 1.0733
TOTAL 41 115.7347
FITTING // LINES 1 60.1477 60.1477 56.0400**
DEVIATIONS FROM // LINES 38 40.7845 1.0733
BETWEEN GROUPS:-
PRE : POST+CONTROLS 1 13.2795 13.2795 12.3726**





ANALYSES OF VARIANCE: FITTING WEIGHTED LINEAR REGRESSIONS
OF THE RESPONSE LATENCY ON THE LOGARITHMIC FREQUENCY OF
THE OBJECT NAME FOR SUBGROUP PE+OP BEFORE AND AFTER
TREATMENT AND FOR THE CONTROLS.
SOURCE OF VARIATION DF SS F
For SUBGROUP PE+OP BEFORE TREATMENT:







TOTAL VARIATION OF RESPONSE LATENCY 1 3 20 .2822
For SUBGROUP PE+OP AFTER TREATMENT:







TOTAL VARIATION OF RESPONSE LATENCY 1 3 1 9 .4688
For CONTROLS:











WEIGHTED LINEAR REGRESSION FOR SUBGROUP PE+OP AND CONTROLS
SOURCE REGRESS 1011
SUBGROUP PE+OP BEFORE TREATMENT y = -0.72 - 0 .38x
SUBGROUP PE+OP AFTER TREATMENT y II 1 o 0 1 0 .37x
CONTROLS y = -0.76 - 0 .35x
TABLE 54
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ANALYSIS OF COVARIANCE: COMPARISONS OF WEIGHTED LINEAR
REGRESSIONS FROM SUBGROUP PE+OP BEFORE TREATMENT, AFTER
TREATMENT, AND FROM THE CONTROLS.
SOURCE OF VARIATION DF SS MS
FITTING THREE LINES











IMPROVEMENT OVER 3 LINES














FITTING ONE LINE 1 60.2382 60.2382 43.4055**
IMPROVEMENT OVER // LINES 2 33.0499 16.5250 11.9073**
DEVIATIONS FROM // LINES 38 52.7347 1.3878
TOTAL 41 146.0228
FITTING // LINES 1 61.2121 61.2121
DEVIATIONS FROM // LINES 38 52.7347 1.3878
BETWEEN GROUPS:-
PRE : POST* CONTROLS 1 16.9228 16.9228
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latency is observed - a reduction of sufficient
magnitude to render the performance of these subgroups
comparable with that of the controls.
Subgroup PE+OP unfortunate1y did not similarly
benefit from treatment (TABLE 55). A significant
difference was found between the intercept of the controls
and this subgroup after treatment (and a significant
difference was also found between this subgroup's before
treatment intercept and its after treatment intercept plus
that of the controls). As can be seen from the regression
equations (TABLE 54 and from FIGURE27 , before treatment,
subgroup PE+OP was far slower than the controls and that
L-dopa treatment hardly affected their level of
performance.
CONSIDERATION OF PSYCHOLOGICAL FACTORS
The results from the analyses of success scores, of
the relative proportions of the type of errors made, and
of the degree of difficulty experienced by subjects throw
an interesting light on another aspect of performance.
Confrontation naming is not a simple task; even the
crudest model of confrontation naming needs recourse to a
number of psychological functions/constructs such as
perception, cognition, and memory.
The performance of the patients in comparison with
the performance of the controls suggests no disturbance of
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higher mental processes. Vocabulary is generally
accepted as a good indication of intellectual ability. The
Object Naming Test, a carefully selected set of graded
vocabulary items, revealed no differences in the number of
items correctly named by the untreated patients and by the
controls. This finding is supported by a second finding,
that the patients and controls experienced comparable
degrees of difficulty with the rarer test-items.
Furthermore, the analyses of the relative proportions of
types of error do net support an alternative hypothesis of
specific disturbance. A predominance of mi sidentification
errors would be expected if the patients had perceptual or
cognitive disturbances and a predominance of misnaming
errors if the patients had some type of memory disturbance.
No differences in the relative proportions of the types of
error were found either between the untreated patient
subgroups, or between the patients and the controls.
Parkinsonian lesions thus appear to have little effect on
the complex psychological functions involved in a
confrontation naming task.
Treatment with L-dopa appears to have had neither a
beneficial nor an adverse effect on psychological functions.
After treatment the patients were able to name as many items
correctly as were the controls, and there was no apparent
difference in the degree of difficulty the subjects
experienced on the rarer test-items. Furthermore, after
treatment no measurable difference in the relative
proportions of the types of error made by patients and
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controls were observed. To confirm that L-dopa has little
relevance for the complex psychological functions that
subserve a confrontation naming task, a small battery of
standard psychological tests was given to the patients
before and after treatment.
SPAN OF APPREHENSION: W.A.I.S. DIGIT SPAN SUBTEST
Before treatment, the mean digit span for the group
as a whole was 10.55*2.4. The mean digit span for the
subgroups are contained in TABLE 56A. As would be
expected from these means, digit span did not vary
significantly with subgroup (TABLE 56B).
Similar results were obtained from the after
treatment data. The group as a whole was found to have a
mean digit span of 11.40*3.1 . As can be'seen from TABLE
56A, the four subgroup means ranged from 11.20*2.70 (for
subgroup PE ) to 9.17-1.32 (for subgroup PE+OP). No
significant variation in digit span with subgroup was
found (TABLE 56C).
On comparing before and after treatment performance,
no significant difference was found for the group as a
whole. Similarly, no significant change in performance
was detected for any of the four subgroups (TABLE 56A).
In the above analyses 'scaled scores' were used in
preference to raw scores. Digit span varies with age.
Since a significant variation in age was found amongst
the four subgroups (see Chapter 5), scaled scores which
are corrected for age allow for meaningful intergroup
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SPAN OF APPREHENSION
A. COMPARISON OF SCORES BEFORE AND AFTER TREATMENT
PRE POST
DF T
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5 0.3952
GROUP 10.545 2 .3729 11.394 3.0816 32 -2.0096
B. ANALYSIS Of VARIANCE BEFORE TREATME NT





















C. ANALYSIS OF VARIANCE AFTER TREATMENT





















comparisons. The scaled scores are based on a large
standardization population. Consequently, scaled-scores
permit a direct comparison of performance of the patients
with the performance of the standardization or 'reference'
population. The mean scaled score for the standardization
population is 10t3. The mean scaled scores for the group
as a whole and for each of the subgroups both before and
after treatment compares favourably with the reference
mean. The patients' means all lie well within one
standard deviation of the reference mean.
IMMEDIATE RECALL FOR STORIES
Before treatment, the group as a whole scored
6 . 5081 i3.2476 on the "immediate" recall of stories test.
The means for the four subgroups are presented in
TABLE 57A. Analysis of variance revealed that the amount
of material recalled varied neither with type of
Parkinsonism nor with surgical history. (See TABLE 57B).
After treatment, the group as a whole scored, on
average, 6.772±3.2348 on the test. TABLE 57A contains
the four subgroup means. As can be seen from TABLE 57C,
the amount of material recalled after treatment did not
vary with type of Parkinsonism or with surgical history.
On comparing the amount of material recalled under
the before and after treatment conditions, no significant
findings were obtained. The group as a whole and each of
the four subgroups showed no significant change at all.
(See TABLE 57A) .
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IMMEDIATE RECALL OF STORIES
A. COMPARISON OF SCORES BEFORE AND AFTER TREATMENT
PRE POST
DF J

























GROUP 6.5081 3.2476 6.7742 3.2348 30 -0.5556
B. ANALYSIS OF VARIANCE BEFORE TREATM ENT




















C. ANALYSIS OF VARIANCE AFTER TREATMENT
SOURCE SS DF MS F
TYPE 10,.5060 1 10 .5060 0,.9437
SURGERY 0..1453 1 0 .1453 0 . 01 31
INTERACTION 2 .6707 1 2 .6707 0 ,.2399
ERROR 300 .5974 27 11 .1 332
TABLE 57
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DELAYED RECALL FOR STORIES
The group of patients as a whole scored, on average,
5.2333+-3.4010 before treatment on the delayed recall for
stories test. The subgroups' mean scores are presented in
TABLE 58A. After treatment, the group's mean score was
5.0750+3.3017. The after treatment subgroup means are
also presented in TABLE 58A.
Analysis of variance revealed that both before (see
TABLE 56B) and after (see TABLE 58C) treatment the amount
of material recalled after an hour's delay did not vary
with either type of Parkinsonism or with surgical history.
When the patients' before and after treatment scores were
compared no significant difference was found. Similarly,
no significant differences were found for any of the
subgroups. (See TABLE 58A).
VISU0-M0T0R TASK: W.A.I.S. BLOCK DESIGN SUBTEST.
The group as a whole scored, oh average, 8.949^2.5335
on the W.A.I.S. Block Design Subtest before treatment
began. After treatment, their mean score was 9.1795±2.7613.
The before and after treatment means for the four
subgroups are contained in TABLE 59A. On comparing the
patients' before and after treatment scores, no
significant changes were found for the group as a whole,
or for any of the subgroups. (See TABLE 59A).
Analysis of variance before treatment revealed no
significant variation in scores on the test with either
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DELAYED RECALL OF STORIES
A. COMPARISON OF SCORES BEFORE AND AFTER TREATMENT
PRE POST






















GROUP 5.2333 3.4010 5 .0750 3.3017 29 0.2501
B. ANALYSIS OF VARIANCE BEF ORE TREATMENT




















C. ANALYSIS OF VARIANCE AFTER TREATMENT
























A. COMPARISON OF SCORES BEFORE AND AFTER TREATMENT
PRE POST
DF T
MEAN STD DEV. MEAN STD.DEV.
PA 9.5000 3.1295 9.7220 3.5114 17 -0 .4320
PE 9.0000 1.5000 8.8890 2.0883 8 0.4843
PA+OP 7.8300 I.7224 8.0000 1 .6733 5 -0.4014
PE+OP 8.3300 2.4221 9.1667 1.8348 5 -0.8333
GROUP 8.9490 2.5335 9.1795 2.7613 38 -0.2635
B. ANALYSIS OF VARIANCE BEFORE TREATMENT
SOURCE SS DF MS F
TYPE 1.1308 1 1.1308 0.1731
SURGERY 12.9808 1 12.9808 1.9869
INTERACTION 1.1192 1 1 .1192 0.1713
ERROR 228.6666 35 6.5333
C. ANALYSIS OF VARIANCE AFTER TREATMENT
SOURCE SS DF MS F
TYPE - 0.7853 1 0 .7853 0.09Q8
SURGERY 6.1603 1 6 .1603 0.7831
INTERACTION 7.4647 1 7.4642 0.9489
ERROR 275 .3332 35 7 .8667
TABLE 59
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type of Parkinsonism or with surgical history. (See
TABLE 59B). Similar findings were obtained from the after
treatment scores. (See TABLE 59C).
As explained in Chapter 5, age-corrected or "scaled"
scores were used in preference to "raw" scores on this
test. The mean for "scaled" scores is 10±3. All the
means obtained for the patients both before and after
treatment compare favourably with this "scaled" mean.
There thus appears to be no indication that there is a
deficit in the patients' . performance on this task either
before or after treatment.
How do the present findings on Parkinsonism, L-dopa,
and psychological functions compare with previous work in
this area? Unfortunately few clear and simple answers are
to be found.
The two studies in which the performance of
Parkinsonian patients and matched controls were compared
are clearly contradictory. Marsh et al. (1971) found that
(untreated) Parkinsonian patients consistently scored less
than controls on tests of auditory and visual perception,
auditory and visual short-term memory, verbal learning (an
'intermediate' memory task), attention and concentration.
However, Donnelly et al. (1973) found no significant
differences in performance levels of (untreated)
Parkinsonian patients and controls on the W.A.I.S. and
Wechsler Memory Test.
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Even less clear is whether L-dopa treatment has an
effect on psychological functions. Cotzias observed
clinically (1969a) that the "mental effects" of L-dopa
treatment included "enhanced interest" and "improved
memory". Beneficial effects on "interest" or "attention"
were experimentally found by Puca et al . (1971), and by
Megna et al . (1971) but denied by Marsh et al . ( 1 9 7 7 )-
Significant improvement in memory had been confirmed by
Yernet et al. (1973), and by Megna et al. (1971), but
denied by Donnelly et al. (1973), and only partially
confirmed (i.e. only for 'intermediate' but not for 'short-
term' memory) by Marsh et al. (1971). Improvement in
general intellectual functioning (as measured on the
W.A.I.S.) was found by Beardsley et al. (1971), but not by
Vernet et al. (1973), nor by Donnelly et al. (1973).
Loranger et al. (1973) found a significant improvement on
the W.A.I.S. in their group of patients on retest after
one year. However, after 30 months of continuous
treatment, this improvement was not maintained.
There is perhaps only one finding common to the
present study and previous findings: L-dopa does not (at
least in the short-term) adversely affect higher mental
processes. Beyond this, clearly, there are contradictions
which need to be accounted for. Riklan (1973) has
criticised a wide spectrum of Parkinsonian literature for
its less than rigorous methods of control, and Donnelly
(1973) has emphasised the hazards of design that are
always present in a test-retest experiment. The present
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author is made uneasy by the tendency shown in the
articles cited above for ignoring variables in subject
selection. The present investigation has shown both
type of Parkinsonism and surgical history to be important.
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CHAPTER 10
EVALUATION/ CONCLUSIONS AND REFLECTIONS
The act of speaking involves highly sophisticated
sequences of a large number of muscle groups. Indeed,
speaking is perhaps the most complex of motor activities
performed by Man, yet its intricacy and delicate
patterning are obscured by the very frequency and apparent
effortlessness with which the activity is performed.
We cannot state exactly the number of muscles that
are necessary for speech and that are active during speech.
But if we consider that ordinarily the muscles of the
thoracic and abdominal walls, the neck and face, the
larynx, pharynx, and the oral cavity are all properly
co-ordinated during the act of speaking, it becomes
obvious that over 100 muscles must be controlled centrally.
Since the passage from any one speech sound to another
depends ultimately on differences in muscular adjustments,
fourteen times per second an "order must be issued to every
muscle," whether to contract, relax, or maintain its
tonus....it is clear, however, that the readjustment does
not occur simultaneously for all muscles, but that various
groups of muscles have characteristic timing; some are
active shortly before the acoustic onset of a phoneme,
some during, and some shortly after. Thus we gather that
the rate at which individual muscular events occur (through¬
out the speech apparatus) is of an order of magnitude of
several hundred events every second. It is evident that
the activation of so many muscles in such a short time span
cannot depend on volition alone. There must be some
automatisms - whole trains of events that are "preprogrammed"
and run off automatically. Automatic sequences such as
these are called synergisms; they form the basis of all
motor phenomena in vertebrates. The physiology of speech
production would be very simple if every phoneme were
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associated with one and only one pattern of muscular
interaction. However, this is not what we find. The
muscular activity associated with one phoneme is influenced
by the phonemes that precede and follow it. Thus.the motor
patterns ... a re comp1 ex.motor configurations that extend
over relatively long periods, as in the duration of a
sy11ab1e or word.
The intricacy of the problem becomes apparent if we
draw an analogy between the sequence of events during
speech and in drumming with the fingers on a table top.
Both proceed at a rapid rate, but when we drum out a
melody with our fingers, it does not matter in which order
each finger falls on the table. The easiest is to use a
single order, letting the sniail finger always be the first
and the index always the last. But in speech production
the order of activation and precise timing is of paramount
importance. (Lenneberg, 1967)
Clearly, even slight alteration in the motor system
will be reflected in disturbed performance. Furthermore,
the alteration may occur at any level of the system, from
the more central control areas to the muscles at the
periphery. For some time now, theoretical assumptions
about dysarthria have ceased to arouse the heated
controversy of former times: it is now appropriately
recognized that under the rubric "dysarthria" many kinds of
speech disturbance may be subsumed and that the disturbance
may be consequent upon lesions located centrally and/or
peripherally in the nervous system. Theory, however, is
not always reflected in practice, and this is nowhere more
apparent than in the area of Parkinsonian dysarthria.
With, perhaps, the exception of Leyser (1924), it has
always been assumed that the speech disturbances in
Parkinsonism are due to the rigid and tremulous state of
the muscles concerned. Speech pathologists and neurologists
alike have long considered the Parkinsonian dysarthria to
be no more than a manifestation of the disturbed state of
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the peripheral musculature. Those facts that are known,
however, in no way support this popular assumption.
Although in 1961 Canter demonstrated, contrary to
expectation, that neither the degree of rigidity nor the
degree of tremor correlated with the magnitude of the
speech disturbance, the most damaging evidence has come
from the field of neurosurgery. Repeatedly it was found
that stereotactic intervention which successfully reduced
tremor and rigidity did not have the predicted effect of
lessening speech disturbances. Moreover, in a substantial
number of patients who pre-operatively had had no trace of
dysarthria, stereotactic intervention actually induced
speech disturbances while at the same time successfully
reducing rigidity and tremor.
It is indeed puzzling that so contradictory a state
of affairs has persisted, and for so long. Perhaps the
reluctance to up-date an outmoded hypothesis is indicative
of the lack of concern with which dysarthria is still
regarded. As it stands, the evidence to date not only
overwhelmingly contradicts the popular assumption that
Parkinsonian dysarthria is due to the dystonia of the
periphery, but it also strongly suggests that, in
rethinking the question, attention should be directed
towards the central rather than the peripheral aspects of
the motor system.
But what is to replace the clearly erroneous popular
explanation of Parkinsonian dysarthria? Since two
elements of the Parkinsonian motor triad - rigidity and
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tremor - have been shown to bear little relevance to the
dysarthria, akinesia may be seen as a possible alternative.
Interestingly enough, in spite of the fact that over the
past few years the re-definition of Parkinsonism as a
dopamine-deficiency syndrome has precipitated an
unprecedented wave of interest in akinesia, no-one has
paid serious attention to the relationship between akinesia
and Parkinsonian dysarthria.
The present investigation was designed to test
precisely this relationship. In discussing the results
from this investigation attention will be drawn to three
aspects: an evaluation of the research hypotheses; the
clinical implication of the research findings; and,
finally, theoretical implications of the research findings.
EVALUATION OF RESEARCH' HYPOTHESES
HYPOTHESIS 1: The lesions which cause akinesia are
responsible for the speech disturbances of Parkinsonian
patients.
Of all the Parkinsonian symptoms, it is akinesia which
is least understood. Kinnier Wilson is generally recognized
as having introduced the term 'akinesia' to neurology, and
in particular to the area of the subcortical disorders.
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However, as de Ajuriaguerra (1971) pointed out, this was
no neologism of Wilson's. Long before Wilson Incorporated
the term in his 1925 articles to the Lancets Wernicke and
some psychiatrists had used the term 'akinesia' in
describing certain motionless aspects of catatonia.
Perusal of current neurology textbooks shows that
although the term is widely used, over the intervening
half century its scope of reference has become highly
restricted. It will be remembered that Wilson postulated
a dual motor system - a 'pyramidal* system which subserved
'voluntary' action, and an 'extra-pyrami da 1 ' system,
centering around the subcortical muclei, that subserved
more 'reflexive' (or, in Wilson's terminology,
'spontaneous') movement. 'Akinesia' is now conventionally
used to refer to symptoms arising from damage to this
'extra-pyrami da 1 1 system, to a loss of automatic and of
associated movements, and to those movements involved in
the expression of emotion. Used in this way, it is
difficult to conceive of any possible connection between
akinesia and dysarthria. Reference to Wilson's own
writing on the subject, however, clearly shows the current
usage of the term to be based on a misconstruction.
Wilson used 'akinesia' in a manner that reflected the
term's psychiatric origins. For him, 'akinesia' implied a
decrease of spontaneous as well as 'voluntary' movement.
It was due to a central lesion involving damage to the
'higher' control centres and resulting in "deprivation of,
or serious reduction in, normal impulses to movement, both
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of the voluntary and spontaneous kind" (Wilson, 1925).
Behaviourally, akinesia was manifest in slowness and
"poverty" of movement. The affected motor system appeared
to Wilson to lack "spontaneity" and "drive", and the
extremities themselves seemed "lazy" and required
"constant coaxing to activity".
The picture of disturbance provided by this
investigation clearly contains all the distinctive
features of akinesia Wilson described in his articles. The
two forms of motor behaviour studied (i.e., writing and
speech) displayed similar disturbances. There was a
substantial delay, in both modalities, before a motor
sequence was initiated. This delay could not be related to
'preparation planning time' since two of the measurements
were based on tasks involving wel1-practised sequences of
activity (writing name and address, and reciting 'rote'
speech sequences such as counting from one to ten and
naming the letters of the alphabet). Moreover, as the
confrontation naming task revealed, the delay in initiation
was related to neither the difficulty of the task nor to
the length of the required response sequence.
When movement did occur, it was seen to take longer
than 'normal' for its elaboration and to be less precise in
execution. Writing, for example, tended to be small,
'cramped' and not easily legible. All patients were
required to write in pencil and their writing produced
strikingly light or faint marks on the paper. The patients
themselves were highly critical cf their writing and
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acutely aware of its inadequacy as a means of communication.
A large proportion of the patients reported that
they had so organized their life style that they no longer
wrote anything at all. Speech revealed comparable
disturbances. It was soft. Words were elongated and
imprecise in articulation. Pauses and prosodic features
were markedly reduced and in some cases even absent. The
panel of judges considered the patients' speech not
easily understandable and only moderately effective as a
means of communication. Writing and speaking also showed
disturbances in the regularity of rate of execution. In
both modalities it was observed that the execution of a
sequence began slowly (after an initial delay), and then
rapidly accelerated ( 1 festination '). This acceleration
was sometimes followed by a prolonged pause ('freezing').
'Akinesia', according to Wilson, is clinically
independent of, and not to be confused with, rigidity; "No
constant relationship between the degree of peripheral
rigidity and decrease of spontaneity of voluntary movement
can be established, for the reason that the motor phenomena
under discussion are frequently found where muscular
rigidity is not a conspicuous feature" (Wilson, 1925).
Denny Brown (1962) has convincingly demonstrated, in
subhuman species, that lesions of the globus pallidus do
produce akinesia unrelated to rigidity. Findings such as
this, and clinical observation, have led him to take an
unequivocal stand regarding the nature and significance of
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akinesia. For Denny Brown, akinesia and not tremor or
rigidity, is the 'true' symptom of damage to the subcortex.
Perhaps the most compelling evidence of the independence
of rigidity and akinesia is to be found in the literature
reporting the results of stereotactic surgery for the
reduction of rigidity (and of tremor). Selby (T967), for
example, found that although in a high proportion of cases
rigidity (and tremor) is alleviated by stereotactic
placement of additional lesions in the subcortical ganglia,
akinesia is not similarly benefited. This is not an
isolated observation. Schwab et al . (1959) found that
akinesia may persist, or even increase after pallidectomy,
and Fager (1968) found that akinesia may be produced by
the very surgical lesions that reduce rigidity (and
tremo r).
In the present study, although all patients had at
least some degree of akinesia, twenty nine per cent of the
group had no rigidity at all (eighteen per cent had
'slight' rigidity, forty one per cent 'moderate' rigidity
and twelve per cent 'marked' rigidity). As has already
been said, all patients in the study had some degree of
akinesia. Only five per cent had a 'slight' degree of
akinesia, twenty seven had 'moderate' akinesia, and sixty
eight per cent had a 'marked' degree of akinesia. When
the speech recordings of these patients were played to the
panel of judges for evaluation, only two patients (five per
cent) were found to have no impairment at all on all five
scales. Clearly within this group there was a sizeable
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number of patients without rigidity but with akinesia and
speech disturbances. Moreover, only those two patients
with 'slight1 akinesia (one with marked rigidity, the other
with moderate rigidity) were found to have 'normal' speech.
Leading on from this last point, a final question,
arising from the first experimental hypothesis, needs to be
considered. Does the degree of speech disturbance vary
with the extent of subcortical damage, and hence the degree
of akinesia? The experimental evidence suggests that this
does appear to be the case. The experimental group was
such that although it comprised paralysis agitans patients'
(with the more circumscribed lesion/s) and post-encepha1itic
Parkinsonian patients (with more extensive, and possibly
more disseminated lesions), both types of Parkinsonism were
found to be associated with comparable degrees of akinesia.
Nevertheless, three of the experimental tasks revealed that
the degree of disturbance to complex motor sequences
varied significantly with type of Parkinsonism. Paralysis
agitans patients (irrespective of surgical history) were
found to be able to begin writing their name and address
sooner than post-encepha1itic patients; and paralysis
agitans patients were considered by the judges to speak
more intelligibly and with less dysarthria than post¬
encephalitic patients.
A significant difference in the degree of akinesia was
found between patients who had and those who had not
previously undergone stereotactic surgery. Patients with
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a surgical history were found to be significantly more
clinically akinetic than their unoperated counterparts.
On four experimental tasks unoperated patients were found
to perform significantly better than operated patients:
size of writing, time taken to write, intelligibility of
speech, and degree of dysarthria.
In brief, therefore, the evidence in support of the
first hypothesis is threefold. First, and perhaps most
importantly, the nature of the disturbances observed
complies fully with the listing of the distinctive features
of akinetic disturbance as described by Wilson, who
introduced the term. Secondly, the incidence of speech
disturbance in the experimental group overlaps more
closely with the incidence of akinesia than with the
incidence of rigidity. And finally, there does appear to
be some evidence to suggest that the degree of disturbance
to complex motor sequences such as writing and speaking
varies with the degree of akinesia.
HYPOTHESIS II: The lesions which occasion the speech
disturbance are biochemically mediated.
De Ajuriaguerra (1971), in an attempt to economically
define akinesia suggested that "akinesia is what L-dopa
modifies". Although this is a circular definition, it does
concisely summarise the current view of L-dopa and akinesia
(see Chapter 3). If the basic hypothesis of this investi¬
gation were correct, i.e. that the speech disturbances in
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Parkinsonism are akinetic, one would expect with L-dopa
treatment similar modifications both of the clinical
aspects of akinesia and the measures of speech disturbance.
The experimental results from this investigation provide
overwhelming support for this hypothesis. All patients in
the study showed at least some evidence of clinical
improvement, and it has been shown throughout the
preceding chapters of results, that the group as a whole
were found to have significantly less disturbed speech
after L-dopa treatment had reached maximum levels than
before treatment had commenced. With treatment, the speech
of the patients was judged to be more intelligible, less
dysarthric, to contain more prosoaic features, and to show
less phonic disturbance. Furthermore, their speech was
shown to be louder, and less monotonous. They were able
to sustain phonations for far longer than they had prior
to treatment. Their reading was more fluent and faster and
they were able to start speaking with 'normal' minimum
delay. On only one dimension of speech disturbance -
festination - was no improvement seen. Both the judges'
ratings, and the analysis of regularity in counting showed
that festination was not altered by L-dopa treatment.
Improvement in complex motor sequences was also found
in the other modality studied. After treatment, patients
were able to start writing sooner, to write larger and
more legibly than they had before treatment had begun.
All these changes in performance were at least at
the 5% level of confidence.
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When the four subgroups are considered separately,
it is seen that each responded differently to treatment.
TABLE 60 summarizes the changes in performance on all the
SUMMARY OF CHANGES WITH TREATMENT
SUBGROUP
PARAMETER GROUP AS
PA PE PA+OP PE+OP A WHOLE
SPEECH PARAMETERS
mean voice volume






























KEY: I = significant improvement.
B = improvement, but not at the 5% level
W = significant deteri orati on.
= no measurable change.
TABLE 60
test times for each subgroup. As can be seen from the table,
subgroup PA showed a significant improvement on eleven
items, improvement (but not significant) on one item, and
no deterioration at all. Thus on fifteen items, subgroup PA
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improved on twelve. Subgroup PE improved significantly on
nine items, but was worse with treatment on one item:
phonation/pause ratio. Subgroup PA+OP improved significantly
on only three items, showed some improvement on another two
and was seen to be adversely affected by treatment on the
phonation/pause ratio item. Subgroup PE+OP improved on
only two items. In addition, this subgroup showed
improvement, but not significant, on the size of writing,
and a significant deterioration on three items: festina-
tion, phonation/pause ratio and mean response latency.
The differences in modification of speech disturbances
in response to treatment are clearly related both to type
of Parkinsonism and to surgical history.
The differences are also related to the ratings of
degree of akinesia, and to the amount of clinical improve¬
ment. Before treatment had commenced, operated patients
were found, on clinical criteria, to be significantly more
akinetic than unoperated patients. Once treatment had
reached an optimal level, it was found that both operated
and unoperated patients showed similar degrees of clinical
improvement. From this it may be inferred, that despite
the fact that both groups improved with treatment (i.e.,
as far as clinical criteria are concerned), the relative
differences between them remained - unoperated patients
were less akinetic than operated patients both before and
after treatment. Type of Parkinsonism was also shown to be
important. Before treatment had commenced there was no
significant difference in the degree of akinesia shown by
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paralysis agitans and post-encephalitic patients. However,
on clinical criteria, paralysis agitans patients were found
to benefit significantly more than post-encephalitic
patients from L-dopa treatment.
The difference between subgroups, however, are not
related to the L-dopa dose level. As demonstrated in
Chapter 5, similar maximum dose levels were empirically
established for each subgroup.
There were a number of parameters investigated that,
as expected, showed no apparent deficit. Neither before
nor after treatment were the patients found to be less
successful than normals in correctly naming the objects in
the confrontation naming task. Furthermore, when the
patients did make errors on this task, the type of errors
were similar to the type of errors the controls made.
Again, the type of errors made by the patients was not
influenced by L-dopa treatment.
The results from the small battery of psychological
tests confirmed the impression formed from the patients'
performance on the confrontation naming test.
The patients were average on the two W.A.I.S. subtests-
'Digit Span' and 'Block Design'. Furthermore L-dopa
treatment had no measurable effect on performance on these
two tasks. L-dcpa treatment also did not affect the
patients' ability to recall verbal material. Recall
tested immediately and after an hour's delay was neither
enhanced nor reduced by treatment.
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GENERAL CONCLUSIONS
The present investigation has yielded unambiguous
support for the basic experimental hypotheses. There
seems little to contradict the hypotheses that the speech
(and writing) disturbances are akinetic in nature; that
the degree of disturbance to both speech and writing varied
according to the degree of akinesia; that the degree of
all these disturbances is closely related to both type of
Parkinsonism and surgical history, i.e. to differing
degrees of subcortical involvement; that these disturbances
are ameliorated by L-dopa treatment; and that the degree
of amelioration is related to both type of Parkinsonism
and surgical history, i.e. the degree of subcortical
involvement.
CLINICAL IMPLICATIONS OF THE RESEARCH FINDINGS
Although the present investigation was primarily
concerned with the nature of the speech disturbances
consequent upon subcortical lesions, the results do also
have practical, clinical relevance.
The results of this investigation have shown that
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L-dopa treatment is associated with a reduction of not
only the clinical aspect of akinesia, but also with a
- . . • Z1 SI I
reduction of the disturbances tof speech and to writing. ^
This is an extremely important finding. No other anti¬
parkinsonian treatment has been shown to benefit speech.
Surgery was found to be associated with an increased
disturbance to speech. In some cases, surgery was found to
actually induce speech disturbances (see Chapter 4).
Anti-cholinergic drugs apparently neither exacerbate nor
ameliorate speech disturbances (Schawb et al., 1959).
The investigation was 1 short-term' . The patients were
retested a few days after they had been stabilized on
their maximum dose levels. That improvement to speech and
writing is seen on retest suggests a) that the changes
observed are an immediate response to treatment, and, b)
that in order to obtain this effect, no more medication is
required than that which is needed to ameliorate the
clinical picture of akinesia.
Despite the fact that the immediate effect of
treatment is encouraging, it is not possible to predict
with confidence the long-term effects. It would be nafve
to expect that altering part of the amine chemistry of the
brain in either the short or the long term would have no
effect on other aspects of neurochemistry. As yet, our
knowledge of this area if not sufficiently advanced to
predict the possible effects of continued treatment.
Furthermore, the disease process is itself progressive.
Whether increasing degeneration will continue to be
312
counteracted by this form of treatment is by no means
clear. Long term studies are urgently needed.
The results of the present investigation have some
relevance to future studies. It has been demonstrated
that both type of Parkinsonism and surgical history are
important variables. Both before and after treatment,
differences between the four subgroups were observed on a
number of parameters. In Chapter 7, for example, it was
shown that not only did the severity of speech disturbances
vary with subgroup, but also that there were differences
in the pattern of the disturbances shown by the subgroups.
Moreover, throughout the investigation resuits have been
obtained that strongly indicate that response to treatment
varies with type of Parkinsonism and with surgical history.
Clearly, future studies cannot ignore these variables.
One can no longer assume that a homogeneous population is
subsumed under the rubric 'Parkinsonism'.
The patient population studies included patients who
had and those who had not previously undergone stereotactic
surgery. The design of the investigation was such that the
performance of operated and unoperated patients,
irrespective of type of Parkinsonism, could be compared
both before and after treatment. The results from these
analyses have direct clinical importance since apart from
a long term reassessment on clinical criteria by
Gillingham (1969), the present writer has been unable to
find any study which provides evidence of a long term
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follow-up of speech disturbances following surgery. Three
important conclusions may be drawn from these results:
1. The beneficial effects that stereotactic subcortical
surgery affords in reducing tremor and/or rigidity do not
last as long as ten years. No significant difference in
degree of tremor and/or rigidity could be found between
operated and unoperated patients in this study.
2. The unwanted effects of stereotactic surgery, i.e.,
increased akinesia and speech and writing disturbances
do, unfortunately, last as long as ten years .
3. Previous stereotactic subcortical surgery limits the
degree of improvement with L-dopa. Patients who had
undergone surgery showed less amelioration of speech and
writing disturbances as well as less reduction in the
clinical signs of akinesia than their unoperated
counterparts .
Clearly the behavioural consequences of subcortical
surgery are serious. Indeed, these results throw doubt
upon whether, ever again, surgery can be offered with
confidence and compassion as a method of treatment for
Parkinsonism. Further long term studies on this
particular implication of the present investigation are
urgently needed.
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THEORETICAL IMPLICATIONS OF THE RESEARCH FINDINGS
The control function for a sequence of movements
such as speech is very complex indeed. This was made most
apparent in the rather lengthy quotation from Lenneberg
at the beginning of this chapter. To postulate a single
level, single type of control system to account for the
extremely complex, delicately timed, highly organized
segments of motor sequences that are patterned to form, for
example, speech or writing, would be to grossly over¬
simplify the nature of the system. Clearly what is
required is not a unitary control system, but rather a
complex function elaborated at a variety of levels, and
comprising a variety of types or forms of control.
However, this investigation relates to only a specific
domain of this control system. We are concerned here not
with the quality of the movement sequence, i.e., for
example, the quality of the articulation of discrete
words, or the syntactic structure of utterances. What we
are concerned with is the timing or the regulation of the
numerous motor events that comprise the speech or writing
sequence. The central issue of this investigation
revolves around the temporal aspects of performance.
The temporal regulation of behaviour with which we
are concerned is non-specific. It is necessary for any
kind of motor sequence - walking, writing, speaking,
playing the piano or cricket, and so on. The present
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investigation has confirmed that both speech and writing
are similarly affected in Parkinsonism, and once L-dopa
treatment has reached an optimal level and clinical
i mpro vement, ' s itrli 1 a r changes in both modalities may be
seen. The control for motor sequences must therefore be
centrally located.
Movement has three discernible parts; an
initiation, a description, and a cessation. For its part,
the nervous system initiates and 'drives' the movement, it
collates information fed back through sensory and
proprioceptive pathways and, on the basis of this, guides
the movement through its description. Finally, at the
appropriate time, the nervous system ends the movement.
However, as Walshe pointed out (1948), the pyramidal
system, although usually accredited with the elaboration
of "voluntary" movement, is itself incapable of exerting
this central control alone. Instead,the 'pyramidal' system
functions in concert with the ' extra-pyramidal 1 system
and it is far more plausible to ascribe the control
function to this latter part of the nervous system.
Indeed, this older part of the system appears more than
adequately provided to act as a central control centre.
It consists of a number of nuclear masses interconnected
with each other and, through complex efferent pathways,
with diverse and important neural centres. It is
reciprocally connected with the very cells of the motor
cortex that give rise to the 'pyramidal' system, with the
main sensory relay station (the thalamus), and with the
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ascending reticular formation. It also exerts some
influence on the y-motoneurones of the periphery through
its (albeit small) rubrospinal tract. The multisynaptic
nature of this system, its diverse connections and many
'looping' pathways establish it as the physiological
servosystem at the centre of the nervous system and enable
it to exert intimate control through all three stages of
all types of movement.
The type of model that seems most appropriate to
describe how control of behaviour is normally elaborated
is a synchronous one. Lashley (1951) argued most
strenuously in favour of this type of control. More
recently, Lenneberg (1967) has dealt at length with this
topic, and after evaluating research findings from a
variety of areas, has given his support to a synchronous
model to describe the control function.
This model makes two important assumptions. The
first assumption is that there is a central time-keeping
mechanism that synchronizes the activity of subsystems or
"synergisms" in Lenneberg's terminology. The control clock
emits signals or pulses and the subsysterns synchronize
their activity with the rate of the central clock. This
type of model is often likened to the manner in which a
busy railway station functions. Trains enter and depart
from the station according to the preplanned times, laid
down in the timetable, and each train observes time
according to the station clock. The second assumption is
that, under normal conditions, the clock runs at a
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reasonable frequency. The periodicity of the clock can be
deduced,for example, from the rate of utterance obtained
in the present investigation - the periodicity of the clock
for speech appears to be 87 words per minute. The clock
may be "overridden". One can talk faster or slower.
Interestingly, however, this overriding results in a less
stable rate of output. One can talk faster, but it is
not with ease that one can talk faster for a prolonged
period. Without concentration, the speed of utterance
tends to rectify, and talking at the normal rate usually
soon occurs. Furthermore, it seems that the clock may be
overridden only in a crude fashion. It is only with
considerable concentration that one can speak at, say,
twice the normal rate of utterance.
Damage to this central clock would clearly produce
disorganized, free-wheeling behaviour. One would expect
difficulty in co-ordinating subsystems and this would be
manifest in erratic performance. Starting and stopping
activity would be difficult, since there would be nothing
for the numerous subsystems to pace themselves by. A
marked delay was observed in the initiation of both
writing and speaking in the (untreated) Parkinsonian
patients. The delay, however, was shown by the
confrontation naming test to be constant for a number of
different words. This finding clearly is not consonant
with the assumption of a disordered central clock, since
random time changes would be expected.
That the present results are not as one would predict
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by a disturbance to a central clock does not in any way
throw doubt on whether such a mechanism can be held to
describe normal function. What has been observed in this
investigation is not simple evidence that a central clock
is disrupted. This statement needs amp!ification.
It has long been the tradition to observe the
disturbance of function in patients with clearly located
neurological lesions in an attempt to understand more
fully the relationship between brain and behaviour. It
has been a tradition that has required much care and
awareness from the investigator lest he fall into any of
the logical pitfalls that litter the past history of this
area of enquiry. A number of the difficulties facing the
investigator centre around the essentially inferential
nature of the method of enquiry. The nervous system is
almost entirely inaccessible to direct observation. The
exceptions to this are trifling: the termination of one
nerve, the optic, can be seen, and, according to Gowers
(1886-1888), "some of the nerve-trunks in the limbs can
be felt, either in the normal state or when enlarged by.
disease". As a rule, the state of the nervous system can
be inferred only by the manner in which its work is done -
and this only with difficulty. Other difficulties concern
the nature of the disturbance in behaviour. It has long
been believed that any performance could be lost or
impaired, and that the type of defect produced depended on
the location of the lesion. The relationship between
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disturbance to performance and location of the lesion,
however, is not quite so simple nor quite so transparent.
Kurt Goldstein, working in the field of asphasia,
. I ■
considered this very problem. In his book, Language and
Language Disturbance (1949), he poses the question : " . . .we
are first of all confronted with the general theoretical
problem of whether and how far we are justified in
assuming such a relationship of simple causality between
lesion and symptorn/s : Are symptoms, i.e.3 modifications
of behaviour, the direct expression of a definite
disturbance of function, or are there other factors
involved which at least contribute to the production of
symptoms?" Later in his book, after reviewing the
literature, Goldstein makes his conclusion quite clear:
The survey regarding the factors determining the
configuration of symptoms in brain damage has shown that
symptoms are only partly the direct results of the damage.
It has further become evident that, to a greater or lesser
degree, the symptoms are an expression of the organism's
struggle with the defect in its attempt to adjust itself
in spite of some interference by the defect. The symptoms
become (understandable only from the. organismic point of
vi ew "
Although the name of Goldstein is most frequently
associated with this particular point of view, he is not
alone. Henry Head, for example, also emphasised the
essential functional plasticity of the nervous system:
The various disorders of speech produced by injuries
of the brain manifest in the ways in which the organism
masters a situation, demanding the use of language, with a
defective mechanism. A certain form.of behaviour becomes
necessary as a sequel to certain external or internal
events: some normal faci1ity is disturbed by.the presence
of the lesion and the orderly exercise of a series of
functions suffers in consequence. A new attitude must be
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assumed; for the patient has to face a familiar situation
with an imperfect apparatus. It is as if he were compelled
to play lawn tennis with a broken racquet; many of his
favourite strokes will become impossible and he will have
to vary his conduct in accordance with the defective
instrument in his hand. . . . . . .
The movements he adopts in consequence of these
unusual conditions do not form integral parts of his normal
method of playing the game. A man who.has a pain in his
toe walks differently from one whose heel is affected.
But neither gait reveals the elements out of which normal
walking is composed.
There are a number of control models that can be
advanced as alternatives to the central clock model. The
model that appears most appropriate to the results of
this investigation is an asynchronous control model. This
type of model does not assume a central time-keeping
mechanism (hence its name). Instead, this model is based
on the assumption that the various subsystems pace
themselves by signalling to each other that an event is
just about to happen, or that an event has just occured.
These inter-subsystem signals are usually alikened to
"handshakes" between subsystems. Coherence and synchrony
of this type of model clearly depend upon these inter-
subsystem signals .
An asynchronous model is readily translatable in terms
of the known neurology of the subcortex. There is
overwhelming evidence that a decrease in striatal dopamine
is an almost invariable factor in the pro duction of the
Parkinsonian syndrome. The literature on this subject has
been dealt with in Chapter 3. Let it suffice to merely
point out here that dopamine applied microelectrophoretically
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leads to inhibition in many neurones in the caudate nucleus
(Bloom et al., 1965). Mettler (1945) has shown, in apes,
that bilateral lesions of the caudate nucleus produce over¬
activity, or hyperkinesis. The principal outflow from the
striatum is to the pallidum which lies in the efferent
pathway, from the thalamus, for movement. According to
Mettler (1967) the striatum normally functions to inhibit
these thaiamopal1idal circuits. Experimental evidence
supports this claim. Purpura et al. (1967) for example
have shown that stimulation of the caudate inhibits the
outflow of impulses from the pallidum. Interestingly, and
highly relevant here, are studies by Van Buren (1963)
demonstrating the behavioural consequences of such
stimulation. During subcortical stereotactic surgery on
Parkinsonian patients, they stimulated the head of the
caudate nucleus and found this induced a "basic
disturbance in which the impulse to speak or to continue
another task has been dulled or forgotten".
All these studies suggest that the integrity of the
striatum is crucial for inter-subsystem transmissions.
Damage to the striatum results in a diminution of its
inhibitory influence on the spontaneous activity of
pallidalthai amic circuits. Under these conditions, inter-
subsystem transmission would clearly be extremely
difficult. The signal-to-noise ratio of any "signalling"
would be poor. Prolonged bombardment of signals may be
necessary in order to be "perceived" by the receiving
subsystem or subsystems.
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This type of model accounts for the delayed
initiation of motor sequences, and for the changes
observed within the sequence - the elongated words
separated by shortened pauses. It explains why the judges
considered the speech of patients as being imprecisely
articulated. It also 'explains the reduction of prosodic
features, since many of these are temporal suprasegmental
patterns. This type of model can also account for the
changes observed following L-dopa treatment. L-dopa
treatment, in restoring striatal dopamine would enable
striatal inhibition to be re-established. The
behavioural consequences of this can readily be deduced
since the signal-to-noise ratio of the system would be
increased, andinter-subsystem transmission facilitated.
This type of model, however, does not account for
festination. Interestingly, L-dopa treatment did not have
an appreciable effect on festination when all the patients
are considered together. However, the judges' ratings of
festination suggest that, with treatment, PE+OP were
significantly more festinant. This type of model also
does not account for the divergent results from the word-
pause ratio analyses. With treatment, subgroup PA, the
subgroup with the least subcortical damage, perform
qualitatively differently from the three other subgroups,
all of which had greater subcortical involvement.
There is one particular study reported in the
literature that has relevance here. Guiot et al . (1961)
found that on stimulating the ventrolateral (VL) thalamic
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nucleus they were able to disrupt speech. They either
slowed down or accelerated their patients' counting. These
results suggest disturbance to the ventrolateral nucleus
fundamentally disrupts a central clock mechanism. That
the VL was a favoured site for stereotactic surgery, and
that this results both in increased akinesia (Fager, 1 968),
and in increased speech disturbances (see Chapter 4) pro¬
vides additional support for the view that the VL nucleus,
which has also been a favoured surgical target, are
intimately bound up with the central regulation of
performance.
The Guiot results suggest that the central clock
mechanism (that so well accounts for normal functioning)
is not destroyed, but rather disrupted. The disruption
does not appear to be simple. Festination is a complex
disturbance. There is a delayed initiation; a slow,
laborious beginning to a sequence of movements; and,
there is a gradual acceleration of the sequence. The
results of the present investigation have shown this
acceleration to be linear. The type of behaviour
described here is highly suggestive of the performance by
a 'stable' system which is sluggish in responding. In
order to actually respond, the system needs to be adjusted:
its threshold-to-respond needs to be lowered to a critical
'trigger' level. This could be achieved through positive
feedback. Once the system is in operation, however, a
progressive acceleration of each successive segment of the
sequence is observed. This is suggestive of continued
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positive feedback activity. Clearly further investigations
of the role that the VL nucleus and of (for our present
purposes) its most important connection with the pallidum,
is required. McLennan (1971) has suggested that the
chemistry of the ventro1atera1 nucleus is complex, but not
critically dependent on dopamine. The nucleus receives
fibres not only from the pallidum but from the cerebellum
as well. Although the chemistry of the fibres is not yet
known, it is known that these fibres have an excitatory
effect on the nucleus. As pointed out in Chapter 2, ACh
and noradrenaline both act as neurotransmitters in
circuits from the ventrolateral nucleus to the
(mesencephalic) reticular formation. Interestingly, ACh
is implicated in the excitatory circuits, and
noradrenaline, which is related to dopamine, in the
inhibitory circuits.
To summarize: normally behaviour is regulated
centrally and all behaviour is monitored and co-ordinated
in synchrony with a central clock. In Parkinsonism the
clock is disrupted. It is suggested that the VL nucleus
of the thalamus and the pallidum and the striatum are all
fundamentally implicated in the disruption. In order for
the damaged system to function at all, of necessity it
needs to re-establish an adequate control mechanism. It
is argued that an asynchronous control model could most
readily account for the type of control function that is
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established in a system damaged by Parkinsonian-producing
lesions. This type of model would account for the
phenomena observed both before and after treatment.
Dopamine is a transmitter substance. No claims can
sensibly be made that L-dopa treatment is able to totally
ameliorate the disturbances of Parkinsonism. To redefine
Parkinsonism as a dopamine deficiency syndrome is to
partially explain the pathology. The degree to which
L-dopa is able to benefit performance is clearly shown in
this investigation. L-dopa helps the damaged system
perform more efficiently without engendering any functional
reorganization approximating to normal function.
Irrespective of whether dopamine is replaced or not, the
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Periodicity of Speech in Parkinsonism
Impairment of speech, leading sometimes to unintelligibility,
was recognized by Parkinson1 to be part of the disease which
now bears his name. Reduced voice volume, dysarthria and
prosodic monotony are common manifestations of Parkin¬
sonism2 and are generally attributed to hypokinesis, a cardinal
feature of the disease, the physiological basis of which is ill
understood. The term itself is difficult of definition, but it is
generally thought to imply a delay in initiation of movement
combined with slowness and restriction in amplitude of move¬
ments once initiated.
Quantitative assessment of hypokinesis is difficult but an
objective analysis of speech function offers a basis for investiga¬
tion. Joshua Steele3 emphasized the importance of pauses in
the rhythm of speech. Little study has been made of the
relationship of sounds to pauses in the speech of Parkinsonian
patients. L-Dopa in large oral doses has been shown by many
investigators to ameliorate Parkinsonism and particularly to
improve the hypokinetic defects thereof. We have studied the
periodicity of phonation and pauses in patients suffering from
Parkinsonism and the alterations produced in these parameters
i by treatment with L-dopa.
Twenty Parkinsonian patients, aged between 41 and 76, were
investigated. Sixteen suffered from the idiopathic disease,
paralysis agitans, and two of these had earlier been treated by
bilateral stereotactic thalamotomies. The remaining four
patients suffered from the post-encephalitic form of Parkin¬
sonism. All derived perceptible benefit from treatment with
l-dopa as gauged by their general functional capacity and
mobility4. This was the only criterion for inclusion. Patients
were not selected because of the nature of their speech defect,
nor because of a specifically noteworthy improvement in
speech function. They were all observed in hospital during the
period of treatment. Recordings of their speech were made
before treatment was instituted, and again when clinically they
were adjudged to have improved, usually after taking l-dopa
for 3 or 4 weeks.
Extensive studies of spontaneous speech and reading were
made at each recording session after an introductory conver¬
sation designed to minimize the inhibitions attendant on the
test situation. During each session the patient was asked to
count from one to ten, with no instructions about loudness or
the rate of utterance required. We thought that counting to ten
would be the most apposite test for a study of speech periodicity.
It is a universally familiar activity with constituents which are,
with one exception, monosyllabic. In the act of counting there






















Fig. 1 Diagram of signal detector.
punctuation delays. CountingconformstoHughlingsJackson's5
"automatic" utterance. It is, therefore, virtually free of those
hesitations consequent on the formulation of "superior" or
propositional speech which have been extensively studied by
Goldman Eisler6.
The recordings were played through a signal detector which
was triggered by sound (Fig. 1). For accurate measurements of
phonations this apparatus required that the patient's speech
should be at least 20 dB louder than the background noise level.
This provided a signal of 10 V, the input threshold of the
detector being IV. In practice these conditions were achieved.
The initial delay to production of the first digit was not
assessed. The phonation times for each of the ten digits and the
duration of each of the nine intervening pauses were measured.
When, as occasionally occurred, two phonations ran together
without detectable pause, the total phonation time was halved
and this value was allotted to each digit. Means and standard
deviations for the duration of each phonation and each pause
were calculated for each patient before treatment was started
and again while on l-dopa, and the results are shown in
Table 1.
These data show that the mean phonation time for single
digits decreased significantly (P<0.01) after treatment (339± 85
ms) compared with the pretreatment figure (389 ± 107 ms). In
addition the variability of the phonations was reduced. Before
treatment the standard deviations of individual patients give
a mean value for the group of 139 ± 55 ms. After treatment the
corresponding figure is 108 ±36 ms. The change is significant
at the 1% level. After treatment the mean duration of each
pause (440±227 ms) was longer than the mean in untreated
patients (372± 194). This difference, however, is significant at
only the 10% level of confidence.
Six patients, 2, 5, 13 and 20, who had suffered from the
post-encephalitic form of Parkinsonism and 8 and 19 who had
earlier undergone bilateral thalamotomies, were assessed
clinically as showing little or no improvement in their speech
after treatment with L-dopa. If they are subtracted from the
group then the lengthening of the duration of pauses in the
remainder becomes significant at the 1% level. There is too an
apparent narrowing of the variation of the pause durations.
Before treatment the mean of the standard deviations for the
2
Table 1 Duration of Phonation of Parkinsonian Patients before and
after Treatment with L-dopa
Patient Duration of phonations Duration of pauses
No. (ms) (ms)
Before After Before After
treatment treatment treatment treatment
Mean s.d. Mean s.d. Mean s.d. Mean s.d.
1 689+199 522+125 382+ 149 638 + 80
2 398+ 153 260+ 126 569+ 157 480+ 142
3 428+104 408 + 95 430+114 411 + 108
4 245 + 142 230+103 138 + 74 394+68
5 415+142 405 + 95 172+ 100 152 + 78
6 314+106 404+126 640+144 827+192
7 305 + 87 322+70 650+142 750+150
8 302+116 242 + 56 470+195 203 + 50
9 366+115 283 + 101 520+ 90 688 + 70
10 320+ 112 261 + 132 705 + 133 493+113
11 464 + 82 255 + 61 328+ 181 504+114
12 315+123 285 + 98 617 + 332 722+184
13 285+ 128 286+106 302 + 138 155 + 45
14 385 + 1 10 330+120 265 + 128 330+149
15 368 + 199 350+110 216 + 72 205 + 93
16 588+182 473 + 71 355+ 138 708+118
17 366+168 336+93 101 + 36 365+154
18 496 + 85 483 + 118 158 + 75 211 + 100
19 415 + 321 350 + 222 132 + 97 86+33
20 320±106 302±139 288 ±72 475 ± 84
Group 389+107 339 ±85 372 ±194 440±227
whole group of twenty patients is 128 ± 62 ms; after treatment
106 ±44 ms. However, this apparent change does not achieve
significance at the 10% level of confidence.
Estimates of the rates of speech during counting can be
derived from these results. In patients before treatment the
mean rate was eighty-nine words per minute, and after treat¬
ment eighty-eight words per minute. These figures are sur¬
prisingly similar to the average rate of eighty-seven words per
minute which we found in twenty subjects, matched for age,
who suffered from no neurological lesion and who were asked
to count from one to ten in similar conditions to the Parkin¬
sonian patients.
The speech ofmost of the patients in this group became more
intelligible after treatment with L-dopa. Improvement in voice
volume and in dysarthria contributed to this, but the changes in
periodicity shown above are also important. The rate of speech
does not alter, but each digit takes a significantly shorter time
for its utterance and is separated from its preceding and
following numbers by lengthened pauses. There is too a
tendency for both phonations and pauses to be more regularly
distributed after treatment. Shorter, crisper sounds separated
by better defined pauses would be expected to improve the
3
clarity of speech, and so they do. These results are compatible
with the observations of others7 about the improvement of
speech function in Parkinsonian patients treated with L-dopa.
They indicate that this improvement is particularly manifest
in patients with paralysis agitans. There is a suggestion, which
needs further study, that in those patients with the post¬
encephalitic disease and in those who have undergone stereo¬
tactic thalamotomy, L-dopa may be less effective in improving
speech.
The concept of motor deficit in Parkinsonism as a simple
slowing and paucity of movements is inadequate to explain
these observed changes in speech periodicity. The more rapid
phonations are explicable on the basis of rectification of hypo-
kinesis; but the greater separation of phonations which our
results suggest implies a process more complex than a mere
speeding up ofmotor activity. Nor is this consideration peculiar
to speech function. The gait of many Parkinsonians is rapid
even though the individual steps be short. Indeed, some
patients show a tendency to involuntary acceleration, or
festination, of their gait. In such patients L-dopa often produces
not a more rapid progress but a more controlled gait, longer
steps being taken more slowly. As Denny-Brown8 has pointed
out, there is in Parkinsonism a defect in the general quality of
motor performance.
It is interesting to speculate, in the light of recent biochemical
and physiological findings on the underlying mechanisms of the
speech disturbances and their amelioration by L-dopa. There
is overwhelming evidence that a decrease in striatal dopamine
is an almost invariable factor in the production of the Parkin¬
sonian syndrome9'10. Dopamine applied microelectro-
phoretically leads to inhibition in many neurones in the caudate
nucleus11.
Mettler12 has shown that bilateral lesions of the caudate
nuclei in apes produce over-activity, or hyperkinesis, which is
driven by proprioception impulses. The principal outflow from
the striatum is to the pallidum which itself lies in the efferent
pathway from the thalamus for movement evoked by proprio¬
ceptive impulses. Purpura et a/.13 have demonstrated that
stimulation of the caudate inhibits the outflow of impulses from
the pallidum. Mettler14 concludes that the striatum normally
inhibits the thalamopallidal circuits and hence allows the
organism to make choices and not to be dominated by sensory,
and particularly proprioceptive, stimuli.
Lenneberg15 postulates that if delays are introduced into a
feedback monitoring system for speech the cues for the
beginning of the next cycle of activity are delayed and hence
there is a prolongation of the ongoing motor activity. This
leads to a drawing out of vowels.
We suggest that the principal lesion in Parkinsonism lies in
the striatum, the malfunction of which releases the thalamo¬
pallidal circuit from inhibition and hence kinaesthetic inform-
4
ation from the speech organs is submerged in random proprio¬
ceptive impulses. The choice of the next pattern of motor
activation is delayed because of this confusion of information
which effectively leads to the prolongation of the ongoing
phonation. Restoration of the inhibitory striatal action, by
activation of dopaminergic neurones, restores a more rapid
selection of the cues for the next stage ofmotor activation, thus
shortening the phonation times for individual words and
lengthening the pauses. This hypothesis ignores the effect of
auditory feedback which would, of course, be normal in most
Parkinsonian patients. It seems likely, however, that kin-
aesthetic impulses from the muscles of the speech organs
function as a monitoring mechanism, additional to auditory
feedback, for spoken speech. Such a theory fits the facts of our
observed data.
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